TE-4::Lestaurtinib
LB647-SCLC::Daporinad
NCI-H1623::AZD3759
AU565::Afuresertib
NOS-1::Talazoparib
RT-112::GDC0810
LB2241-RCC::GDC0810
WM-115::Vinorelbine
DMS-114::LJI308
LB2241-RCC::CCT-018159
NCI-H1993::BMS-536924
CPC-N::Fulvestrant
A388::Picolinici-acid
KCL-22::Camptothecin
KP-4::Bosutinib
A388::Veliparib
OCI-M1::Dasatinib
NALM-6::JQ1
LU-135::EPZ5676
CAL-29::Navitoclax
OCI-M1::KU-55933
NUGC-4::Tanespimycin
UMC-11::OF-1
D-566MG::Entinostat
CPC-N::AZD5582
CHP-134::OTX015
NCI-H1993::EHT-1864
LB2241-RCC::PF-4708671
AU565::Sepantronium bromide
JHOS-3::Nilotinib
D-566MG::BX795
DMS-114::Alisertib
NOS-1::Lenalidomide
U031::Pictilisib
NALM-6::MIM1
NCI-H1623::Dactolisib
EFO-21::PD0325901
AU565::XAV939
GA-10::Gefitinib
CHP-134::NVP-ADW742
GA-10::AZ960
KGN::Luminespib
EW-22::Alpelisib
JHOS-3::Telomerase Inhibitor IX
U031::Leflunomide
A388::Tamoxifen
Becker::TW 37
MEL-HO::Luminespib
NOS-1::SB216763
KP-4::SGC0946
JHOS-3::WEHI-539
KCL-22::PRIMA-1MET
LB647-SCLC::Erlotinib
RT-112::Trametinib
RT-112::Crizotinib
A388::Oxaliplatin
SN12C::PFI-1
CPC-N::Tanespimycin
LS-1034::SB590885
DMS-114::GSK2578215A
UMC-11::Niraparib
CP50-MEL-B::AZD8186
DMS-114::Rapamycin
EFO-21::BMS-536924
LB2241-RCC::Refametinib
GA-10::Talazoparib
NCI-H1993::Venetoclax
UMC-11::Picolinici-acid
A388::BX795
KARPAS-620::SN-38
HCC1143::PRIMA-1MET
KARPAS-620::GSK2830371
HCC1143::Venetoclax
UMC-11::MN-64
RT-112::Palbociclib
A388::MK-8776
KARPAS-620::Taselisib
NUGC-4::VE-822
EFO-21::GDC0810
KGN::Wee1 Inhibitor
SN12C::YK-4-279
GA-10::PD0325901
LC-2-ad::Cyclophosphamide
HCC1143::Entospletinib
DMS-114::Obatoclax Mesylate
TE-4::Pyridostatin
DMS-114::Wnt-C59
NUGC-4::WIKI4
SU8686::Pyridostatin
CHP-134::KRAS (G12C) Inhibitor-12
EFO-21::Obatoclax Mesylate
EW-22::PCI-34051
KARPAS-620::YK-4-279
NOS-1::PRT062607
LU-135::Dinaciclib
LB2241-RCC::SL0101
Becker::Gefitinib
LC-2-ad::PF-4708671
CP50-MEL-B::PRIMA-1MET
U031::Temsirolimus
U031::NVP-ADW742
GA-10::Cediranib
NALM-6::AZD4547
TE-4::PRT062607
KGN::Alpelisib
GA-10::Dasatinib
RT-112::Veliparib
KP-4::Rucaparib
LS-1034::BMS-345541
CP50-MEL-B::GSK343
NALM-6::BI-2536
NUGC-4::Cisplatin
NCI-H1993::Afuresertib
LC-2-ad::Wee1 Inhibitor
DMS-114::AZD8186
Becker::XAV939
KGN::Ribociclib
DMS-114::MK-2206
LC-2-ad::AZD8186
ESO51::AZD8055
EW-22::GDC0810
HPAF-II::Foretinib
EFO-21::AZD7762
A388::Rucaparib
D-566MG::Avagacestat
HCC1143::VE821
NOS-1::Serdemetan
NOS-1::GSK2606414
NOS-1::GSK343
LB647-SCLC::AZD5582
HPAF-II::Taselisib
JHOS-3::CHIR-99021
KP-4::LY2109761
KARPAS-620::Savolitinib
A388::Sapitinib
LB647-SCLC::MG-132
CPC-N::TW 37
U031::Tamoxifen
EW-22::LJI308
KP-4::Afuresertib
HPAF-II::Dinaciclib
TE-4::Cytarabine
JHOS-3::SL0101
Becker::GSK2606414
NALM-6::5-Fluorouracil
WM-115::Cytarabine
WM-115::Leflunomide
HCC1143::SGC0946
LB2241-RCC::WZ4003
NCI-H1623::AZD4547
CPC-N::Sabutoclax
A388::Ibrutinib
NUGC-4::Ipatasertib
CAL-29::Picolinici-acid
KP-4::AZ960
LB647-SCLC::Trametinib
KARPAS-620::Rapamycin
D-566MG::Motesanib
NALM-6::Pictilisib
NUGC-4::Camptothecin
LB2241-RCC::Cyclophosphamide
HPAF-II::Venetoclax
KGN::Cediranib
HCC1143::Uprosertib
HPAF-II::Linsitinib
EFO-21::Nutlin-3a (-)
KCL-22::Trametinib
GA-10::Lenalidomide
LB2241-RCC::MN-64
MEL-HO::PRIMA-1MET
SU8686::Pevonedistat
NUGC-4::Gefitinib
D-566MG::Rucaparib
A388::Afatinib
KARPAS-620::KU-55933
AU565::Dactolisib
ESO51::Erlotinib
LB647-SCLC::Rucaparib
KGN::AGI-5198
LU-135::AMG-319
AU565::Rucaparib
CPC-N::LCL161
CPC-N::IWP-2
LS-1034::Paclitaxel
CPC-N::SCH772984
JHOS-3::AZ960
LU-135::KRAS (G12C) Inhibitor-12
ESO51::UMI-77
ESO51::MK-2206
HCC1143::Entinostat
NCI-H1623::Temsirolimus
LU-135::Trametinib
JHOS-3::IWP-2
OCI-M1::MN-64
EW-22::MN-64
TE-4::LJI308
HPAF-II::Dactolisib
SIMA::OSI-027
KP-4::SB216763
SIMA::Erlotinib
NOS-1::Savolitinib
KARPAS-620::Avagacestat
JHOS-3::BMS-345541
Becker::Foretinib
LC-2-ad::Alpelisib
KGN::Linsitinib
WM-115::SB590885
GA-10::GSK2578215A
MEL-HO::Taselisib
LU-135::ABT737
MEL-HO::AGI-5198
LC-2-ad::Rapamycin
MEL-HO::MIRA-1
CAL-29::Ipatasertib
KCL-22::IWP-2
LB2241-RCC::PFI3
MEL-HO::Dasatinib
GA-10::GNE-317
U031::Crizotinib
KARPAS-620::Linsitinib
Becker::Cediranib
LS-1034::GSK2830371
D-566MG::LY2109761
CPC-N::NVP-ADW742
NCI-H1623::Sabutoclax
D-566MG::Docetaxel
NCI-H1623::Dinaciclib
RT-112::Bosutinib
LS-1034::Serdemetan
SN12C::AZ960
A388::Entospletinib
CPC-N::MIM1
KCL-22::OSI-027
NALM-6::Ipatasertib
AU565::Docetaxel
A388::Sorafenib
NUGC-4::Pyridostatin
Becker::Wee1 Inhibitor
LS-1034::Motesanib
LS-1034::Veliparib
KARPAS-620::Dactolisib
NOS-1::Sapitinib
LS-1034::NU7441
NCI-H1623::Erlotinib
CHP-134::PD173074
NCI-H1993::KRAS (G12C) Inhibitor-12
D-566MG::Bicalutamide
LS-1034::AZ6102
Becker::Linsitinib
RT-112::Sorafenib
JHOS-3::SGC0946
D-566MG::OSI-027
AU565::PLX-4720
KARPAS-620::Crizotinib
HCC1143::SB590885
LC-2-ad::CHIR-99021
CAL-29::Bortezomib
MEL-HO::Vinorelbine
HPAF-II::SCH772984
HPAF-II::GSK591
EW-22::AZD8186
JHOS-3::Entospletinib
JHOS-3::Palbociclib
NUGC-4::PFI-1
TE-4::Telomerase Inhibitor IX
TE-4::GSK343
KARPAS-620::Methotrexate
MEL-HO::SL0101
SU8686::WZ4003
KGN::Cytarabine
NCI-H1623::Bortezomib
JHOS-3::Alpelisib
NOS-1::AZD6738
EFO-21::Linsitinib
CAL-29::WIKI4
KCL-22::GSK591
A388::Crizotinib
KP-4::OTX015
RT-112::AZ6102
LC-2-ad::Cediranib
KP-4::Cediranib
KP-4::GSK2830371
NCI-H1623::Talazoparib
GA-10::Sepantronium bromide
D-566MG::BMS-345541
NUGC-4::CZC24832
AU565::AZ960
SN12C::PD173074
EW-22::Luminespib
NUGC-4::Foretinib
SN12C::PCI-34051
DMS-114::Tamoxifen
Becker::Nilotinib
SIMA::Dabrafenib
U031::JQ1
KARPAS-620::Pyridostatin
DMS-114::Osimertinib
RT-112::GSK1904529A
Becker::CCT007093
SIMA::Avagacestat
EW-22::Tamoxifen
D-566MG::Tozasertib
LS-1034::Niraparib
Becker::ABT737
SU8686::Ribociclib
NCI-H1623::Ribociclib
LC-2-ad::WZ4003
LS-1034::Luminespib
NCI-H1993::SB590885
KCL-22::BIBR-1532
U031::Doramapimod
NCI-H1993::Erlotinib
NALM-6::Palbociclib
GA-10::Entospletinib
KARPAS-620::Cytarabine
SU8686::GSK2606414
MEL-HO::AZD7762
LS-1034::MK-1775
UMC-11::Olaparib
AU565::Tozasertib
KP-4::SN-38
NOS-1::Bleomycin (50 uM)
SU8686::MK-1775
JHOS-3::CCT-018159
KGN::ZM447439
SIMA::PRT062607
KP-4::Avagacestat
LC-2-ad::AMG-319
CAL-29::Irinotecan
Becker::Dabrafenib
NUGC-4::AGI-5198
MEL-HO::GSK2578215A
NCI-H1993::CZC24832
HPAF-II::GSK2606414
D-566MG::Irinotecan
MEL-HO::VE-822
NCI-H1623::Selumetinib
SIMA::AGI-5198
EFO-21::Palbociclib
SU8686::BMS-345541
KARPAS-620::IWP-2
NUGC-4::LJI308
WM-115::Pyridostatin
DMS-114::WEHI-539
NALM-6::Vinorelbine
LS-1034::Leflunomide
KP-4::AZD4547
LB2241-RCC::Selumetinib
U031::GSK1904529A
LS-1034::Tanespimycin
KCL-22::RVX-208
A388::GW441756
LU-135::Bosutinib
GA-10::GSK591
U031::Selumetinib
CPC-N::GSK2578215A
NALM-6::CZC24832
KARPAS-620::Vorinostat
DMS-114::5-Fluorouracil
NALM-6::OF-1
NCI-H1993::Sepantronium bromide
EW-22::Cisplatin
EFO-21::Lestaurtinib
LB2241-RCC::WIKI4
SN12C::Ruxolitinib
LB647-SCLC::IOX2
SN12C::Oxaliplatin
NALM-6::NU7441
NOS-1::BMS-345541
UMC-11::GSK2578215A
LS-1034::AGI-5198
KARPAS-620::SGC0946
U031::BX795
NOS-1::VX-11e
LC-2-ad::EPZ004777
KARPAS-620::VX-11e
NUGC-4::Niraparib
LU-135::LY2109761
LU-135::WZ4003
EW-22::BIBR-1532
A388::ZM447439
KP-4::MN-64
DMS-114::Cediranib
SU8686::Gefitinib
CP50-MEL-B::EPZ5676
HCC1143::WEHI-539
KCL-22::Methotrexate
NCI-H1993::P22077
A388::LCL161
SU8686::PCI-34051
CP50-MEL-B::BIBR-1532
SU8686::Lenalidomide
JHOS-3::AZD6738
KGN::Pevonedistat
ESO51::Lenalidomide
GA-10::AZD4547
Becker::Temozolomide
RT-112::PRIMA-1MET
NUGC-4::PD173074
EW-22::Motesanib
HPAF-II::RO-3306
AU565::Irinotecan
LS-1034::I-BET-762
A388::Wnt-C59
KCL-22::PLX-4720
LU-135::I-BET-762
SU8686::MIRA-1
LC-2-ad::XAV939
AU565::SB590885
U031::Ipatasertib
KARPAS-620::MK-1775
UMC-11::MIRA-1
RT-112::Nilotinib
LB647-SCLC::Sapitinib
HCC1143::LY2109761
WM-115::Dinaciclib
OCI-M1::Ribociclib
LS-1034::Wnt-C59
EW-22::Uprosertib
SN12C::Gemcitabine
EW-22::GSK1904529A
AU565::GSK2830371
NCI-H1993::Pyridostatin
JHOS-3::Sabutoclax
NALM-6::MK-8776
SU8686::Vinorelbine
LB647-SCLC::PRIMA-1MET
D-566MG::P22077
NCI-H1623::Entinostat
SIMA::ABT737
LB647-SCLC::MK-8776
LU-135::OTX015
WM-115::Entospletinib
NUGC-4::EPZ5676
SIMA::Savolitinib
SN12C::Dabrafenib
OCI-M1::AZD7762
LS-1034::CZC24832
LC-2-ad::Irinotecan
EFO-21::JNK Inhibitor VIII
TE-4::Afatinib
SU8686::AZ960
KGN::Crizotinib
HCC1143::Olaparib
NALM-6::Lapatinib
GA-10::PLX-4720
D-566MG::Wee1 Inhibitor
NUGC-4::Erlotinib
WM-115::PFI-1
LU-135::UMI-77
EW-22::Lestaurtinib
LC-2-ad::MIRA-1
NOS-1::PRIMA-1MET
OCI-M1::EHT-1864
TE-4::Sepantronium bromide
LU-135::Pevonedistat
CAL-29::ZM447439
LS-1034::PRT062607
UMC-11::PRT062607
CHP-134::EPZ004777
JHOS-3::Dasatinib
NCI-H1623::SCH772984
NUGC-4::Bleomycin (50 uM)
OCI-M1::Palbociclib
KCL-22::Navitoclax
SIMA::CZC24832
NCI-H1623::CCT007093
NALM-6::SCH772984
LU-135::Vorinostat
EFO-21::Veliparib
WM-115::AGI-6780
U031::WZ4003
NOS-1::PLX-4720
SU8686::Bleomycin (50 uM)
LB2241-RCC::Motesanib
CPC-N::AGI-5198
CAL-29::SCH772984
KARPAS-620::CZC24832
LB647-SCLC::GDC0810
U031::Bicalutamide
Becker::AZD6738
JHOS-3::Savolitinib
GA-10::VE-822
NCI-H1993::Navitoclax
LU-135::MK-2206
HPAF-II::Nilotinib
OCI-M1::MIRA-1
KP-4::Oxaliplatin
TE-4::PFI-1
UMC-11::IWP-2
OCI-M1::5-Fluorouracil
U031::Cyclophosphamide
WM-115::MIM1
WM-115::ABT737
LB647-SCLC::Pyridostatin
OCI-M1::CCT007093
EFO-21::Wee1 Inhibitor
OCI-M1::Venetoclax
NOS-1::RO-3306
CAL-29::Ribociclib
GA-10::VE821
UMC-11::Avagacestat
HPAF-II::Erlotinib
JHOS-3::CCT007093
TE-4::Dasatinib
SN12C::MK-8776
NALM-6::Rapamycin
HCC1143::Trametinib
D-566MG::Veliparib
LB647-SCLC::PD173074
HPAF-II::Epirubicin
EFO-21::Temsirolimus
AU565::Paclitaxel
NALM-6::GSK1904529A
A388::Fulvestrant
NALM-6::Cisplatin
LB647-SCLC::Temozolomide
LB2241-RCC::Temozolomide
CP50-MEL-B::Temozolomide
SU8686::MN-64
NCI-H1623::Vinorelbine
HCC1143::AZD6738
HCC1143::GSK1904529A
JHOS-3::Gefitinib
WM-115::Fulvestrant
EFO-21::PLX-4720
RT-112::Dasatinib
NCI-H1993::OSI-027
GA-10::Nutlin-3a (-)
D-566MG::Alisertib
ESO51::PLX-4720
AU565::Pevonedistat
GA-10::WZ4003
A388::CCT-018159
NCI-H1993::Alpelisib
HPAF-II::Navitoclax
LB647-SCLC::Bortezomib
ESO51::Veliparib
AU565::Telomerase Inhibitor IX
KARPAS-620::PRT062607
MEL-HO::Uprosertib
KCL-22::Temozolomide
Becker::AZD4547
SN12C::Motesanib
CPC-N::AZD6738
NOS-1::Pictilisib
HCC1143::PFI3
SN12C::PRIMA-1MET
LB647-SCLC::5-Fluorouracil
ESO51::Vinorelbine
LB2241-RCC::MG-132
WM-115::VE821
TE-4::Trametinib
NOS-1::Cytarabine
HCC1143::Ibrutinib
CPC-N::MG-132
JHOS-3::MN-64
JHOS-3::GDC0810
LU-135::WIKI4
NUGC-4::Osimertinib
OCI-M1::AGI-6780
HCC1143::Vinorelbine
LB647-SCLC::Motesanib
SN12C::GSK2830371
ESO51::SB590885
CAL-29::AZD7762
NUGC-4::Ibrutinib
EFO-21::Pictilisib
DMS-114::Dinaciclib
LC-2-ad::Axitinib
NCI-H1623::Foretinib
KARPAS-620::Alpelisib
SN12C::Daporinad
UMC-11::Docetaxel
CPC-N::JNK Inhibitor VIII
CPC-N::LGK974
RT-112::MK-8776
HPAF-II::Vinorelbine
LB647-SCLC::Vinorelbine
DMS-114::SCH772984
NOS-1::P22077
SIMA::MK-1775
LB2241-RCC::OSI-027
D-566MG::Lestaurtinib
KCL-22::JQ1
MEL-HO::Savolitinib
A388::Vinorelbine
RT-112::EPZ004777
CHP-134::WIKI4
MEL-HO::Leflunomide
AU565::LJI308
CAL-29::Linsitinib
NOS-1::Vinblastine
WM-115::Olaparib
NOS-1::Obatoclax Mesylate
RT-112::Fulvestrant
KGN::Dactolisib
D-566MG::SGC0946
KGN::Temozolomide
A388::RVX-208
JHOS-3::PFI3
D-566MG::IOX2
GA-10::Linsitinib
LU-135::Navitoclax
MEL-HO::Alisertib
LS-1034::Picolinici-acid
SU8686::EHT-1864
NALM-6::Ribociclib
EW-22::LY2109761
KCL-22::Dactolisib
KCL-22::SB590885
TE-4::AZD5582
Becker::Venetoclax
TE-4::Sorafenib
LU-135::PLX-4720
D-566MG::SN-38
KCL-22::PFI3
MEL-HO::GDC0810
DMS-114::MG-132
A388::Sepantronium bromide
SU8686::SB590885
KARPAS-620::SB216763
U031::Cediranib
TE-4::I-BRD9
GA-10::Gemcitabine
UMC-11::Gefitinib
SN12C::ABT737
SIMA::Bosutinib
SN12C::Crizotinib
CAL-29::CCT007093
UMC-11::RO-3306
CPC-N::AGI-6780
LB2241-RCC::Axitinib
KP-4::Ribociclib
LC-2-ad::IOX2
NCI-H1623::ZM447439
TE-4::Dactolisib
RT-112::Methotrexate
HCC1143::UMI-77
ESO51::Rucaparib
TE-4::WEHI-539
NOS-1::MK-2206
LU-135::Uprosertib
LS-1034::P22077
NALM-6::GSK343
NALM-6::CCT007093
GA-10::NU7441
AU565::GSK591
U031::Tozasertib
NCI-H1993::AZD3759
KP-4::Cytarabine
SU8686::Picolinici-acid
CPC-N::Picolinici-acid
A388::PFI3
RT-112::NVP-ADW742
UMC-11::VE-822
KARPAS-620::Afuresertib
D-566MG::AZD3759
LS-1034::GDC0810
KP-4::WIKI4
WM-115::Lestaurtinib
NOS-1::OF-1
D-566MG::Bortezomib
LB647-SCLC::Tanespimycin
NUGC-4::Cyclophosphamide
NUGC-4::Obatoclax Mesylate
EW-22::Daporinad
HCC1143::Vorinostat
DMS-114::Taselisib
MEL-HO::Palbociclib
Becker::PCI-34051
SIMA::LGK974
GA-10::Savolitinib
KP-4::AZD3759
RT-112::CZC24832
OCI-M1::Gefitinib
NOS-1::LY2109761
NALM-6::Niraparib
SU8686::ML323
CAL-29::SN-38
NCI-H1623::Dasatinib
SU8686::AZD4547
LU-135::PD0325901
NCI-H1993::Savolitinib
SN12C::Refametinib
CPC-N::Dactolisib
LC-2-ad::AZD7762
EW-22::ZM447439
MEL-HO::JNK Inhibitor VIII
U031::Sapitinib
KGN::Irinotecan
NCI-H1623::SN-38
SIMA::Temozolomide
NCI-H1993::Gemcitabine
HCC1143::Gemcitabine
KP-4::Ibrutinib
KARPAS-620::BMS-345541
NALM-6::Veliparib
SU8686::Foretinib
DMS-114::ZM447439
D-566MG::Methotrexate
RT-112::WEHI-539
SIMA::MN-64
NALM-6::Ibrutinib
U031::P22077
EW-22::Dabrafenib
MEL-HO::Crizotinib
NUGC-4::Luminespib
LB2241-RCC::ABT737
LC-2-ad::GSK591
KCL-22::Lenalidomide
LB647-SCLC::Sabutoclax
A388::Bicalutamide
EFO-21::VX-11e
TE-4::AZ960
CHP-134::Taselisib
DMS-114::TW 37
AU565::CZC24832
CAL-29::PD173074
JHOS-3::Taselisib
EFO-21::NVP-ADW742
AU565::MN-64
CAL-29::YK-4-279
KCL-22::AGI-6780
NUGC-4::Trametinib
RT-112::AZD8055
ESO51::Olaparib
RT-112::Paclitaxel
LU-135::Dasatinib
ESO51::Savolitinib
KCL-22::WIKI4
UMC-11::Temozolomide
NALM-6::Axitinib
CP50-MEL-B::Pevonedistat
UMC-11::MK-2206
EW-22::Navitoclax
GA-10::Navitoclax
OCI-M1::Osimertinib
LB647-SCLC::Afuresertib
LU-135::WEHI-539
JHOS-3::PFI-1
NCI-H1623::SB216763
CAL-29::MK-1775
HPAF-II::AZ6102
U031::Irinotecan
LB2241-RCC::Irinotecan
AU565::Bleomycin (50 uM)
KARPAS-620::Palbociclib
NCI-H1993::GNE-317
HCC1143::Niraparib
HCC1143::YK-4-279
DMS-114::Temozolomide
UMC-11::Refametinib
NCI-H1623::Dabrafenib
EFO-21::SB590885
NOS-1::PD173074
NALM-6::Foretinib
CAL-29::Methotrexate
KP-4::Leflunomide
NCI-H1623::Wnt-C59
DMS-114::Niraparib
AU565::ML323
CP50-MEL-B::Temsirolimus
EW-22::GW441756
NUGC-4::Savolitinib
LU-135::Ibrutinib
LU-135::Gemcitabine
NCI-H1993::Obatoclax Mesylate
UMC-11::GSK2606414
OCI-M1::GSK2578215A
CP50-MEL-B::SB505124
ESO51::CCT007093
SU8686::GNE-317
JHOS-3::PD0325901
KARPAS-620::Luminespib
A388::Osimertinib
SU8686::AZD7762
KARPAS-620::KRAS (G12C) Inhibitor-12
NOS-1::Avagacestat
CPC-N::Tamoxifen
UMC-11::BMS-345541
NOS-1::I-BET-762
OCI-M1::MK-8776
UMC-11::OTX015
CHP-134::Alisertib
KARPAS-620::Gefitinib
MEL-HO::OSI-027
UMC-11::SN-38
LB2241-RCC::Fulvestrant
CP50-MEL-B::JNK Inhibitor VIII
TE-4::MIM1
LS-1034::Erlotinib
KGN::Paclitaxel
CHP-134::MIM1
KGN::Lenalidomide
NOS-1::Lapatinib
LB2241-RCC::PD0325901
UMC-11::Cyclophosphamide
RT-112::SB216763
WM-115::Rucaparib
WM-115::CZC24832
NALM-6::UMI-77
SU8686::Bortezomib
NOS-1::Doramapimod
NUGC-4::BMS-536924
MEL-HO::Refametinib
SN12C::GSK343
OCI-M1::WIKI4
KARPAS-620::I-BET-762
AU565::Vinblastine
A388::PD173074
OCI-M1::Alisertib
NALM-6::Bosutinib
Becker::Camptothecin
NUGC-4::GSK2606414
RT-112::AZD8186
RT-112::LJI308
NALM-6::ZM447439
LS-1034::Dinaciclib
KCL-22::AZ6102
LC-2-ad::OTX015
OCI-M1::Ruxolitinib
SU8686::Niraparib
TE-4::Vinorelbine
HPAF-II::ABT737
U031::Lenalidomide
SU8686::Rucaparib
EFO-21::MG-132
GA-10::Crizotinib
EFO-21::AZD3759
UMC-11::Temsirolimus
SN12C::Obatoclax Mesylate
UMC-11::5-Fluorouracil
KCL-22::LY2109761
KCL-22::Refametinib
LB647-SCLC::CHIR-99021
CAL-29::Bosutinib
D-566MG::Foretinib
NOS-1::KRAS (G12C) Inhibitor-12
GA-10::Irinotecan
LS-1034::BIBR-1532
CHP-134::GNE-317
KP-4::Docetaxel
ESO51::Wnt-C59
ESO51::Nilotinib
EW-22::Dinaciclib
HPAF-II::AZD5582
D-566MG::ML323
EFO-21::Luminespib
NCI-H1623::PRT062607
UMC-11::AZD7762
GA-10::KU-55933
UMC-11::KU-55933
D-566MG::Picolinici-acid
EW-22::AMG-319
LC-2-ad::YK-4-279
KP-4::Dactolisib
CP50-MEL-B::Refametinib
DMS-114::AZD8055
NOS-1::BI-2536
EW-22::Cyclophosphamide
SN12C::Linsitinib
ESO51::AZD8186
RT-112::JQ1
KARPAS-620::VE821
NUGC-4::Wee1 Inhibitor
WM-115::PCI-34051
NCI-H1993::BI-2536
NCI-H1993::LJI308
LC-2-ad::Alisertib
NCI-H1623::Refametinib
SN12C::Sepantronium bromide
WM-115::LY2109761
NCI-H1993::Bosutinib
LC-2-ad::Dinaciclib
NALM-6::LCL161
HPAF-II::MK-1775
CPC-N::Irinotecan
CHP-134::Bortezomib
NUGC-4::Paclitaxel
EW-22::AZD6738
LB647-SCLC::BMS-345541
LS-1034::CCT007093
CPC-N::Taselisib
DMS-114::Ipatasertib
LU-135::XAV939
SIMA::Taselisib
EFO-21::Picolinici-acid
D-566MG::SCH772984
NUGC-4::OSI-027
RT-112::IWP-2
A388::PFI-1
NOS-1::AZ960
KCL-22::MIM1
SN12C::Pevonedistat
LC-2-ad::Epirubicin
OCI-M1::Doramapimod
KCL-22::Paclitaxel
RT-112::Savolitinib
KARPAS-620::GW441756
KGN::Avagacestat
LB647-SCLC::EPZ004777
LB647-SCLC::Uprosertib
KP-4::P22077
MEL-HO::Afuresertib
SU8686::Ipatasertib
SN12C::IWP-2
CHP-134::Entinostat
LB2241-RCC::MK-8776
NCI-H1993::Vorinostat
KP-4::Pyridostatin
CAL-29::MIM1
NCI-H1623::P22077
HCC1143::ABT737
JHOS-3::AGI-6780
U031::Ibrutinib
NOS-1::JQ1
CPC-N::Entospletinib
EFO-21::PCI-34051
D-566MG::MG-132
SN12C::JNK Inhibitor VIII
RT-112::VE-822
ESO51::OF-1
ESO51::BMS-345541
TE-4::Luminespib
ESO51::BI-2536
WM-115::EPZ004777
NOS-1::Trametinib
LS-1034::SN-38
NCI-H1993::SCH772984
LB647-SCLC::Dactolisib
CP50-MEL-B::MIRA-1
EFO-21::Doramapimod
SN12C::ML323
LB647-SCLC::GNE-317
CAL-29::Wnt-C59
OCI-M1::BMS-536924
NUGC-4::Temozolomide
LC-2-ad::Lenalidomide
AU565::RO-3306
KCL-22::Vismodegib
KCL-22::Temsirolimus
NOS-1::NVP-ADW742
NALM-6::Pevonedistat
ESO51::JNK Inhibitor VIII
LB2241-RCC::EPZ004777
CP50-MEL-B::Vismodegib
LS-1034::ABT737
MEL-HO::Talazoparib
OCI-M1::SB216763
LB647-SCLC::WZ4003
KP-4::Motesanib
KCL-22::MG-132
DMS-114::Crizotinib
CAL-29::AGI-5198
D-566MG::VE821
ESO51::GSK2578215A
GA-10::Bosutinib
CAL-29::Dasatinib
HCC1143::I-BET-762
NCI-H1993::I-BRD9
KP-4::MK-8776
LB2241-RCC::Veliparib
GA-10::PFI3
LC-2-ad::PD173074
NCI-H1993::Refametinib
LB647-SCLC::AZD7762
JHOS-3::NU7441
NOS-1::AZD8186
CAL-29::Refametinib
SU8686::KRAS (G12C) Inhibitor-12
NCI-H1623::PFI3
EFO-21::Motesanib
EFO-21::P22077
KP-4::Gemcitabine
RT-112::Vinorelbine
LC-2-ad::Camptothecin
LC-2-ad::PD0325901
JHOS-3::OTX015
Becker::GDC0810
WM-115::Entinostat
CPC-N::LY2109761
NALM-6::Entospletinib
KCL-22::Erlotinib
LC-2-ad::Pictilisib
SIMA::Rucaparib
CPC-N::GNE-317
A388::Uprosertib
SU8686::Tanespimycin
NCI-H1623::YK-4-279
D-566MG::Temsirolimus
HCC1143::Sabutoclax
LB647-SCLC::Lenalidomide
HPAF-II::BMS-345541
TE-4::MK-2206
A388::Savolitinib
NUGC-4::Lapatinib
LB2241-RCC::GW441756
LU-135::VX-11e
SIMA::Sepantronium bromide
ESO51::I-BRD9
LB647-SCLC::VX-11e
LB2241-RCC::VE-822
ESO51::Afuresertib
CHP-134::AGI-6780
KARPAS-620::Bosutinib
NCI-H1993::XAV939
CAL-29::Axitinib
NUGC-4::Dasatinib
KCL-22::Niraparib
CPC-N::Pevonedistat
A388::LY2109761
LC-2-ad::Crizotinib
CHP-134::Vinorelbine
NALM-6::LJI308
AU565::Ruxolitinib
MEL-HO::IOX2
MEL-HO::PLX-4720
LB2241-RCC::Tamoxifen
HCC1143::Bleomycin (50 uM)
JHOS-3::Cediranib
UMC-11::ZM447439
KCL-22::Lapatinib
KP-4::GSK591
NCI-H1623::Docetaxel
KCL-22::Sepantronium bromide
A388::LJI308
SU8686::Cyclophosphamide
HCC1143::Dabrafenib
HCC1143::Camptothecin
SIMA::Niraparib
OCI-M1::Nilotinib
LB647-SCLC::AZ960
GA-10::BIBR-1532
NCI-H1623::UMI-77
SN12C::NU7441
LS-1034::OF-1
CAL-29::ML323
ESO51::GSK1904529A
LS-1034::Lenalidomide
RT-112::Doramapimod
UMC-11::Sepantronium bromide
NCI-H1993::TW 37
LU-135::AZD5582
WM-115::Gefitinib
LU-135::Picolinici-acid
LB2241-RCC::Methotrexate
SU8686::P22077
LB647-SCLC::Dinaciclib
A388::JQ1
D-566MG::Elesclomol
EW-22::Vinorelbine
CP50-MEL-B::Rucaparib
UMC-11::Methotrexate
A388::Niraparib
NUGC-4::Rucaparib
MEL-HO::AZD8186
EFO-21::Vorinostat
NCI-H1993::Gefitinib
KCL-22::Ribociclib
ESO51::Vinblastine
SU8686::AGI-6780
A388::Pyridostatin
LB647-SCLC::Navitoclax
HPAF-II::Sapitinib
ESO51::Cytarabine
DMS-114::Lapatinib
SIMA::Uprosertib
LU-135::Dabrafenib
NCI-H1993::PFI-1
GA-10::ABT737
UMC-11::GSK591
LB2241-RCC::Ibrutinib
UMC-11::AGI-6780
NOS-1::Erlotinib
LC-2-ad::PRT062607
WM-115::EHT-1864
KP-4::5-Fluorouracil
OCI-M1::Sorafenib
LB647-SCLC::Ribociclib
NCI-H1623::Vinblastine
U031::Sabutoclax
MEL-HO::Methotrexate
LB2241-RCC::Sapitinib
OCI-M1::Vismodegib
NUGC-4::Fulvestrant
CAL-29::Sabutoclax
TE-4::Alisertib
GA-10::AZD8186
CP50-MEL-B::PFI3
CPC-N::AZ960
CHP-134::OF-1
RT-112::VE821
LS-1034::GW441756
HCC1143::Savolitinib
LC-2-ad::Sorafenib
KP-4::ABT737
SN12C::Entinostat
CP50-MEL-B::Tretinoin
CP50-MEL-B::AZD4547
D-566MG::VX-11e
DMS-114::PLX-4720
NOS-1::EPZ5676
EW-22::OTX015
CP50-MEL-B::EHT-1864
NUGC-4::BMS-345541
KCL-22::GNE-317
HPAF-II::PD0325901
LB647-SCLC::MN-64
CPC-N::Doramapimod
CPC-N::OF-1
LC-2-ad::GSK2578215A
RT-112::Gefitinib
A388::Gemcitabine
DMS-114::GDC0810
SN12C::GW441756
KCL-22::Veliparib
LS-1034::Osimertinib
NALM-6::Erlotinib
KGN::YK-4-279
SU8686::MIM1
MEL-HO::VE821
NCI-H1623::Picolinici-acid
SU8686::Bosutinib
U031::PLX-4720
NUGC-4::Cediranib
DMS-114::Ribociclib
LC-2-ad::Lestaurtinib
AU565::Alpelisib
NOS-1::Dasatinib
NCI-H1993::Trametinib
CAL-29::GNE-317
NCI-H1993::Daporinad
LS-1034::LCL161
UMC-11::SGC0946
CHP-134::Olaparib
KCL-22::Nilotinib
DMS-114::Ibrutinib
SU8686::WIKI4
NOS-1::Rapamycin
ESO51::AZD3759
CHP-134::ABT737
GA-10::Dinaciclib
WM-115::Trametinib
NUGC-4::GW441756
NCI-H1623::SGC0946
KCL-22::Rucaparib
NCI-H1993::Epirubicin
SN12C::AMG-319
CHP-134::Sorafenib
KP-4::VE821
AU565::ZM447439
LB647-SCLC::Pictilisib
KP-4::Palbociclib
LS-1034::Dasatinib
CAL-29::Gefitinib
NCI-H1993::Doramapimod
SU8686::Afatinib
LB647-SCLC::Leflunomide
NOS-1::ZM447439
D-566MG::Tanespimycin
KCL-22::Motesanib
NALM-6::MIRA-1
Becker::Crizotinib
CP50-MEL-B::Elesclomol
A388::GSK2606414
UMC-11::Telomerase Inhibitor IX
ESO51::CZC24832
SIMA::Irinotecan
D-566MG::Tretinoin
SU8686::Selumetinib
NALM-6::Entinostat
AU565::KU-55933
WM-115::Alisertib
SN12C::LCL161
EFO-21::JQ1
JHOS-3::Pevonedistat
LS-1034::Wee1 Inhibitor
KGN::MK-8776
RT-112::Epirubicin
JHOS-3::Picolinici-acid
HCC1143::SN-38
NCI-H1993::OTX015
A388::Entinostat
NALM-6::PD173074
NUGC-4::Pevonedistat
MEL-HO::AZD5582
KGN::Sapitinib
OCI-M1::AZD8186
SIMA::Telomerase Inhibitor IX
TE-4::BIBR-1532
SU8686::PD0325901
HPAF-II::WEHI-539
HCC1143::AZ960
NALM-6::SN-38
ESO51::Refametinib
LB2241-RCC::Paclitaxel
TE-4::AMG-319
SN12C::Olaparib
RT-112::PFI-1
LB2241-RCC::Tretinoin
ESO51::Cisplatin
RT-112::Pyridostatin
DMS-114::Sabutoclax
SU8686::Leflunomide
NOS-1::Gemcitabine
EFO-21::CCT007093
WM-115::Lenalidomide
A388::CZC24832
RT-112::SGC0946
TE-4::Camptothecin
HCC1143::GW441756
SU8686::MK-8776
SN12C::Dinaciclib
HCC1143::VX-11e
KCL-22::BI-2536
JHOS-3::Osimertinib
U031::Entinostat
Becker::Sorafenib
EW-22::P22077
NCI-H1993::Docetaxel
WM-115::Cyclophosphamide
LB647-SCLC::Telomerase Inhibitor IX
LU-135::P22077
MEL-HO::JQ1
CPC-N::Bosutinib
LC-2-ad::Dasatinib
SIMA::Selumetinib
CPC-N::Talazoparib
HPAF-II::AZD6738
JHOS-3::Sepantronium bromide
SN12C::Wee1 Inhibitor
LB2241-RCC::Palbociclib
EFO-21::Cisplatin
ESO51::Bleomycin (50 uM)
NCI-H1993::BMS-345541
KP-4::RO-3306
Becker::Ribociclib
U031::Sorafenib
U031::XAV939
EFO-21::Pyridostatin
NCI-H1623::MK-2206
NCI-H1623::JQ1
LS-1034::OTX015
SIMA::Entospletinib
DMS-114::Dabrafenib
CAL-29::AZD3759
NUGC-4::I-BRD9
KGN::WIKI4
KARPAS-620::AZD8055
LS-1034::GSK591
KARPAS-620::PD0325901
LU-135::Entinostat
SU8686::Lestaurtinib
KGN::Tanespimycin
CAL-29::Tanespimycin
KGN::Pictilisib
TE-4::Talazoparib
JHOS-3::BIBR-1532
NCI-H1623::AZ6102
SN12C::TW 37
EW-22::Ibrutinib
CHP-134::Temozolomide
CP50-MEL-B::GSK269962A
EFO-21::AMG-319
LU-135::Olaparib
CHP-134::Epirubicin
Becker::AZ960
A388::Bosutinib
GA-10::OF-1
CPC-N::Alisertib
KGN::AZD8055
SIMA::Crizotinib
DMS-114::Paclitaxel
CP50-MEL-B::Rapamycin
CPC-N::Lenalidomide
CAL-29::Cyclophosphamide
NCI-H1623::PLX-4720
KCL-22::Docetaxel
U031::Temozolomide
MEL-HO::Nutlin-3a (-)
NALM-6::AZ960
NUGC-4::LGK974
NCI-H1993::Cytarabine
CP50-MEL-B::Leflunomide
OCI-M1::Lenalidomide
NCI-H1623::I-BRD9
RT-112::Gemcitabine
RT-112::Alisertib
SIMA::Vinblastine
NCI-H1623::Savolitinib
LB2241-RCC::PRIMA-1MET
KP-4::Linsitinib
LU-135::VE821
LB647-SCLC::PCI-34051
LU-135::Lestaurtinib
LB2241-RCC::XAV939
SU8686::UMI-77
ESO51::LGK974
Becker::ML323
SIMA::EPZ004777
NOS-1::Docetaxel
EFO-21::BIBR-1532
D-566MG::Erlotinib
SU8686::Axitinib
HCC1143::Afuresertib
JHOS-3::ABT737
CHP-134::ML323
EW-22::Docetaxel
LB647-SCLC::ML323
MEL-HO::IWP-2
OCI-M1::PD173074
U031::Tanespimycin
TE-4::WZ4003
A388::VE821
NOS-1::AMG-319
CP50-MEL-B::VX-11e
Becker::AZD3759
SIMA::Bleomycin (50 uM)
SN12C::Temsirolimus
CHP-134::GDC0810
DMS-114::PD173074
NCI-H1623::OTX015
LU-135::KU-55933
CP50-MEL-B::Lenalidomide
ESO51::Afatinib
U031::Sepantronium bromide
CPC-N::AMG-319
KP-4::VE-822
UMC-11::WIKI4
WM-115::GSK2578215A
AU565::MIRA-1
CHP-134::Axitinib
KGN::ABT737
HCC1143::SCH772984
TE-4::CCT007093
Becker::Niraparib
A388::MG-132
TE-4::MG-132
Becker::AZD7762
CPC-N::Ribociclib
MEL-HO::MN-64
NCI-H1623::EPZ5676
KGN::VE821
UMC-11::Tamoxifen
CAL-29::Obatoclax Mesylate
EFO-21::MK-8776
CP50-MEL-B::Gemcitabine
CAL-29::AZ6102
EFO-21::GSK1904529A
LB647-SCLC::AZD6738
CPC-N::RVX-208
NOS-1::AZ6102
CP50-MEL-B::Trametinib
UMC-11::LGK974
KCL-22::VE-822
CPC-N::PCI-34051
LC-2-ad::MN-64
OCI-M1::Afuresertib
SU8686::Sabutoclax
SU8686::I-BRD9
UMC-11::Motesanib
DMS-114::Nilotinib
SN12C::PRT062607
SN12C::Cisplatin
KP-4::PD173074
NCI-H1993::Foretinib
NUGC-4::Vorinostat
NCI-H1623::Tamoxifen
AU565::SGC0946
LC-2-ad::Serdemetan
NALM-6::AMG-319
UMC-11::XAV939
SIMA::I-BRD9
D-566MG::Luminespib
MEL-HO::Olaparib
EW-22::KU-55933
KP-4::Vinorelbine
AU565::Wnt-C59
NALM-6::Sepantronium bromide
KARPAS-620::LGK974
UMC-11::P22077
LU-135::Avagacestat
NUGC-4::5-Fluorouracil
NALM-6::PFI-1
U031::Afatinib
SU8686::Nutlin-3a (-)
HPAF-II::Talazoparib
OCI-M1::Sepantronium bromide
NOS-1::AZD3759
NOS-1::Veliparib
SN12C::Vorinostat
WM-115::AZD8186
JHOS-3::Pictilisib
LB647-SCLC::Rapamycin
CP50-MEL-B::Motesanib
LS-1034::RVX-208
CAL-29::MN-64
NCI-H1993::Fulvestrant
NOS-1::Dactolisib
UMC-11::Wee1 Inhibitor
TE-4::Wee1 Inhibitor
KCL-22::AZD8186
CP50-MEL-B::PD173074
CAL-29::PRT062607
KARPAS-620::Ipatasertib
UMC-11::EHT-1864
SN12C::SN-38
LS-1034::Entospletinib
LU-135::JNK Inhibitor VIII
NUGC-4::Ribociclib
CP50-MEL-B::Bicalutamide
LB647-SCLC::AZD3759
NCI-H1623::EPZ004777
U031::AGI-6780
HPAF-II::Rapamycin
EW-22::Sorafenib
AU565::Sapitinib
UMC-11::BI-2536
CP50-MEL-B::Picolinici-acid
ESO51::Fulvestrant
SU8686::KU-55933
ESO51::NU7441
SU8686::Navitoclax
LU-135::GSK2606414
CPC-N::Cediranib
SU8686::GDC0810
SU8686::Pictilisib
LB647-SCLC::Gemcitabine
CPC-N::WZ4003
D-566MG::EPZ004777
NOS-1::OSI-027
KP-4::Entinostat
SU8686::Cytarabine
Becker::Refametinib
CAL-29::Oxaliplatin
NALM-6::GNE-317
LS-1034::Vinorelbine
OCI-M1::SCH772984
NCI-H1993::Sorafenib
RT-112::VX-11e
Becker::AGI-6780
UMC-11::OSI-027
EW-22::Fulvestrant
CHP-134::AZD8055
CHP-134::Selumetinib
ESO51::Ibrutinib
TE-4::GDC0810
TE-4::Niraparib
UMC-11::EPZ004777
CPC-N::Erlotinib
KCL-22::Bosutinib
SN12C::Ibrutinib
KP-4::Cyclophosphamide
KCL-22::Afatinib
MEL-HO::MK-2206
LU-135::Selumetinib
NALM-6::LY2109761
GA-10::Selumetinib
KP-4::KRAS (G12C) Inhibitor-12
NCI-H1993::MK-8776
LU-135::MIM1
ESO51::PD173074
U031::AZD3759
UMC-11::Lestaurtinib
KP-4::Axitinib
WM-115::XAV939
ESO51::GNE-317
MEL-HO::Entospletinib
HPAF-II::YK-4-279
CHP-134::Entospletinib
RT-112::Lapatinib
MEL-HO::AZD6482
NOS-1::VE-822
D-566MG::Dactolisib
CHP-134::LGK974
EFO-21::Osimertinib
A388::Lenalidomide
CP50-MEL-B::VE821
NCI-H1623::Pictilisib
EW-22::Oxaliplatin
CPC-N::Lestaurtinib
U031::PD173074
OCI-M1::AZ6102
EFO-21::MN-64
D-566MG::MN-64
Becker::PRT062607
CP50-MEL-B::Bortezomib
D-566MG::PFI-1
AU565::Serdemetan
TE-4::Olaparib
KP-4::Uprosertib
HCC1143::Cytarabine
WM-115::Osimertinib
NUGC-4::Ruxolitinib
LB2241-RCC::Gemcitabine
NCI-H1993::PD0325901
SIMA::Wee1 Inhibitor
LS-1034::KU-55933
CHP-134::VE821
NUGC-4::ZM447439
OCI-M1::GNE-317
NCI-H1993::Wee1 Inhibitor
WM-115::Dabrafenib
LC-2-ad::Olaparib
Becker::CZC24832
SU8686::Talazoparib
Becker::Gemcitabine
GA-10::Temozolomide
DMS-114::Oxaliplatin
NCI-H1623::Ruxolitinib
LU-135::Nutlin-3a (-)
ESO51::AZD7762
GA-10::Epirubicin
KCL-22::P22077
SIMA::Ibrutinib
CP50-MEL-B::Dactolisib
LC-2-ad::Rucaparib
DMS-114::PRIMA-1MET
SIMA::Sorafenib
KP-4::MIRA-1
D-566MG::PRT062607
SIMA::Entinostat
KARPAS-620::Picolinici-acid
A388::P22077
GA-10::Refametinib
KGN::Osimertinib
NALM-6::MK-2206
A388::MN-64
NCI-H1993::Paclitaxel
D-566MG::PFI3
AU565::Lapatinib
SN12C::BMS-536924
A388::NU7441
LU-135::Pictilisib
DMS-114::Navitoclax
EW-22::PRT062607
AU565::Savolitinib
U031::Navitoclax
JHOS-3::EPZ004777
KARPAS-620::Navitoclax
CP50-MEL-B::Dasatinib
MEL-HO::GNE-317
KGN::PFI-1
NOS-1::AGI-6780
DMS-114::Docetaxel
LC-2-ad::Tretinoin
TE-4::Leflunomide
MEL-HO::PCI-34051
NCI-H1623::GW441756
Becker::Cisplatin
Becker::PD173074
LU-135::PFI3
Becker::Tanespimycin
CHP-134::Cytarabine
ESO51::Serdemetan
NOS-1::Sepantronium bromide
OCI-M1::VE-822
KP-4::Afatinib
LS-1034::Bortezomib
MEL-HO::SN-38
KCL-22::MN-64
LB647-SCLC::Entospletinib
KCL-22::LGK974
NOS-1::Fulvestrant
CP50-MEL-B::SN-38
CAL-29::Uprosertib
DMS-114::Axitinib
NUGC-4::Sabutoclax
KGN::Fulvestrant
RT-112::Daporinad
NCI-H1993::MIRA-1
NUGC-4::JNK Inhibitor VIII
CPC-N::Savolitinib
JHOS-3::OF-1
D-566MG::Vorinostat
CAL-29::AZD8055
KP-4::Cisplatin
WM-115::Temsirolimus
LU-135::Irinotecan
AU565::Veliparib
KGN::EHT-1864
U031::BIBR-1532
EW-22::ML323
AU565::MG-132
UMC-11::Taselisib
A388::Navitoclax
RT-112::Ibrutinib
NCI-H1623::Crizotinib
NCI-H1623::AMG-319
LB2241-RCC::CZC24832
CPC-N::Sepantronium bromide
LS-1034::OSI-027
KGN::GNE-317
LB2241-RCC::Docetaxel
MEL-HO::PFI-1
EFO-21::Bortezomib
LB2241-RCC::Luminespib
CAL-29::Osimertinib
Becker::MK-1775
NCI-H1993::Cediranib
SIMA::Motesanib
KP-4::Nutlin-3a (-)
ESO51::VE821
UMC-11::UMI-77
WM-115::BMS-536924
LB2241-RCC::Talazoparib
ESO51::WZ4003
CHP-134::UMI-77
DMS-114::MIM1
HCC1143::Veliparib
LB647-SCLC::WIKI4
NCI-H1623::Axitinib
KGN::BMS-536924
NALM-6::Osimertinib
MEL-HO::Sepantronium bromide
Becker::I-BET-762
AU565::WZ4003
SN12C::PD0325901
WM-115::Dasatinib
GA-10::Erlotinib
A388::BMS-536924
NCI-H1623::Serdemetan
NUGC-4::MK-1775
U031::Linsitinib
KCL-22::Alpelisib
KGN::Erlotinib
LS-1034::Navitoclax
MEL-HO::AMG-319
Becker::AZD5582
KP-4::Temsirolimus
TE-4::Bleomycin (50 uM)
HCC1143::ML323
HPAF-II::PD173074
KCL-22::Lestaurtinib
KP-4::AZD8055
JHOS-3::Vorinostat
LB647-SCLC::PFI3
NCI-H1993::LY2109761
DMS-114::Methotrexate
UMC-11::AMG-319
NUGC-4::PCI-34051
LC-2-ad::I-BET-762
RT-112::Picolinici-acid
EFO-21::Axitinib
SN12C::Nutlin-3a (-)
KARPAS-620::Tamoxifen
TE-4::Navitoclax
WM-115::AZD5582
GA-10::Ruxolitinib
NCI-H1623::AZD7762
SU8686::VX-11e
KGN::OSI-027
A388::Ruxolitinib
DMS-114::Linsitinib
CP50-MEL-B::RVX-208
SIMA::AGI-6780
CAL-29::AZD6738
LU-135::Vinorelbine
KCL-22::Wee1 Inhibitor
A388::Temozolomide
LB647-SCLC::Entinostat
EW-22::AZ6102
ESO51::Paclitaxel
LS-1034::Bleomycin (50 uM)
SIMA::MK-8776
ESO51::Wee1 Inhibitor
U031::ZM447439
SN12C::Ribociclib
CAL-29::Sorafenib
LS-1034::AZD8186
CPC-N::Camptothecin
LB2241-RCC::Epirubicin
KCL-22::Foretinib
HCC1143::WIKI4
LB2241-RCC::MK-2206
CPC-N::Afuresertib
GA-10::NVP-ADW742
GA-10::SB216763
LC-2-ad::KU-55933
NALM-6::Sorafenib
A388::WIKI4
RT-112::Leflunomide
CHP-134::OSI-027
KGN::SB590885
HPAF-II::GSK343
HPAF-II::Ibrutinib
JHOS-3::KU-55933
CHP-134::AZD8186
AU565::GSK2578215A
SN12C::Tanespimycin
WM-115::ML323
OCI-M1::JQ1
UMC-11::Alpelisib
CP50-MEL-B::SB590885
CHP-134::VE-822
U031::Epirubicin
KP-4::Dinaciclib
NUGC-4::Afuresertib
OCI-M1::Cyclophosphamide
HCC1143::Alisertib
SU8686::Palbociclib
DMS-114::YK-4-279
EW-22::OF-1
TE-4::5-Fluorouracil
LB2241-RCC::Serdemetan
JHOS-3::Bortezomib
A388::GSK2578215A
CAL-29::Crizotinib
NCI-H1993::Pevonedistat
CPC-N::VE821
EFO-21::I-BRD9
NUGC-4::Axitinib
CPC-N::Daporinad
TE-4::Tanespimycin
NOS-1::Telomerase Inhibitor IX
AU565::Bortezomib
CHP-134::Wnt-C59
RT-112::PLX-4720
EFO-21::XAV939
D-566MG::Afuresertib
NCI-H1993::I-BET-762
NOS-1::Temozolomide
CAL-29::GW441756
CAL-29::Savolitinib
JHOS-3::Selumetinib
AU565::Vinorelbine
JHOS-3::5-Fluorouracil
HPAF-II::Oxaliplatin
EW-22::Obatoclax Mesylate
CPC-N::OTX015
GA-10::Afuresertib
LU-135::Temozolomide
LU-135::Telomerase Inhibitor IX
KARPAS-620::OF-1
HCC1143::I-BRD9
MEL-HO::Avagacestat
NALM-6::I-BRD9
KGN::AZD8186
NOS-1::I-BRD9
CP50-MEL-B::YK-4-279
KCL-22::I-BET-762
EW-22::Palbociclib
LU-135::JQ1
U031::NU7441
KGN::PD173074
NUGC-4::GSK343
SN12C::Dactolisib
LC-2-ad::CZC24832
JHOS-3::PD173074
CAL-29::KU-55933
RT-112::SCH772984
EW-22::Tanespimycin
LB647-SCLC::Veliparib
CP50-MEL-B::ZM447439
DMS-114::Bosutinib
KCL-22::Gemcitabine
HCC1143::Vismodegib
KP-4::Trametinib
U031::GNE-317
A388::PD0325901
JHOS-3::SN-38
LB2241-RCC::CCT007093
CHP-134::PRT062607
AU565::LGK974
TE-4::AGI-5198
WM-115::P22077
MEL-HO::BMS-536924
TE-4::MIRA-1
NALM-6::ABT737
SIMA::AZ960
LB2241-RCC::JNK Inhibitor VIII
HPAF-II::Temozolomide
MEL-HO::Lenalidomide
HCC1143::Oxaliplatin
UMC-11::EPZ5676
EFO-21::Epirubicin
KP-4::GSK1904529A
TE-4::PD173074
CAL-29::GSK2830371
KP-4::PD0325901
LC-2-ad::SN-38
JHOS-3::WIKI4
EFO-21::AZD6738
DMS-114::Rucaparib
CAL-29::XAV939
EFO-21::Afuresertib
JHOS-3::Afuresertib
LB2241-RCC::VE821
NUGC-4::Dabrafenib
CPC-N::Pictilisib
D-566MG::LGK974
MEL-HO::Ipatasertib
WM-115::Ipatasertib
NALM-6::Vismodegib
NCI-H1623::Nutlin-3a (-)
NCI-H1623::Taselisib
U031::SB216763
AU565::GSK343
AU565::PRIMA-1MET
HCC1143::VE-822
NUGC-4::Alpelisib
CPC-N::Gemcitabine
GA-10::Taselisib
KARPAS-620::OSI-027
CAL-29::Vinblastine
KP-4::Irinotecan
DMS-114::LGK974
WM-115::Selumetinib
LS-1034::EPZ004777
CP50-MEL-B::I-BRD9
NUGC-4::OF-1
DMS-114::Pevonedistat
KCL-22::Pictilisib
KARPAS-620::Nilotinib
EW-22::BI-2536
CHP-134::VX-11e
CP50-MEL-B::GSK2578215A
LC-2-ad::Gemcitabine
NCI-H1623::MN-64
CHP-134::EPZ5676
MEL-HO::ML323
NCI-H1993::AZD5582
EFO-21::Sepantronium bromide
LU-135::AZD6738
CPC-N::Serdemetan
CPC-N::Refametinib
EFO-21::SN-38
NOS-1::Sabutoclax
JHOS-3::MK-2206
SN12C::AZD7762
CP50-MEL-B::Luminespib
D-566MG::SL0101
NOS-1::Motesanib
KARPAS-620::AZD5582
CHP-134::PCI-34051
CAL-29::Talazoparib
NUGC-4::KU-55933
NALM-6::KU-55933
HPAF-II::Dabrafenib
NUGC-4::Crizotinib
ESO51::MG-132
DMS-114::Refametinib
Becker::Nutlin-3a (-)
RT-112::CCT007093
NCI-H1993::LGK974
NCI-H1623::Gefitinib
HPAF-II::LCL161
LC-2-ad::Motesanib
LB2241-RCC::PFI-1
EW-22::Erlotinib
CPC-N::RO-3306
LB647-SCLC::SB216763
NCI-H1993::PRIMA-1MET
CHP-134::RVX-208
U031::Dinaciclib
GA-10::Cytarabine
EW-22::VX-11e
LU-135::ML323
LB647-SCLC::EHT-1864
NCI-H1623::Sapitinib
NCI-H1993::Vismodegib
NALM-6::EPZ5676
LB2241-RCC::GSK591
CHP-134::Obatoclax Mesylate
NOS-1::Methotrexate
Becker::UMI-77
KCL-22::AZD3759
AU565::Olaparib
SU8686::Uprosertib
SN12C::Uprosertib
CAL-29::Avagacestat
A388::LGK974
CAL-29::Cisplatin
Becker::Erlotinib
ESO51::RVX-208
D-566MG::Fulvestrant
SU8686::Doramapimod
LU-135::Nilotinib
TE-4::Bosutinib
KP-4::Erlotinib
HCC1143::Rapamycin
WM-115::Axitinib
AU565::PFI3
AU565::AZD3759
LU-135::AZD8055
CPC-N::MIRA-1
KP-4::GW441756
SIMA::ZM447439
EFO-21::Sapitinib
LS-1034::Ruxolitinib
U031::PCI-34051
NUGC-4::WZ4003
HPAF-II::AGI-5198
HCC1143::AZD8055
LB2241-RCC::LJI308
HCC1143::Bortezomib
NCI-H1623::ML323
OCI-M1::SGC0946
AU565::Wee1 Inhibitor
LC-2-ad::Venetoclax
LS-1034::MK-2206
EFO-21::AZD8055
ESO51::OTX015
A388::AZD8186
EW-22::Rucaparib
LB2241-RCC::LY2109761
NALM-6::KRAS (G12C) Inhibitor-12
NCI-H1993::ZM447439
OCI-M1::AZD6738
HPAF-II::Ribociclib
NALM-6::Irinotecan
WM-115::WEHI-539
TE-4::Bortezomib
SIMA::PFI3
SU8686::JQ1
CP50-MEL-B::CCT-018159
DMS-114::P22077
NCI-H1993::SN-38
CPC-N::Sorafenib
NUGC-4::BI-2536
KCL-22::Alisertib
RT-112::OSI-027
DMS-114::BMS-345541
RT-112::5-Fluorouracil
CP50-MEL-B::CCT007093
RT-112::Alpelisib
LC-2-ad::Elesclomol
CP50-MEL-B::Irinotecan
NALM-6::Dinaciclib
NCI-H1623::BI-2536
HCC1143::Ribociclib
NALM-6::Pyridostatin
NCI-H1993::NVP-ADW742
NCI-H1993::5-Fluorouracil
SU8686::Camptothecin
MEL-HO::Selumetinib
Becker::SGC0946
JHOS-3::Alisertib
TE-4::Ibrutinib
HPAF-II::Telomerase Inhibitor IX
CAL-29::Wee1 Inhibitor
LS-1034::SGC0946
KCL-22::Axitinib
D-566MG::PF-4708671
LB647-SCLC::NU7441
KGN::AZD6738
LS-1034::Dactolisib
HPAF-II::Leflunomide
NCI-H1623::Fulvestrant
Becker::PFI-1
KARPAS-620::GSK591
HPAF-II::Ruxolitinib
TE-4::MN-64
LC-2-ad::PFI3
EW-22::CZC24832
NCI-H1993::WZ4003
EFO-21::GW441756
KARPAS-620::PLX-4720
MEL-HO::P22077
LU-135::GSK2830371
KGN::VX-11e
CP50-MEL-B::Savolitinib
GA-10::Docetaxel
UMC-11::Dactolisib
LU-135::Bortezomib
LS-1034::Alpelisib
MEL-HO::WEHI-539
SU8686::Veliparib
LB2241-RCC::Ipatasertib
HCC1143::Crizotinib
HCC1143::Leflunomide
LS-1034::LY2109761
DMS-114::Vorinostat
CP50-MEL-B::IWP-2
NUGC-4::AZD7762
EFO-21::Talazoparib
NALM-6::Linsitinib
JHOS-3::MIRA-1
TE-4::Alpelisib
U031::SB590885
NCI-H1623::PCI-34051
LB647-SCLC::Nutlin-3a (-)
D-566MG::Ruxolitinib
LC-2-ad::Lapatinib
NCI-H1993::Tanespimycin
TE-4::VX-11e
NUGC-4::AZD8055
A388::Motesanib
U031::Nilotinib
Becker::AZD8186
LU-135::Erlotinib
DMS-114::GSK2830371
LC-2-ad::Bicalutamide
KP-4::Ruxolitinib
LB647-SCLC::SB505124
WM-115::Epirubicin
Becker::Osimertinib
LB647-SCLC::Docetaxel
LB647-SCLC::MIRA-1
MEL-HO::Osimertinib
OCI-M1::Leflunomide
NUGC-4::BIBR-1532
KGN::TW 37
KARPAS-620::P22077
SN12C::MIRA-1
UMC-11::GSK2830371
SU8686::Serdemetan
EFO-21::WIKI4
U031::I-BET-762
GA-10::ZM447439
NUGC-4::ML323
KARPAS-620::EPZ004777
NOS-1::AZD5582
SU8686::Paclitaxel
WM-115::Erlotinib
GA-10::RVX-208
Becker::MIM1
CP50-MEL-B::Oxaliplatin
DMS-114::AMG-319
D-566MG::MIRA-1
LS-1034::Palbociclib
SIMA::Talazoparib
SN12C::Cyclophosphamide
AU565::Nutlin-3a (-)
LB2241-RCC::Leflunomide
EFO-21::Dactolisib
ESO51::AZD5582
SIMA::BMS-345541
GA-10::Dabrafenib
OCI-M1::Tanespimycin
OCI-M1::PLX-4720
SN12C::SB590885
KP-4::GNE-317
JHOS-3::Navitoclax
SIMA::Fulvestrant
HPAF-II::UMI-77
WM-115::Paclitaxel
OCI-M1::Selumetinib
LB2241-RCC::Trametinib
SN12C::Sorafenib
EFO-21::LJI308
U031::Piperlongumine
MEL-HO::XAV939
NUGC-4::RO-3306
SU8686::GSK591
TE-4::SN-38
CAL-29::Taselisib
HCC1143::MN-64
LB647-SCLC::PRT062607
KGN::AZD3759
LB647-SCLC::MK-1775
KCL-22::Telomerase Inhibitor IX
HPAF-II::Bortezomib
KGN::GSK2830371
DMS-114::PCI-34051
CHP-134::Ribociclib
LB647-SCLC::Cyclophosphamide
NCI-H1623::VE-822
NALM-6::XAV939
CPC-N::UMI-77
CAL-29::CZC24832
KARPAS-620::SB590885
LB2241-RCC::SB216763
NCI-H1993::PLX-4720
HCC1143::Avagacestat
D-566MG::Leflunomide
OCI-M1::GSK1904529A
UMC-11::PCI-34051
KARPAS-620::MIM1
RT-112::Niraparib
WM-115::Navitoclax
LC-2-ad::GW441756
U031::Pyridostatin
LC-2-ad::NU7441
AU565::GSK2606414
D-566MG::Savolitinib
OCI-M1::Axitinib
LU-135::Gefitinib
MEL-HO::Motesanib
HPAF-II::Docetaxel
LB2241-RCC::Ribociclib
KP-4::Bleomycin (50 uM)
JHOS-3::Sapitinib
ESO51::Methotrexate
LC-2-ad::Tanespimycin
NCI-H1623::AZD6738
Becker::Olaparib
KARPAS-620::Vinblastine
LB2241-RCC::PLX-4720
HCC1143::Serdemetan
LC-2-ad::Entospletinib
NUGC-4::Taselisib
NOS-1::AZD7762
SIMA::Lenalidomide
KP-4::Paclitaxel
NCI-H1993::BIBR-1532
TE-4::Lenalidomide
HPAF-II::Fulvestrant
HPAF-II::Camptothecin
NCI-H1993::AMG-319
LB647-SCLC::PD0325901
HPAF-II::Uprosertib
KGN::Nilotinib
LB2241-RCC::BI-2536
SU8686::Taselisib
MEL-HO::Bicalutamide
ESO51::Alpelisib
CAL-29::UMI-77
KARPAS-620::Wee1 Inhibitor
HCC1143::PLX-4720
OCI-M1::AZD5582
A388::BI-2536
CHP-134::Ibrutinib
NCI-H1993::VE821
A388::Tanespimycin
CPC-N::Epirubicin
LB647-SCLC::Olaparib
CAL-29::SB216763
ESO51::Vorinostat
A388::MK-1775
SIMA::PLX-4720
Becker::Methotrexate
KP-4::Lestaurtinib
NUGC-4::ABT737
OCI-M1::Erlotinib
OCI-M1::AZD4547
NUGC-4::EPZ004777
CAL-29::EPZ5676
AU565::OSI-027
OCI-M1::Olaparib
SN12C::SB216763
NCI-H1993::WEHI-539
LC-2-ad::AZ6102
LB647-SCLC::Picolinici-acid
LB647-SCLC::Tozasertib
NALM-6::SB590885
HCC1143::Afatinib
EW-22::GSK2830371
ESO51::Niraparib
NALM-6::WEHI-539
NUGC-4::GSK591
HPAF-II::MIM1
SIMA::VX-11e
Becker::Dactolisib
NOS-1::IWP-2
TE-4::Temsirolimus
JHOS-3::I-BRD9
RT-112::MK-1775
RT-112::Cytarabine
CP50-MEL-B::Tamoxifen
UMC-11::SB216763
A388::YK-4-279
CP50-MEL-B::AZ960
HPAF-II::Selumetinib
LS-1034::Sapitinib
HCC1143::EPZ004777
KCL-22::GSK2578215A
WM-115::SGC0946
DMS-114::Doramapimod
NUGC-4::VE821
SU8686::GSK343
LC-2-ad::Savolitinib
HPAF-II::Gemcitabine
SN12C::NVP-ADW742
HCC1143::MIM1
LU-135::RO-3306
LU-135::AGI-5198
CP50-MEL-B::EPZ004777
LU-135::Alpelisib
A388::SL0101
CPC-N::Obatoclax Mesylate
A388::Epirubicin
EFO-21::PRIMA-1MET
CPC-N::I-BET-762
EW-22::Wee1 Inhibitor
NCI-H1993::AZD7762
WM-115::AZ960
CP50-MEL-B::AZ6102
ESO51::GDC0810
SU8686::IWP-2
TE-4::PLX-4720
AU565::Foretinib
UMC-11::JNK Inhibitor VIII
NALM-6::Bortezomib
SIMA::RVX-208
EW-22::PD0325901
LB647-SCLC::LGK974
SU8686::Crizotinib
NCI-H1993::Vinblastine
KP-4::BI-2536
CHP-134::Crizotinib
A388::VE-822
LB2241-RCC::MK-1775
DMS-114::Gemcitabine
EFO-21::Erlotinib
D-566MG::Entospletinib
CP50-MEL-B::Avagacestat
SU8686::Dabrafenib
AU565::Leflunomide
UMC-11::AZD4547
D-566MG::XAV939
EW-22::Dasatinib
HPAF-II::Alpelisib
LC-2-ad::BIBR-1532
SN12C::Cytarabine
CP50-MEL-B::GSK2606414
TE-4::Picolinici-acid
ESO51::PRT062607
A388::Cediranib
MEL-HO::SCH772984
ESO51::Ruxolitinib
SIMA::Oxaliplatin
NUGC-4::Vismodegib
KGN::Sepantronium bromide
LB647-SCLC::Foretinib
CP50-MEL-B::Entinostat
NCI-H1623::Alisertib
U031::EHT-1864
KCL-22::CCT007093
LB2241-RCC::Wee1 Inhibitor
SN12C::LGK974
NOS-1::MIRA-1
LB647-SCLC::AMG-319
OCI-M1::Lapatinib
AU565::CCT007093
NCI-H1623::RVX-208
Becker::MN-64
U031::Rucaparib
Becker::RVX-208
A388::Trametinib
HPAF-II::Entospletinib
ESO51::VX-11e
NCI-H1623::PFI-1
CPC-N::PLX-4720
UMC-11::Gemcitabine
KGN::GSK343
Becker::Rapamycin
HCC1143::Cisplatin
CP50-MEL-B::PCI-34051
LB647-SCLC::GSK269962A
EFO-21::PFI-1
MEL-HO::Dinaciclib
LB647-SCLC::JNK Inhibitor VIII
D-566MG::Lenalidomide
NALM-6::AGI-6780
A388::SB590885
NCI-H1993::Vinorelbine
NUGC-4::YK-4-279
LB647-SCLC::Afatinib
RT-112::Telomerase Inhibitor IX
NCI-H1993::AZ960
MEL-HO::Elesclomol
JHOS-3::Ruxolitinib
LU-135::Methotrexate
KP-4::AGI-6780
OCI-M1::Navitoclax
OCI-M1::PRIMA-1MET
NCI-H1993::Wnt-C59
NCI-H1623::Obatoclax Mesylate
GA-10::MG-132
GA-10::MK-1775
OCI-M1::Foretinib
A388::ML323
AU565::Avagacestat
KP-4::WZ4003
NCI-H1623::Rapamycin
GA-10::EPZ004777
DMS-114::Ruxolitinib
SU8686::PD173074
D-566MG::CZC24832
LC-2-ad::Sepantronium bromide
NOS-1::Ruxolitinib
WM-115::OTX015
LB2241-RCC::AZ960
KP-4::PRT062607
LB647-SCLC::Lestaurtinib
D-566MG::AMG-319
EFO-21::SGC0946
CPC-N::MK-2206
LB647-SCLC::Palbociclib
NCI-H1623::MK-1775
NUGC-4::AZD6738
JHOS-3::Leflunomide
WM-115::KU-55933
A388::Olaparib
SN12C::RVX-208
RT-112::AGI-6780
LB2241-RCC::KU-55933
NCI-H1993::GSK1904529A
CPC-N::GSK2830371
DMS-114::Selumetinib
LB2241-RCC::Sepantronium bromide
OCI-M1::Sapitinib
KGN::LGK974
KCL-22::PFI-1
SN12C::Picolinici-acid
SN12C::AGI-5198
WM-115::Sapitinib
SU8686::PFI3
JHOS-3::PLX-4720
SIMA::I-BET-762
NCI-H1623::MG-132
ESO51::Motesanib
TE-4::Wnt-C59
DMS-114::GW441756
NCI-H1623::GDC0810
RT-112::Temozolomide
KGN::Olaparib
LB647-SCLC::LCL161
SIMA::AZD7762
A388::AZD6482
KARPAS-620::Gemcitabine
CPC-N::Nutlin-3a (-)
LC-2-ad::Trametinib
MEL-HO::ZM447439
CHP-134::MG-132
NCI-H1993::VX-11e
LB2241-RCC::BX795
EW-22::Pictilisib
EW-22::EHT-1864
HPAF-II::MIRA-1
UMC-11::Uprosertib
CAL-29::VX-11e
Becker::NU7441
KARPAS-620::Sapitinib
NUGC-4::EHT-1864
GA-10::Tamoxifen
CAL-29::Rapamycin
JHOS-3::Veliparib
ESO51::Telomerase Inhibitor IX
LC-2-ad::MK-2206
CAL-29::GSK1904529A
AU565::LCL161
HPAF-II::AZD4547
OCI-M1::Ibrutinib
EW-22::PFI-1
KARPAS-620::Motesanib
UMC-11::Crizotinib
HPAF-II::Afuresertib
CAL-29::RO-3306
TE-4::KU-55933
U031::JNK Inhibitor VIII
LC-2-ad::Vismodegib
LU-135::Fulvestrant
AU565::AZD8055
CP50-MEL-B::AMG-319
LS-1034::NVP-ADW742
NOS-1::Niraparib
KP-4::NVP-ADW742
CP50-MEL-B::5-Fluorouracil
AU565::Temsirolimus
CPC-N::Vorinostat
NALM-6::Selumetinib
LU-135::AZD7762
UMC-11::Sapitinib
A388::Selumetinib
UMC-11::ML323
MEL-HO::BIBR-1532
ESO51::KU-55933
LB647-SCLC::RO-3306
OCI-M1::VE821
KP-4::Obatoclax Mesylate
ESO51::Leflunomide
MEL-HO::Axitinib
ESO51::Axitinib
NCI-H1623::VE821
LC-2-ad::SB505124
LU-135::Wnt-C59
HCC1143::Pevonedistat
KP-4::Pevonedistat
WM-115::Vorinostat
NUGC-4::Methotrexate
KGN::JNK Inhibitor VIII
EW-22::Vismodegib
HCC1143::Dasatinib
CP50-MEL-B::P22077
NOS-1::WIKI4
CHP-134::Cyclophosphamide
EW-22::AGI-5198
CHP-134::SN-38
KCL-22::EPZ5676
KP-4::Wee1 Inhibitor
AU565::5-Fluorouracil
EW-22::I-BRD9
KARPAS-620::Venetoclax
KGN::Savolitinib
MEL-HO::Tamoxifen
NCI-H1623::Entospletinib
UMC-11::Cediranib
LS-1034::Alisertib
NCI-H1993::AGI-5198
SU8686::Afuresertib
CPC-N::BIBR-1532
KP-4::CZC24832
EFO-21::Vinorelbine
OCI-M1::Nutlin-3a (-)
UMC-11::Veliparib
U031::IWP-2
TE-4::LCL161
HCC1143::AZD5582
Becker::Cytarabine
SIMA::GDC0810
NOS-1::Dinaciclib
NCI-H1623::GSK343
A388::Taselisib
UMC-11::Dinaciclib
SIMA::AZD8055
SIMA::Dactolisib
CP50-MEL-B::Nilotinib
JHOS-3::AZD6482
SU8686::XAV939
KGN::Lestaurtinib
LC-2-ad::Luminespib
HPAF-II::WIKI4
ESO51::Entinostat
WM-115::PRT062607
SN12C::WZ4003
ESO51::AZD6738
D-566MG::Alpelisib
ESO51::Picolinici-acid
RT-112::Taselisib
NALM-6::PFI3
CAL-29::Afuresertib
LB2241-RCC::Elesclomol
WM-115::NVP-ADW742
EW-22::EPZ5676
OCI-M1::Picolinici-acid
NCI-H1623::LY2109761
HCC1143::Methotrexate
OCI-M1::Refametinib
MEL-HO::Pevonedistat
U031::Rapamycin
Becker::Cyclophosphamide
KARPAS-620::SCH772984
HCC1143::ZM447439
HPAF-II::Methotrexate
KGN::GDC0810
SIMA::Sapitinib
KARPAS-620::GNE-317
TE-4::VE821
DMS-114::EPZ004777
KCL-22::EHT-1864
LU-135::Cisplatin
CAL-29::WEHI-539
LB647-SCLC::MK-2206
WM-115::WIKI4
GA-10::CZC24832
CAL-29::Paclitaxel
KP-4::GSK2578215A
WM-115::MG-132
Becker::RO-3306
OCI-M1::VX-11e
ESO51::ABT737
CHP-134::Gemcitabine
RT-112::I-BRD9
KP-4::Gefitinib
AU565::Pyridostatin
CHP-134::Telomerase Inhibitor IX
LB2241-RCC::Cediranib
NOS-1::ABT737
CP50-MEL-B::IOX2
LB647-SCLC::GSK1904529A
DMS-114::Nutlin-3a (-)
KGN::Temsirolimus
CPC-N::Luminespib
OCI-M1::MK-2206
U031::Fulvestrant
GA-10::Cyclophosphamide
A388::Ipatasertib
NCI-H1623::PRIMA-1MET
KGN::GSK1904529A
D-566MG::Piperlongumine
SN12C::Cediranib
U031::AZ960
HPAF-II::KU-55933
KP-4::SB590885
KGN::Taselisib
UMC-11::Camptothecin
NCI-H1623::Doramapimod
D-566MG::Gemcitabine
Becker::BMS-345541
HCC1143::Erlotinib
JHOS-3::PRIMA-1MET
KARPAS-620::JNK Inhibitor VIII
NUGC-4::LY2109761
NUGC-4::Sapitinib
KP-4::YK-4-279
NALM-6::Sapitinib
SIMA::Palbociclib
EFO-21::YK-4-279
EW-22::WZ4003
MEL-HO::MK-1775
CHP-134::Niraparib
LC-2-ad::Gefitinib
NALM-6::Doramapimod
UMC-11::Luminespib
CP50-MEL-B::Lestaurtinib
KGN::Afatinib
EFO-21::ZM447439
Becker::Paclitaxel
UMC-11::Entospletinib
EFO-21::Foretinib
SU8686::Avagacestat
Becker::Obatoclax Mesylate
KP-4::PLX-4720
LS-1034::LJI308
CHP-134::MK-2206
KGN::Venetoclax
CHP-134::AZD4547
HPAF-II::OTX015
JHOS-3::Cyclophosphamide
D-566MG::AZD6482
EFO-21::Afatinib
LB2241-RCC::Dabrafenib
LU-135::SB216763
MEL-HO::Lapatinib
LB647-SCLC::Methotrexate
TE-4::MK-1775
RT-112::UMI-77
LB647-SCLC::Crizotinib
CP50-MEL-B::PRT062607
RT-112::Refametinib
CPC-N::Vinblastine
MEL-HO::PFI3
U031::KRAS (G12C) Inhibitor-12
LU-135::MG-132
KP-4::AZ6102
MEL-HO::Vismodegib
JHOS-3::Crizotinib
HCC1143::CZC24832
NALM-6::Talazoparib
KGN::Veliparib
D-566MG::WEHI-539
CHP-134::I-BRD9
Becker::SCH772984
EFO-21::ML323
NOS-1::BIBR-1532
KP-4::Dabrafenib
DMS-114::OSI-027
NCI-H1993::Picolinici-acid
LC-2-ad::RO-3306
KARPAS-620::WZ4003
NOS-1::LCL161
EFO-21::Trametinib
CPC-N::EHT-1864
UMC-11::Cisplatin
LB2241-RCC::Pictilisib
U031::Olaparib
GA-10::Obatoclax Mesylate
JHOS-3::Ibrutinib
WM-115::Niraparib
AU565::I-BRD9
OCI-M1::ABT737
CAL-29::BMS-536924
TE-4::Ruxolitinib
LB2241-RCC::KRAS (G12C) Inhibitor-12
D-566MG::GSK1904529A
SIMA::Sabutoclax
CP50-MEL-B::Bosutinib
NUGC-4::GDC0810
KGN::Docetaxel
DMS-114::Sorafenib
TE-4::LY2109761
NALM-6::Temsirolimus
KARPAS-620::Trametinib
KP-4::WEHI-539
RT-112::Linsitinib
CPC-N::Paclitaxel
LB2241-RCC::PD173074
LB2241-RCC::Piperlongumine
MEL-HO::Picolinici-acid
KGN::SCH772984
EFO-21::Olaparib
CPC-N::SB590885
KGN::Telomerase Inhibitor IX
HPAF-II::AGI-6780
A388::AGI-6780
OCI-M1::Bortezomib
A388::MK-2206
NCI-H1623::Vorinostat
HPAF-II::RVX-208
UMC-11::I-BRD9
U031::PFI-1
DMS-114::Alpelisib
LB2241-RCC::IWP-2
MEL-HO::Rucaparib
GA-10::AZD3759
HPAF-II::GSK2578215A
ESO51::XAV939
HPAF-II::Lapatinib
NCI-H1993::Ibrutinib
EFO-21::Bosutinib
LU-135::CCT007093
UMC-11::PD173074
OCI-M1::Niraparib
ESO51::MN-64
LB2241-RCC::SN-38
GA-10::Foretinib
KCL-22::Wnt-C59
RT-112::Obatoclax Mesylate
SIMA::Veliparib
EFO-21::AGI-5198
EW-22::Afatinib
NCI-H1623::Vismodegib
LS-1034::AZ960
EW-22::Lapatinib
KP-4::Taselisib
HPAF-II::PCI-34051
CP50-MEL-B::Niraparib
U031::WEHI-539
ESO51::Irinotecan
LS-1034::Rucaparib
U031::MN-64
CHP-134::Sapitinib
GA-10::I-BET-762
RT-112::Selumetinib
LB647-SCLC::Lapatinib
NUGC-4::Navitoclax
NALM-6::VX-11e
HCC1143::EHT-1864
GA-10::PCI-34051
ESO51::Dasatinib
NALM-6::GDC0810
LB647-SCLC::VE-822
LB647-SCLC::Talazoparib
KP-4::BMS-345541
RT-112::P22077
KARPAS-620::Nutlin-3a (-)
KARPAS-620::AZD8186
ESO51::GW441756
LU-135::PCI-34051
SN12C::MN-64
NCI-H1623::Oxaliplatin
WM-115::TW 37
A388::Alisertib
CP50-MEL-B::AZD7762
EW-22::Vinblastine
Becker::Docetaxel
EFO-21::Sorafenib
LU-135::PRT062607
RT-112::AZD3759
CHP-134::PD0325901
EW-22::SB216763
HPAF-II::Axitinib
OCI-M1::Ipatasertib
NCI-H1623::IWP-2
KARPAS-620::Daporinad
RT-112::LGK974
NUGC-4::Lestaurtinib
CP50-MEL-B::Pyridostatin
CHP-134::P22077
LS-1034::UMI-77
KARPAS-620::LCL161
KCL-22::Sorafenib
NUGC-4::AZD4547
SN12C::LY2109761
NCI-H1993::PCI-34051
CHP-134::Rapamycin
LU-135::LCL161
NCI-H1623::Afuresertib
SU8686::CZC24832
LS-1034::Afatinib
CHP-134::GSK343
OCI-M1::Dinaciclib
U031::Lestaurtinib
JHOS-3::GSK2606414
JHOS-3::Lenalidomide
GA-10::MIM1
D-566MG::BI-2536
SIMA::5-Fluorouracil
LS-1034::MK-8776
CPC-N::WIKI4
DMS-114::Venetoclax
LS-1034::JNK Inhibitor VIII
JHOS-3::BX795
AU565::PCI-34051
U031::AZD5582
SIMA::Vorinostat
NCI-H1993::GSK591
NALM-6::Ruxolitinib
A388::GDC0810
LS-1034::VE-822
HPAF-II::CZC24832
WM-115::Pevonedistat
LS-1034::LGK974
KGN::SN-38
KCL-22::UMI-77
KGN::Alisertib
Becker::Alisertib
JHOS-3::BMS-536924
KGN::Bosutinib
LB2241-RCC::EHT-1864
SIMA::Pevonedistat
DMS-114::PRT062607
LU-135::AZD4547
GA-10::Veliparib
NCI-H1993::Ruxolitinib
HPAF-II::Tamoxifen
LU-135::5-Fluorouracil
LC-2-ad::LJI308
GA-10::EPZ5676
KP-4::GSK2606414
EFO-21::WEHI-539
DMS-114::Luminespib
HPAF-II::VE-822
HCC1143::GSK343
NUGC-4::Serdemetan
DMS-114::Avagacestat
SIMA::Trametinib
GA-10::BMS-536924
ESO51::PD0325901
NOS-1::Refametinib
NALM-6::Picolinici-acid
HCC1143::Dactolisib
NOS-1::Tanespimycin
RT-112::BMS-536924
Becker::Vismodegib
EW-22::Selumetinib
OCI-M1::Gemcitabine
KCL-22::Doramapimod
SU8686::Cisplatin
CAL-29::Ruxolitinib
A388::Elesclomol
CP50-MEL-B::Wee1 Inhibitor
EFO-21::MK-1775
NCI-H1993::Dabrafenib
CP50-MEL-B::PF-4708671
U031::Alpelisib
Becker::Dasatinib
MEL-HO::Irinotecan
NCI-H1623::WZ4003
D-566MG::Camptothecin
CAL-29::5-Fluorouracil
CHP-134::GSK591
NUGC-4::Epirubicin
KCL-22::JNK Inhibitor VIII
GA-10::Ribociclib
LU-135::Osimertinib
CAL-29::EHT-1864
A388::GNE-317
JHOS-3::Daporinad
CHP-134::Cisplatin
KGN::Tamoxifen
A388::OSI-027
KP-4::AZD8186
HPAF-II::SN-38
CHP-134::MK-1775
DMS-114::AZD3759
EFO-21::AGI-6780
CAL-29::Veliparib
ESO51::GSK2606414
KP-4::GDC0810
CP50-MEL-B::Entospletinib
HCC1143::Epirubicin
CHP-134::Gefitinib
SU8686::EPZ5676
NOS-1::ML323
OCI-M1::MIM1
U031::Motesanib
NCI-H1993::GSK2578215A
NALM-6::Sabutoclax
OCI-M1::MK-1775
RT-112::GSK2578215A
D-566MG::Serdemetan
EW-22::MK-1775
KGN::Motesanib
NUGC-4::MIRA-1
KGN::Ipatasertib
LU-135::Sorafenib
TE-4::GSK2578215A
NCI-H1623::GSK591
MEL-HO::GSK2606414
LB647-SCLC::Savolitinib
NOS-1::Dabrafenib
LC-2-ad::BMS-345541
U031::SCH772984
LB2241-RCC::BMS-536924
LB2241-RCC::Venetoclax
HPAF-II::MK-8776
LC-2-ad::AZD6482
CAL-29::Entinostat
MEL-HO::Cediranib
KARPAS-620::Dasatinib
SN12C::Ipatasertib
NALM-6::PRIMA-1MET
TE-4::GNE-317
TE-4::AZD8186
OCI-M1::OTX015
SU8686::Gemcitabine
KCL-22::Linsitinib
KP-4::SCH772984
EFO-21::Avagacestat
CPC-N::Niraparib
HCC1143::Selumetinib
CP50-MEL-B::Taselisib
EW-22::Trametinib
D-566MG::I-BET-762
SU8686::Sepantronium bromide
D-566MG::AZ6102
DMS-114::Cyclophosphamide
KCL-22::Serdemetan
U031::Tretinoin
KCL-22::MK-8776
NOS-1::WZ4003
U031::RO-3306
LS-1034::Vorinostat
WM-115::Wnt-C59
AU565::Cediranib
ESO51::MK-1775
HPAF-II::AMG-319
OCI-M1::Entospletinib
LS-1034::Pevonedistat
Becker::MK-2206
AU565::Linsitinib
CHP-134::Navitoclax
D-566MG::NU7441
LS-1034::Axitinib
SU8686::Epirubicin
D-566MG::EPZ5676
LS-1034::Docetaxel
LS-1034::GSK2578215A
LB2241-RCC::Bicalutamide
U031::Bortezomib
LC-2-ad::Afatinib
GA-10::Vinorelbine
UMC-11::Fulvestrant
CPC-N::Afatinib
MEL-HO::Telomerase Inhibitor IX
D-566MG::Talazoparib
NOS-1::BMS-536924
NCI-H1623::GSK2606414
KP-4::JNK Inhibitor VIII
LS-1034::ML323
KGN::Palbociclib
Becker::OSI-027
SU8686::AZ6102
LS-1034::Lestaurtinib
SIMA::GSK591
HPAF-II::Entinostat
JHOS-3::Camptothecin
CAL-29::Olaparib
KCL-22::Cisplatin
RT-112::Osimertinib
U031::Talazoparib
NCI-H1623::Leflunomide
NOS-1::Paclitaxel
OCI-M1::SB590885
CP50-MEL-B::ABT737
EW-22::Alisertib
D-566MG::Vismodegib
ESO51::Crizotinib
EW-22::GSK343
KCL-22::ABT737
RT-112::YK-4-279
LC-2-ad::SCH772984
LS-1034::Pyridostatin
EW-22::Cediranib
EFO-21::Telomerase Inhibitor IX
SN12C::Gefitinib
KCL-22::Bleomycin (50 uM)
KARPAS-620::AZD3759
CHP-134::Ipatasertib
EFO-21::Dasatinib
KARPAS-620::ABT737
KCL-22::NU7441
EW-22::GSK591
LU-135::OSI-027
EFO-21::Fulvestrant
LB2241-RCC::AZD7762
U031::MK-1775
LS-1034::IWP-2
KARPAS-620::Vinorelbine
SU8686::AZD8055
JHOS-3::Vismodegib
CHP-134::Pyridostatin
JHOS-3::VX-11e
U031::BMS-536924
ESO51::LJI308
AU565::Afatinib
NALM-6::GSK2830371
A388::AZD6738
D-566MG::Bosutinib
DMS-114::Telomerase Inhibitor IX
NOS-1::MK-1775
DMS-114::AZD5582
GA-10::Sapitinib
D-566MG::GSK2606414
A388::Vismodegib
GA-10::OSI-027
OCI-M1::SN-38
MEL-HO::5-Fluorouracil
MEL-HO::RVX-208
LC-2-ad::Erlotinib
ESO51::Dinaciclib
LU-135::Taselisib
HPAF-II::I-BRD9
CAL-29::ABT737
D-566MG::WIKI4
DMS-114::SB216763
D-566MG::GSK269962A
ESO51::YK-4-279
EW-22::Pyridostatin
CPC-N::PFI-1
EW-22::Gemcitabine
NCI-H1993::Osimertinib
KCL-22::RO-3306
OCI-M1::BIBR-1532
CHP-134::AZD6738
NOS-1::Osimertinib
EFO-21::AZ960
SU8686::Temozolomide
A388::RO-3306
JHOS-3::Dabrafenib
JHOS-3::EPZ5676
Becker::Sapitinib
D-566MG::Telomerase Inhibitor IX
CPC-N::SGC0946
SU8686::Trametinib
CP50-MEL-B::Camptothecin
MEL-HO::Foretinib
TE-4::Osimertinib
NCI-H1993::GW441756
AU565::Palbociclib
CHP-134::Dinaciclib
CHP-134::AZ960
D-566MG::Cyclophosphamide
HPAF-II::MK-2206
LC-2-ad::JNK Inhibitor VIII
JHOS-3::LGK974
HCC1143::JNK Inhibitor VIII
ESO51::VE-822
KGN::JQ1
LB647-SCLC::Refametinib
Becker::Ruxolitinib
LB647-SCLC::IWP-2
RT-112::WIKI4
KGN::Doramapimod
SU8686::CCT007093
LB647-SCLC::VE821
A388::Irinotecan
SN12C::Tamoxifen
KARPAS-620::PCI-34051
JHOS-3::Niraparib
Becker::Selumetinib
CHP-134::GSK2606414
JHOS-3::Ribociclib
LC-2-ad::SL0101
CPC-N::EPZ5676
MEL-HO::Bosutinib
D-566MG::Ibrutinib
LU-135::Tanespimycin
EW-22::Methotrexate
CPC-N::VX-11e
LB647-SCLC::Linsitinib
NOS-1::Rucaparib
U031::Entospletinib
TE-4::EHT-1864
NCI-H1623::Venetoclax
JHOS-3::Paclitaxel
SIMA::WIKI4
NCI-H1623::Irinotecan
CHP-134::Talazoparib
Becker::Daporinad
LB2241-RCC::AGI-5198
NCI-H1993::Cyclophosphamide
LB2241-RCC::VX-11e
UMC-11::MG-132
JHOS-3::Elesclomol
LS-1034::Lapatinib
SIMA::NVP-ADW742
JHOS-3::Dinaciclib
CP50-MEL-B::LGK974
TE-4::ML323
NOS-1::Wnt-C59
KP-4::Sepantronium bromide
JHOS-3::KRAS (G12C) Inhibitor-12
LB2241-RCC::SGC0946
MEL-HO::OTX015
MEL-HO::LJI308
EW-22::SGC0946
SIMA::Nutlin-3a (-)
CAL-29::SB590885
D-566MG::RVX-208
Becker::Entinostat
RT-112::Cisplatin
OCI-M1::Veliparib
HCC1143::Fulvestrant
LC-2-ad::Wnt-C59
JHOS-3::Erlotinib
LC-2-ad::VE-822
RT-112::I-BET-762
WM-115::PD0325901
WM-115::Taselisib
Becker::Palbociclib
MEL-HO::OF-1
RT-112::BMS-345541
LU-135::I-BRD9
U031::VE821
NALM-6::Wnt-C59
HCC1143::MIRA-1
A388::GSK269962A
LC-2-ad::MG-132
RT-112::JNK Inhibitor VIII
EW-22::Osimertinib
D-566MG::IWP-2
EFO-21::Vismodegib
U031::Serdemetan
LB647-SCLC::SGC0946
ESO51::LY2109761
KCL-22::KRAS (G12C) Inhibitor-12
Becker::GSK591
UMC-11::LJI308
KGN::Serdemetan
LU-135::GSK1904529A
EW-22::AGI-6780
AU565::Luminespib
NCI-H1993::Axitinib
LB647-SCLC::BIBR-1532
NCI-H1623::Ibrutinib
CAL-29::VE821
GA-10::Motesanib
HPAF-II::AZD3759
CPC-N::BMS-345541
NALM-6::Dasatinib
NOS-1::Entinostat
SIMA::Olaparib
EW-22::IWP-2
RT-112::XAV939
A388::Gefitinib
CPC-N::Crizotinib
NALM-6::Navitoclax
GA-10::MN-64
HCC1143::GDC0810
DMS-114::WZ4003
NOS-1::MG-132
EW-22::Axitinib
KGN::Uprosertib
A388::AZD5582
WM-115::Irinotecan
TE-4::Venetoclax
EFO-21::GSK2830371
HPAF-II::EPZ004777
CHP-134::Dactolisib
CP50-MEL-B::JQ1
DMS-114::GSK1904529A
A388::Pictilisib
CPC-N::5-Fluorouracil
KCL-22::AZD8055
LB2241-RCC::Olaparib
A388::I-BET-762
UMC-11::VX-11e
LB2241-RCC::AZD3759
SU8686::NVP-ADW742
SU8686::RVX-208
EFO-21::Entospletinib
UMC-11::Vinorelbine
NOS-1::Tamoxifen
TE-4::I-BET-762
Becker::Pictilisib
KCL-22::Talazoparib
NOS-1::RVX-208
JHOS-3::Temsirolimus
JHOS-3::PCI-34051
SN12C::WIKI4
KP-4::OF-1
NCI-H1623::LJI308
EW-22::Wnt-C59
AU565::Ipatasertib
KGN::Dabrafenib
GA-10::BMS-345541
SN12C::Temozolomide
KCL-22::Cediranib
NCI-H1623::Gemcitabine
WM-115::AZD3759
OCI-M1::Pictilisib
AU565::Erlotinib
JHOS-3::BI-2536
TE-4::NVP-ADW742
NCI-H1623::Pevonedistat
CHP-134::Linsitinib
AU565::Lestaurtinib
KCL-22::Osimertinib
NCI-H1623::OF-1
JHOS-3::GSK591
EW-22::Entospletinib
CPC-N::Nilotinib
KGN::Afuresertib
KP-4::Bortezomib
CHP-134::LY2109761
D-566MG::VE-822
JHOS-3::GW441756
KGN::Daporinad
NCI-H1993::Sapitinib
UMC-11::Trametinib
LS-1034::Foretinib
SN12C::RO-3306
CAL-29::Selumetinib
GA-10::MK-8776
RT-112::Dinaciclib
SIMA::Epirubicin
CPC-N::Ruxolitinib
D-566MG::KU-55933
MEL-HO::I-BRD9
U031::Palbociclib
CAL-29::MK-2206
NCI-H1993::Tamoxifen
CPC-N::XAV939
EW-22::AZD4547
U031::Nutlin-3a (-)
GA-10::Pyridostatin
HCC1143::GNE-317
LC-2-ad::AZD3759
EFO-21::LCL161
D-566MG::Lapatinib
NUGC-4::Vinorelbine
LS-1034::JQ1
KCL-22::Cyclophosphamide
UMC-11::Sabutoclax
ESO51::Foretinib
A388::XAV939
AU565::Navitoclax
MEL-HO::NU7441
LU-135::GW441756
UMC-11::Rucaparib
NCI-H1623::Paclitaxel
NCI-H1993::Ipatasertib
LB647-SCLC::NVP-ADW742
SIMA::ML323
HCC1143::GSK269962A
Becker::PRIMA-1MET
TE-4::P22077
LB2241-RCC::Gefitinib
RT-112::Erlotinib
KGN::Gefitinib
CAL-29::Dabrafenib
LC-2-ad::Ruxolitinib
CHP-134::WEHI-539
GA-10::Rucaparib
D-566MG::I-BRD9
EW-22::Rapamycin
A388::Sabutoclax
HCC1143::Docetaxel
NCI-H1993::Luminespib
RT-112::MG-132
NALM-6::Camptothecin
LC-2-ad::Selumetinib
JHOS-3::Wnt-C59
KGN::Sorafenib
MEL-HO::Temozolomide
SU8686::VE821
SIMA::Camptothecin
UMC-11::CZC24832
CAL-29::OTX015
EFO-21::MK-2206
RT-112::Dabrafenib
Becker::Doramapimod
MEL-HO::Ibrutinib
LU-135::NU7441
Becker::Ibrutinib
CP50-MEL-B::Vinorelbine
DMS-114::MN-64
KARPAS-620::JQ1
A388::AZD7762
DMS-114::Serdemetan
CPC-N::Alpelisib
D-566MG::AZD7762
CP50-MEL-B::Crizotinib
U031::I-BRD9
ESO51::Venetoclax
Becker::Vorinostat
KP-4::Temozolomide
NCI-H1623::JNK Inhibitor VIII
EW-22::Avagacestat
CP50-MEL-B::Cediranib
KCL-22::MIRA-1
HPAF-II::Sorafenib
LS-1034::Doramapimod
LB2241-RCC::Rucaparib
MEL-HO::GW441756
WM-115::Ribociclib
TE-4::JNK Inhibitor VIII
NCI-H1623::Pyridostatin
JHOS-3::VE-822
CAL-29::Temsirolimus
DMS-114::EPZ5676
LB2241-RCC::Nutlin-3a (-)
NALM-6::Vorinostat
LB647-SCLC::SN-38
KARPAS-620::PRIMA-1MET
NCI-H1993::Entinostat
KP-4::VX-11e
OCI-M1::LCL161
HCC1143::JQ1
GA-10::Sorafenib
EFO-21::VE821
D-566MG::RO-3306
CP50-MEL-B::MG-132
CP50-MEL-B::Osimertinib
D-566MG::SB216763
EFO-21::Daporinad
NALM-6::GW441756
UMC-11::Bosutinib
RT-112::Docetaxel
NALM-6::P22077
NCI-H1623::KRAS (G12C) Inhibitor-12
DMS-114::IWP-2
WM-115::UMI-77
RT-112::RVX-208
SIMA::Cediranib
GA-10::P22077
SN12C::CZC24832
KP-4::Alpelisib
NALM-6::BIBR-1532
TE-4::Obatoclax Mesylate
D-566MG::CHIR-99021
KCL-22::Dasatinib
LU-135::AZD3759
KARPAS-620::Doramapimod
DMS-114::Cisplatin
U031::Telomerase Inhibitor IX
A388::Temsirolimus
KARPAS-620::Ribociclib
JHOS-3::Dactolisib
EFO-21::MIRA-1
SIMA::LCL161
CPC-N::Olaparib
TE-4::Erlotinib
GA-10::Uprosertib
HCC1143::Tamoxifen
SN12C::Trametinib
LB2241-RCC::GSK2578215A
EW-22::Sapitinib
AU565::MIM1
NCI-H1993::WIKI4
KARPAS-620::Niraparib
LC-2-ad::Afuresertib
NALM-6::PRT062607
TE-4::AZD8055
CP50-MEL-B::XAV939
CPC-N::Docetaxel
NOS-1::Ipatasertib
CPC-N::GSK343
LC-2-ad::WEHI-539
Becker::Vinblastine
LS-1034::TW 37
NALM-6::Obatoclax Mesylate
JHOS-3::AMG-319
Becker::NVP-ADW742
U031::Taselisib
A388::Doramapimod
LS-1034::Tamoxifen
AU565::VE821
U031::Refametinib
KP-4::EPZ5676
EW-22::Epirubicin
WM-115::RO-3306
EW-22::PFI3
DMS-114::Erlotinib
CAL-29::Cediranib
EW-22::SN-38
EW-22::LCL161
LS-1034::SB505124
KARPAS-620::RO-3306
TE-4::Ribociclib
RT-112::PCI-34051
A388::AZD4547
NOS-1::YK-4-279
JHOS-3::Tanespimycin
NOS-1::JNK Inhibitor VIII
NUGC-4::MK-8776
KGN::MG-132
CHP-134::PFI3
NOS-1::WEHI-539
HCC1143::NVP-ADW742
UMC-11::Wnt-C59
KP-4::OSI-027
SN12C::UMI-77
Becker::5-Fluorouracil
EW-22::Venetoclax
EFO-21::AZD4547
LB647-SCLC::GSK343
UMC-11::AGI-5198
LB647-SCLC::OF-1
WM-115::GSK343
CP50-MEL-B::Alpelisib
KARPAS-620::Osimertinib
NOS-1::MN-64
HPAF-II::MG-132
LS-1034::Cyclophosphamide
SN12C::SCH772984
CAL-29::Pictilisib
HCC1143::GSK2606414
NCI-H1623::WEHI-539
LU-135::Rucaparib
KGN::5-Fluorouracil
JHOS-3::Oxaliplatin
KARPAS-620::MK-2206
Becker::Fulvestrant
LB647-SCLC::RVX-208
ESO51::NVP-ADW742
ESO51::LCL161
KP-4::Picolinici-acid
NALM-6::SGC0946
NUGC-4::SGC0946
NALM-6::GSK591
OCI-M1::Alpelisib
NALM-6::Tanespimycin
CAL-29::AMG-319
HCC1143::AGI-5198
KGN::Vorinostat
A388::AZ960
GA-10::Temsirolimus
D-566MG::Pictilisib
HPAF-II::Paclitaxel
LS-1034::Savolitinib
NCI-H1993::VE-822
KP-4::Daporinad
SIMA::Tamoxifen
WM-115::Oxaliplatin
NOS-1::MIM1
SIMA::Paclitaxel
NCI-H1623::Linsitinib
NCI-H1623::Sepantronium bromide
TE-4::Entospletinib
UMC-11::Palbociclib
OCI-M1::P22077
DMS-114::AZD6738
LS-1034::Camptothecin
CHP-134::AZD7762
SIMA::Gefitinib
MEL-HO::Sorafenib
AU565::I-BET-762
WM-115::GSK2830371
NOS-1::Taselisib
JHOS-3::Afatinib
U031::SGC0946
SIMA::Alpelisib
HCC1143::GSK591
LC-2-ad::Pyridostatin
LC-2-ad::OSI-027
NUGC-4::Tamoxifen
DMS-114::PFI3
KCL-22::GW441756
NALM-6::AZD8055
CPC-N::Axitinib
CAL-29::AZD5582
AU565::Cisplatin
A388::Vorinostat
DMS-114::WIKI4
GA-10::I-BRD9
U031::BI-2536
NUGC-4::Veliparib
OCI-M1::UMI-77
CP50-MEL-B::MK-8776
SIMA::WEHI-539
U031::EPZ5676
LS-1034::Avagacestat
DMS-114::Cytarabine
MEL-HO::Oxaliplatin
NUGC-4::PD0325901
TE-4::Vinblastine
KCL-22::Fulvestrant
NCI-H1993::Niraparib
SU8686::SGC0946
HPAF-II::Vorinostat
LC-2-ad::Veliparib
WM-115::AZD8055
LB2241-RCC::Telomerase Inhibitor IX
HPAF-II::Irinotecan
CAL-29::Cytarabine
NUGC-4::RVX-208
LB647-SCLC::Cediranib
MEL-HO::WZ4003
EW-22::Savolitinib
NOS-1::Crizotinib
RT-112::Talazoparib
KARPAS-620::Sepantronium bromide
CPC-N::AZD8186
SU8686::SN-38
TE-4::Cisplatin
LS-1034::MIM1
WM-115::NU7441
JHOS-3::RO-3306
EFO-21::ABT737
Becker::Pevonedistat
LU-135::LJI308
WM-115::Sepantronium bromide
CP50-MEL-B::Sapitinib
SN12C::Erlotinib
CPC-N::KU-55933
NCI-H1993::YK-4-279
LB2241-RCC::Pyridostatin
EW-22::SB590885
SN12C::Irinotecan
LB2241-RCC::BIBR-1532
NOS-1::Cyclophosphamide
SIMA::Leflunomide
D-566MG::Dasatinib
DMS-114::I-BET-762
LU-135::Serdemetan
OCI-M1::Savolitinib
CP50-MEL-B::Daporinad
SN12C::PFI3
CHP-134::Afuresertib
LB647-SCLC::SB590885
WM-115::BI-2536
LB647-SCLC::P22077
LB647-SCLC::ZM447439
SU8686::WEHI-539
GA-10::AZD6738
JHOS-3::GSK269962A
CP50-MEL-B::BX795
CP50-MEL-B::MK-1775
LS-1034::ZM447439
WM-115::Picolinici-acid
HCC1143::SB216763
U031::KU-55933
SIMA::AMG-319
EFO-21::Alpelisib
LU-135::Palbociclib
CHP-134::IWP-2
GA-10::SN-38
CP50-MEL-B::MK-2206
MEL-HO::KU-55933
LB647-SCLC::Fulvestrant
LB2241-RCC::Vorinostat
LS-1034::KRAS (G12C) Inhibitor-12
KP-4::ML323
U031::Niraparib
CPC-N::Temozolomide
CPC-N::Wnt-C59
CAL-29::MK-8776
CPC-N::Motesanib
DMS-114::MK-8776
HCC1143::GSK2830371
CAL-29::GSK343
HPAF-II::Afatinib
NALM-6::Venetoclax
TE-4::RVX-208
NCI-H1993::Sabutoclax
LS-1034::PRIMA-1MET
NALM-6::I-BET-762
OCI-M1::GSK343
CP50-MEL-B::Pictilisib
CAL-29::PD0325901
KGN::Navitoclax
LU-135::Ribociclib
CAL-29::Dinaciclib
UMC-11::MK-8776
AU565::Lenalidomide
ESO51::Sapitinib
NALM-6::Alisertib
LB2241-RCC::Lenalidomide
HPAF-II::VE821
HPAF-II::AZD8186
AU565::MK-2206
KCL-22::NVP-ADW742
ESO51::GSK343
KP-4::Veliparib
JHOS-3::AZD8186
NOS-1::Irinotecan
A388::AZ6102
A388::SB216763
NCI-H1623::SB590885
OCI-M1::GSK2830371
ESO51::Pyridostatin
KCL-22::Nutlin-3a (-)
NUGC-4::AZD8186
UMC-11::AZ960
NUGC-4::MIM1
NCI-H1993::Avagacestat
U031::WIKI4
OCI-M1::GSK2606414
KARPAS-620::XAV939
CP50-MEL-B::Sorafenib
RT-112::BI-2536
UMC-11::Sorafenib
EW-22::GSK2578215A
CAL-29::Luminespib
LU-135::YK-4-279
MEL-HO::Veliparib
OCI-M1::MG-132
CAL-29::AGI-6780
NALM-6::Cytarabine
NCI-H1993::Methotrexate
EFO-21::Wnt-C59
WM-115::Cediranib
EW-22::Sepantronium bromide
UMC-11::PFI3
D-566MG::AGI-6780
AU565::GW441756
CP50-MEL-B::Doramapimod
KARPAS-620::Irinotecan
EFO-21::AZD8186
CHP-134::Uprosertib
KP-4::Wnt-C59
GA-10::JNK Inhibitor VIII
KCL-22::AGI-5198
KP-4::UMI-77
LU-135::Ruxolitinib
UMC-11::Pyridostatin
LC-2-ad::GNE-317
RT-112::Luminespib
CAL-29::Entospletinib
LB647-SCLC::Paclitaxel
NOS-1::Gefitinib
LB647-SCLC::BI-2536
DMS-114::I-BRD9
NCI-H1623::Cediranib
UMC-11::PFI-1
NALM-6::Motesanib
HPAF-II::Palbociclib
EW-22::Taselisib
LS-1034::Bosutinib
WM-115::Dactolisib
NCI-H1993::Lapatinib
GA-10::GSK343
Becker::Temsirolimus
UMC-11::NVP-ADW742
WM-115::IWP-2
LC-2-ad::Dactolisib
NOS-1::Nilotinib
CP50-MEL-B::ML323
RT-112::Lestaurtinib
NOS-1::Pyridostatin
LS-1034::Linsitinib
CAL-29::WZ4003
OCI-M1::GW441756
OCI-M1::AZD8055
WM-115::CCT007093
RT-112::ML323
DMS-114::AZ6102
TE-4::RO-3306
NOS-1::Luminespib
U031::Camptothecin
LB2241-RCC::Doramapimod
CP50-MEL-B::AGI-6780
KARPAS-620::MIRA-1
GA-10::Wnt-C59
SN12C::EPZ004777
AU565::BMS-536924
NCI-H1623::Sorafenib
DMS-114::RVX-208
GA-10::AGI-6780
CAL-29::KRAS (G12C) Inhibitor-12
HCC1143::Wnt-C59
LB2241-RCC::LCL161
RT-112::PD173074
NOS-1::Cisplatin
NOS-1::LJI308
SIMA::Obatoclax Mesylate
LS-1034::WZ4003
CPC-N::AZ6102
SIMA::Pyridostatin
MEL-HO::SGC0946
A388::KU-55933
UMC-11::GSK343
GA-10::Niraparib
LU-135::GNE-317
DMS-114::Uprosertib
U031::Dabrafenib
HPAF-II::AZ960
SU8686::LY2109761
SU8686::LGK974
KGN::P22077
LU-135::SCH772984
AU565::WIKI4
DMS-114::Picolinici-acid
EW-22::Nilotinib
CP50-MEL-B::PLX-4720
LB647-SCLC::SL0101
UMC-11::Afuresertib
CPC-N::GSK2606414
LU-135::VE-822
KCL-22::PD0325901
Becker::Afatinib
HPAF-II::I-BET-762
HPAF-II::PFI3
TE-4::AZD4547
NCI-H1623::GSK2830371
CPC-N::SN-38
LU-135::NVP-ADW742
U031::Venetoclax
ESO51::Lestaurtinib
GA-10::Afatinib
NALM-6::NVP-ADW742
SU8686::OF-1
SU8686::Vorinostat
SN12C::Luminespib
KARPAS-620::Paclitaxel
HCC1143::OSI-027
RT-112::PRT062607
KCL-22::Selumetinib
KCL-22::GSK343
NUGC-4::Rapamycin
UMC-11::Epirubicin
SIMA::Nilotinib
NOS-1::LGK974
EFO-21::Taselisib
CP50-MEL-B::Tozasertib
LB647-SCLC::GSK591
KCL-22::Vorinostat
SU8686::Wnt-C59
KP-4::KU-55933
U031::Ruxolitinib
TE-4::Vismodegib
NCI-H1993::Dasatinib
AU565::JNK Inhibitor VIII
NCI-H1623::Tanespimycin
CAL-29::VE-822
RT-112::Cediranib
KCL-22::Obatoclax Mesylate
SN12C::GNE-317
EFO-21::SB216763
SN12C::Osimertinib
JHOS-3::SB505124
CHP-134::YK-4-279
AU565::PFI-1
ESO51::Palbociclib
OCI-M1::Tamoxifen
KCL-22::AZD5582
KCL-22::Oxaliplatin
KARPAS-620::AMG-319
HPAF-II::Dasatinib
NALM-6::Cyclophosphamide
JHOS-3::LCL161
HCC1143::Doramapimod
LS-1034::Nilotinib
RT-112::Wnt-C59
SU8686::SCH772984
KCL-22::XAV939
NUGC-4::Entospletinib
WM-115::AZD6738
LU-135::Paclitaxel
NALM-6::Paclitaxel
LS-1034::Ibrutinib
HCC1143::PFI-1
LU-135::PFI-1
UMC-11::Bortezomib
NCI-H1993::Ribociclib
SU8686::OSI-027
SN12C::Camptothecin
WM-115::AZ6102
LB2241-RCC::LGK974
A388::Leflunomide
TE-4::AZD6738
EFO-21::Pevonedistat
UMC-11::NU7441
JHOS-3::Ipatasertib
EFO-21::PD173074
SU8686::YK-4-279
SIMA::VE821
AU565::Picolinici-acid
KARPAS-620::BMS-536924
HPAF-II::Nutlin-3a (-)
LU-135::Sepantronium bromide
CP50-MEL-B::SL0101
LB2241-RCC::Tanespimycin
SN12C::Lenalidomide
NUGC-4::VX-11e
LU-135::Axitinib
KP-4::Vinblastine
NALM-6::IWP-2
WM-115::Sorafenib
SIMA::AZD6738
JHOS-3::Tretinoin
HCC1143::GSK2578215A
EFO-21::Nilotinib
AU565::GSK269962A
KGN::MK-2206
CP50-MEL-B::AGI-5198
Becker::IWP-2
AU565::Tanespimycin
NOS-1::Pevonedistat
LU-135::ZM447439
JHOS-3::Lapatinib
KP-4::CCT007093
JHOS-3::PRT062607
KARPAS-620::Axitinib
ESO51::P22077
NALM-6::Lestaurtinib
AU565::BMS-345541
LC-2-ad::Telomerase Inhibitor IX
GA-10::WIKI4
EFO-21::BMS-345541
CP50-MEL-B::Selumetinib
KP-4::AZD7762
KCL-22::VE821
EW-22::Doramapimod
UMC-11::Vismodegib
NCI-H1993::Lenalidomide
Becker::AZD8055
SIMA::Vinorelbine
CHP-134::AZD3759
HCC1143::MK-2206
UMC-11::Pevonedistat
AU565::Vismodegib
UMC-11::Alisertib
TE-4::Cyclophosphamide
LS-1034::I-BRD9
SU8686::Alisertib
SN12C::JQ1
EFO-21::Alisertib
HPAF-II::Picolinici-acid
D-566MG::AZD4547
LB647-SCLC::YK-4-279
NCI-H1623::AGI-5198
KGN::KU-55933
LC-2-ad::ABT737
CPC-N::OSI-027
CAL-29::MIRA-1
DMS-114::SN-38
CP50-MEL-B::Serdemetan
U031::Savolitinib
HCC1143::Dinaciclib
CPC-N::VE-822
EW-22::Paclitaxel
EFO-21::Venetoclax
LB2241-RCC::NU7441
JHOS-3::YK-4-279
NALM-6::AZD7762
SIMA::BI-2536
LC-2-ad::Paclitaxel
NOS-1::GSK1904529A
OCI-M1::YK-4-279
CP50-MEL-B::Ruxolitinib
LB2241-RCC::Sorafenib
CPC-N::Bleomycin (50 uM)
NALM-6::Refametinib
UMC-11::Savolitinib
LB2241-RCC::Rapamycin
KCL-22::Avagacestat
OCI-M1::Camptothecin
JHOS-3::Motesanib
NOS-1::GW441756
RT-112::Cyclophosphamide
HCC1143::PF-4708671
LB647-SCLC::AGI-6780
NOS-1::XAV939
TE-4::Axitinib
KARPAS-620::MN-64
OCI-M1::Luminespib
AU565::AZD7762
Becker::Avagacestat
LC-2-ad::Foretinib
RT-112::Oxaliplatin
HPAF-II::Crizotinib
NUGC-4::SCH772984
JHOS-3::LJI308
CAL-29::GDC0810
CAL-29::Lapatinib
LB2241-RCC::Tozasertib
CP50-MEL-B::Wnt-C59
EFO-21::AZD5582
MEL-HO::VX-11e
GA-10::Picolinici-acid
KARPAS-620::Cediranib
NALM-6::VE821
NCI-H1623::Cisplatin
CP50-MEL-B::Dabrafenib
HCC1143::XAV939
NOS-1::Entospletinib
JHOS-3::JNK Inhibitor VIII
NALM-6::Savolitinib
Becker::LJI308
SN12C::Rapamycin
DMS-114::Sapitinib
LB2241-RCC::Picolinici-acid
SU8686::AGI-5198
SIMA::Cisplatin
NCI-H1993::MG-132
LS-1034::Temozolomide
LC-2-ad::PCI-34051
A388::Dinaciclib
AU565::Uprosertib
LB647-SCLC::Vismodegib
KARPAS-620::LJI308
NCI-H1993::Crizotinib
CAL-29::AZ960
KCL-22::Irinotecan
CPC-N::PD0325901
MEL-HO::Tozasertib
D-566MG::MK-2206
KGN::Camptothecin
CAL-29::GSK2606414
OCI-M1::ML323
OCI-M1::Methotrexate
Becker::AGI-5198
LB2241-RCC::Dinaciclib
CAL-29::Alisertib
UMC-11::Ipatasertib
LS-1034::GNE-317
LB647-SCLC::AZD6482
CAL-29::LY2109761
NCI-H1623::Afatinib
Becker::KU-55933
HCC1143::WZ4003
GA-10::Axitinib
D-566MG::ZM447439
AU565::SB216763
SN12C::Sabutoclax
CAL-29::Nilotinib
NOS-1::PFI3
NUGC-4::P22077
MEL-HO::AZ960
KCL-22::AMG-319
GA-10::Entinostat
SN12C::Bleomycin (50 uM)
MEL-HO::SB216763
SIMA::Alisertib
SU8686::EPZ004777
LC-2-ad::SGC0946
CPC-N::BMS-536924
RT-112::Sabutoclax
CAL-29::Dactolisib
MEL-HO::EHT-1864
TE-4::Gemcitabine
U031::Oxaliplatin
TE-4::Linsitinib
D-566MG::Sapitinib
DMS-114::BIBR-1532
NALM-6::Serdemetan
OCI-M1::WZ4003
NCI-H1623::AZD8055
NUGC-4::WEHI-539
D-566MG::Oxaliplatin
EW-22::RO-3306
NOS-1::GNE-317
GA-10::JQ1
EFO-21::SCH772984
NCI-H1623::BIBR-1532
SN12C::EHT-1864
GA-10::Luminespib
WM-115::GSK2606414
EW-22::Vorinostat
UMC-11::WEHI-539
ESO51::Dabrafenib
NOS-1::EPZ004777
LB647-SCLC::CCT007093
EW-22::GNE-317
DMS-114::JNK Inhibitor VIII
OCI-M1::Temsirolimus
KARPAS-620::Sabutoclax
MEL-HO::Ribociclib
NALM-6::Rucaparib
SIMA::AZD4547
WM-115::GDC0810
AU565::RVX-208
LC-2-ad::Nilotinib
JHOS-3::CZC24832
KARPAS-620::AZD6738
CHP-134::PLX-4720
LC-2-ad::Taselisib
WM-115::Talazoparib
MEL-HO::RO-3306
EW-22::JQ1
NCI-H1623::LGK974
RT-112::Vinblastine
GA-10::Bortezomib
U031::EPZ004777
DMS-114::Entinostat
CPC-N::ABT737
CHP-134::GSK2578215A
EFO-21::Crizotinib
LU-135::Cytarabine
KP-4::Refametinib
NOS-1::Vismodegib
EW-22::BMS-345541
U031::GDC0810
EFO-21::Entinostat
UMC-11::Foretinib
LS-1034::AZD5582
SU8686::PFI-1
HCC1143::OF-1
A388::AMG-319
EW-22::AZD8055
CP50-MEL-B::Epirubicin
KP-4::Olaparib
NCI-H1623::Wee1 Inhibitor
KARPAS-620::Lestaurtinib
NUGC-4::Afatinib
DMS-114::Epirubicin
DMS-114::Sepantronium bromide
LS-1034::Sorafenib
LB2241-RCC::Oxaliplatin
EFO-21::Irinotecan
KCL-22::SCH772984
OCI-M1::Telomerase Inhibitor IX
NCI-H1993::Linsitinib
NUGC-4::Linsitinib
KGN::Vinorelbine
NCI-H1623::Olaparib
OCI-M1::Bosutinib
NUGC-4::MK-2206
LB647-SCLC::AGI-5198
LU-135::GDC0810
SN12C::Paclitaxel
WM-115::Ruxolitinib
NCI-H1623::I-BET-762
TE-4::Rapamycin
ESO51::SN-38
NOS-1::Leflunomide
SN12C::GDC0810
KP-4::Telomerase Inhibitor IX
GA-10::Leflunomide
LB647-SCLC::Bicalutamide
AU565::OF-1
KGN::CCT007093
TE-4::CZC24832
HPAF-II::Gefitinib
LC-2-ad::LCL161
UMC-11::Vinblastine
ESO51::Bosutinib
KARPAS-620::GSK2578215A
OCI-M1::Taselisib
SN12C::SGC0946
AU565::Trametinib
TE-4::Gefitinib
JHOS-3::RVX-208
KARPAS-620::Bleomycin (50 uM)
SIMA::OTX015
MEL-HO::ABT737
CAL-29::GSK2578215A
NUGC-4::Selumetinib
EFO-21::Docetaxel
KGN::SGC0946
LB2241-RCC::Vismodegib
LC-2-ad::WIKI4
AU565::AZD6738
KCL-22::Tamoxifen
CAL-29::Fulvestrant
KP-4::MG-132
NCI-H1623::Lestaurtinib
SIMA::GSK343
U031::OSI-027
HPAF-II::Pictilisib
GA-10::XAV939
LB647-SCLC::Gefitinib
KP-4::Niraparib
NCI-H1623::ABT737
ESO51::Doramapimod
HPAF-II::5-Fluorouracil
TE-4::Methotrexate
LC-2-ad::Methotrexate
CP50-MEL-B::Ipatasertib
AU565::Dasatinib
LC-2-ad::Temsirolimus
NALM-6::LGK974
U031::LGK974
KGN::Pyridostatin
OCI-M1::EPZ004777
CAL-29::BIBR-1532
CHP-134::Cediranib
KGN::Lapatinib
LS-1034::Dabrafenib
NALM-6::Gemcitabine
OCI-M1::PCI-34051
TE-4::Avagacestat
KARPAS-620::Lapatinib
SN12C::AZD8055
EW-22::Entinostat
KCL-22::Entospletinib
LC-2-ad::Ribociclib
KP-4::I-BET-762
TE-4::Savolitinib
ESO51::5-Fluorouracil
EW-22::Pevonedistat
AU565::Gemcitabine
KGN::Bortezomib
MEL-HO::Temsirolimus
MEL-HO::PRT062607
SIMA::GNE-317
HPAF-II::Alisertib
A388::I-BRD9
ESO51::KRAS (G12C) Inhibitor-12
CP50-MEL-B::Veliparib
JHOS-3::AZD7762
OCI-M1::KRAS (G12C) Inhibitor-12
LS-1034::Olaparib
EFO-21::Sabutoclax
LC-2-ad::Nutlin-3a (-)
CHP-134::SCH772984
TE-4::Fulvestrant
WM-115::JQ1
OCI-M1::Vinorelbine
NCI-H1993::Veliparib
CAL-29::Rucaparib
LB2241-RCC::NVP-ADW742
KCL-22::OTX015
D-566MG::SB590885
KP-4::Venetoclax
JHOS-3::SCH772984
UMC-11::SCH772984
LB647-SCLC::ABT737
JHOS-3::GSK1904529A
MEL-HO::GSK269962A
CP50-MEL-B::SGC0946
Becker::MK-8776
CAL-29::LJI308
KP-4::Vismodegib
LS-1034::XAV939
TE-4::BMS-345541
SN12C::Alpelisib
A388::Cyclophosphamide
CPC-N::P22077
DMS-114::AZD7762
LB2241-RCC::GSK1904529A
GA-10::Tanespimycin
D-566MG::Sorafenib
CPC-N::Sapitinib
NALM-6::Tamoxifen
MEL-HO::Wnt-C59
KGN::AZD7762
NCI-H1993::RO-3306
SIMA::Venetoclax
GA-10::OTX015
MEL-HO::Camptothecin
NOS-1::VE821
NCI-H1623::Motesanib
LS-1034::Temsirolimus
EFO-21::Lenalidomide
NCI-H1993::NU7441
CHP-134::MN-64
WM-115::Refametinib
EFO-21::EPZ5676
NCI-H1993::RVX-208
A388::Camptothecin
KGN::Selumetinib
CPC-N::YK-4-279
SIMA::SB590885
NCI-H1623::Cytarabine
AU565::AZD4547
ESO51::AZ6102
KARPAS-620::AZD4547
CPC-N::AZD3759
DMS-114::Talazoparib
EFO-21::LGK974
HCC1143::Talazoparib
NOS-1::GSK591
JHOS-3::Trametinib
KARPAS-620::I-BRD9
HPAF-II::PRIMA-1MET
Becker::GSK1904529A
LC-2-ad::AZD6738
EFO-21::Ipatasertib
MEL-HO::BX795
LC-2-ad::Linsitinib
WM-115::WZ4003
SN12C::WEHI-539
Becker::Talazoparib
CPC-N::Ipatasertib
TE-4::Foretinib
LU-135::SN-38
WM-115::Docetaxel
HCC1143::Lenalidomide
CPC-N::PFI3
GA-10::SGC0946
LS-1034::Pictilisib
CPC-N::Gefitinib
SU8686::BIBR-1532
TE-4::ZM447439
LB647-SCLC::Nilotinib
TE-4::GSK1904529A
LU-135::Ipatasertib
U031::CHIR-99021
SN12C::GSK2606414
EW-22::AZD3759
WM-115::JNK Inhibitor VIII
LB2241-RCC::AMG-319
WM-115::GSK591
DMS-114::GSK2606414
LB647-SCLC::Temsirolimus
CPC-N::Linsitinib
MEL-HO::Linsitinib
CP50-MEL-B::Talazoparib
RT-112::Afuresertib
KARPAS-620::CCT007093
TE-4::Afuresertib
EW-22::Lenalidomide
EW-22::WIKI4
HCC1143::Cediranib
RT-112::Sapitinib
LC-2-ad::PFI-1
CAL-29::LGK974
DMS-114::Camptothecin
EW-22::YK-4-279
U031::Gemcitabine
TE-4::Irinotecan
SN12C::Navitoclax
RT-112::AZD7762
NOS-1::GSK2578215A
CP50-MEL-B::Cyclophosphamide
SIMA::BMS-536924
CPC-N::KRAS (G12C) Inhibitor-12
RT-112::AZ960
LS-1034::Talazoparib
KP-4::BIBR-1532
AU565::Rapamycin
LS-1034::Irinotecan
U031::IOX2
RT-112::BIBR-1532
RT-112::Vismodegib
HCC1143::Picolinici-acid
LU-135::Dactolisib
HCC1143::PRT062607
RT-112::MN-64
SIMA::LJI308
Becker::ZM447439
CHP-134::Trametinib
D-566MG::LCL161
D-566MG::Uprosertib
KCL-22::Epirubicin
NOS-1::GDC0810
SN12C::CCT007093
CAL-29::RVX-208
KARPAS-620::Fulvestrant
LS-1034::Cytarabine
LU-135::BMS-536924
D-566MG::PD173074
CP50-MEL-B::GNE-317
NOS-1::AZD4547
HPAF-II::Osimertinib
CAL-29::LCL161
CP50-MEL-B::SB216763
NCI-H1623::Nilotinib
NOS-1::Ibrutinib
CP50-MEL-B::AZD3759
CPC-N::Palbociclib
A388::Avagacestat
CHP-134::MIRA-1
RT-112::Avagacestat
CP50-MEL-B::OF-1
Becker::Vinorelbine
Becker::BI-2536
KGN::NVP-ADW742
KP-4::Vorinostat
D-566MG::AGI-5198
WM-115::PFI3
RT-112::Wee1 Inhibitor
A388::PLX-4720
U031::Pevonedistat
LB647-SCLC::Ruxolitinib
CP50-MEL-B::LCL161
KARPAS-620::Entinostat
EW-22::Gefitinib
OCI-M1::Linsitinib
CAL-29::BMS-345541
LB647-SCLC::Avagacestat
LB647-SCLC::GSK2606414
MEL-HO::Daporinad
TE-4::NU7441
LB2241-RCC::Entospletinib
U031::Veliparib
UMC-11::Dabrafenib
NCI-H1623::Alpelisib
LU-135::Leflunomide
LS-1034::Afuresertib
AU565::OTX015
U031::AGI-5198
WM-115::Ibrutinib
HCC1143::MG-132
JHOS-3::Venetoclax
SIMA::Ruxolitinib
HCC1143::NU7441
NOS-1::Picolinici-acid
KARPAS-620::AGI-5198
MEL-HO::Gefitinib
KGN::I-BRD9
CAL-29::Sepantronium bromide
U031::VE-822
DMS-114::PFI-1
DMS-114::SGC0946
NALM-6::AZD5582
RT-112::PFI3
EFO-21::Ruxolitinib
MEL-HO::Trametinib
WM-115::Bleomycin (50 uM)
SIMA::GSK2606414
HPAF-II::Savolitinib
OCI-M1::GDC0810
SIMA::YK-4-279
NCI-H1993::SGC0946
KARPAS-620::MK-8776
CAL-29::Serdemetan
LC-2-ad::SB590885
WM-115::Telomerase Inhibitor IX
AU565::Bosutinib
LB2241-RCC::PCI-34051
KARPAS-620::Foretinib
Becker::Veliparib
KARPAS-620::GSK2606414
KGN::PLX-4720
SN12C::Epirubicin
RT-112::Vorinostat
EW-22::AZ960
OCI-M1::Cytarabine
LC-2-ad::AZD5582
RT-112::Temsirolimus
LC-2-ad::VX-11e
KARPAS-620::Epirubicin
CPC-N::BI-2536
EW-22::Niraparib
CPC-N::Cyclophosphamide
HPAF-II::Trametinib
KCL-22::Pevonedistat
NUGC-4::NU7441
CP50-MEL-B::Ribociclib
HPAF-II::WZ4003
CP50-MEL-B::Erlotinib
AU565::KRAS (G12C) Inhibitor-12
NALM-6::Avagacestat
DMS-114::Lenalidomide
LS-1034::MG-132
A388::Ribociclib
AU565::AZD5582
RT-112::Rapamycin
GA-10::Oxaliplatin
GA-10::Dactolisib
ESO51::Oxaliplatin
LC-2-ad::Avagacestat
EW-22::Ruxolitinib
SU8686::GSK2578215A
U031::MG-132
DMS-114::Wee1 Inhibitor
A388::PRIMA-1MET
KGN::Foretinib
UMC-11::Entinostat
LB2241-RCC::Pevonedistat
A388::Telomerase Inhibitor IX
CPC-N::PD173074
KARPAS-620::UMI-77
ESO51::ZM447439
LB2241-RCC::GSK2606414
KGN::MIRA-1
HCC1143::Refametinib
D-566MG::SB505124
NCI-H1993::AZ6102
NALM-6::Leflunomide
JHOS-3::NVP-ADW742
DMS-114::EHT-1864
CHP-134::AZD5582
Becker::VX-11e
LB647-SCLC::Wee1 Inhibitor
Becker::VE821
EW-22::Bleomycin (50 uM)
Becker::VE-822
RT-112::SB590885
D-566MG::Rapamycin
NUGC-4::Pictilisib
SIMA::Luminespib
EW-22::KRAS (G12C) Inhibitor-12
ESO51::EPZ004777
NCI-H1993::Nilotinib
NCI-H1623::Palbociclib
HCC1143::Nutlin-3a (-)
CHP-134::WZ4003
CPC-N::Rapamycin
MEL-HO::LY2109761
KGN::GSK2578215A
Becker::Savolitinib
SN12C::Doramapimod
SN12C::BIBR-1532
CPC-N::AZD8055
LB647-SCLC::Luminespib
MEL-HO::Afatinib
NCI-H1993::Dinaciclib
EFO-21::RO-3306
WM-115::I-BET-762
CPC-N::AZD4547
A388::Rapamycin
KGN::Methotrexate
HCC1143::PD0325901
OCI-M1::I-BRD9
ESO51::Uprosertib
SN12C::Afatinib
LB2241-RCC::Wnt-C59
KCL-22::Pyridostatin
D-566MG::AZ960
JHOS-3::Rapamycin
U031::GSK343
LS-1034::Ipatasertib
NCI-H1623::Bosutinib
EW-22::MIRA-1
SN12C::XAV939
KARPAS-620::Rucaparib
U031::5-Fluorouracil
SN12C::P22077
CAL-29::Alpelisib
NCI-H1623::Telomerase Inhibitor IX
OCI-M1::Lestaurtinib
CAL-29::PRIMA-1MET
OCI-M1::Dabrafenib
WM-115::Venetoclax
WM-115::LJI308
SN12C::OTX015
A388::Dabrafenib
NALM-6::OTX015
SN12C::Pictilisib
CP50-MEL-B::Docetaxel
Becker::Sabutoclax
MEL-HO::Erlotinib
AU565::NU7441
A388::PRT062607
NALM-6::Bleomycin (50 uM)
SN12C::Lapatinib
AU565::Taselisib
A388::Methotrexate
LC-2-ad::GDC0810
KARPAS-620::Ibrutinib
CPC-N::PRIMA-1MET
DMS-114::Irinotecan
ESO51::PRIMA-1MET
KCL-22::AZ960
LB647-SCLC::Wnt-C59
NUGC-4::Temsirolimus
A388::Foretinib
NCI-H1623::Temozolomide
SIMA::EHT-1864
CAL-29::JNK Inhibitor VIII
LB647-SCLC::AZ6102
GA-10::SCH772984
DMS-114::Bortezomib
TE-4::IWP-2
HCC1143::Foretinib
KCL-22::BMS-345541
GA-10::VX-11e
Becker::Bleomycin (50 uM)
RT-112::Ipatasertib
EW-22::OSI-027
CP50-MEL-B::LJI308
RT-112::Entinostat
JHOS-3::Bicalutamide
LB647-SCLC::Oxaliplatin
UMC-11::I-BET-762
SIMA::Serdemetan
U031::Luminespib
CPC-N::Vismodegib
SU8686::Refametinib
CP50-MEL-B::WZ4003
JHOS-3::PF-4708671
NCI-H1623::Lapatinib
LB647-SCLC::Osimertinib
LS-1034::EHT-1864
KARPAS-620::BIBR-1532
UMC-11::Oxaliplatin
UMC-11::Lapatinib
Becker::Epirubicin
SN12C::Avagacestat
MEL-HO::LGK974
OCI-M1::OSI-027
LS-1034::YK-4-279
EFO-21::Lapatinib
HCC1143::Temozolomide
SIMA::IWP-2
NUGC-4::Gemcitabine
A388::Piperlongumine
KP-4::EPZ004777
KGN::Gemcitabine
RT-112::EHT-1864
NCI-H1993::KU-55933
JHOS-3::AZ6102
AU565::Entinostat
NOS-1::AGI-5198
HPAF-II::Wnt-C59
UMC-11::CCT007093
A388::EPZ004777
KARPAS-620::WIKI4
D-566MG::PRIMA-1MET
NUGC-4::GNE-317
LB2241-RCC::Navitoclax
A388::NVP-ADW742
LB2241-RCC::Niraparib
GA-10::GW441756
WM-115::Obatoclax Mesylate
WM-115::AMG-319
GA-10::Olaparib
MEL-HO::Dactolisib
D-566MG::Nilotinib
CP50-MEL-B::GW441756
NUGC-4::AZD5582
LU-135::EPZ004777
SN12C::KRAS (G12C) Inhibitor-12
LC-2-ad::Sabutoclax
U031::PRT062607
UMC-11::AZ6102
LU-135::Vismodegib
SIMA::Cytarabine
KGN::NU7441
LS-1034::BI-2536
TE-4::GSK2606414
U031::Wnt-C59
HCC1143::CCT007093
JHOS-3::EHT-1864
NUGC-4::Palbociclib
GA-10::PRIMA-1MET
OCI-M1::Sabutoclax
CP50-MEL-B::Uprosertib
LS-1034::AZD4547
NALM-6::Oxaliplatin
EFO-21::VE-822
LS-1034::GSK343
GA-10::Nilotinib
D-566MG::OF-1
EFO-21::Camptothecin
LC-2-ad::AZ960
SN12C::Alisertib
SN12C::PLX-4720
OCI-M1::LJI308
HPAF-II::Daporinad
CP50-MEL-B::GSK1904529A
NCI-H1993::MK-2206
KP-4::GSK343
NCI-H1623::Cyclophosphamide
CHP-134::Pictilisib
NCI-H1993::LCL161
LB2241-RCC::Lestaurtinib
KP-4::Dasatinib
TE-4::Cediranib
UMC-11::Vorinostat
NALM-6::AZ6102
ESO51::Trametinib
NUGC-4::Dactolisib
CP50-MEL-B::MN-64
MEL-HO::AZ6102
NCI-H1623::RO-3306
RT-112::Irinotecan
AU565::AZD6482
HPAF-II::OF-1
SN12C::Leflunomide
LB647-SCLC::Tretinoin
NUGC-4::JQ1
EFO-21::Uprosertib
SN12C::ZM447439
EW-22::Bosutinib
D-566MG::GNE-317
EFO-21::Serdemetan
NCI-H1993::AZD8186
CHP-134::BMS-345541
LB647-SCLC::LJI308
HCC1143::AZ6102
Becker::Tamoxifen
A388::Luminespib
D-566MG::Epirubicin
DMS-114::AGI-6780
JHOS-3::Talazoparib
EFO-21::I-BET-762
KARPAS-620::PD173074
KCL-22::OF-1
WM-115::Nilotinib
A388::Serdemetan
GA-10::Telomerase Inhibitor IX
D-566MG::Daporinad
U031::Avagacestat
KCL-22::Luminespib
NALM-6::Uprosertib
CP50-MEL-B::GDC0810
HCC1143::KU-55933
MEL-HO::Gemcitabine
EFO-21::MIM1
SIMA::GSK1904529A
WM-115::Lapatinib
CP50-MEL-B::RO-3306
OCI-M1::Talazoparib
EFO-21::KRAS (G12C) Inhibitor-12
UMC-11::Doramapimod
CHP-134::Leflunomide
OCI-M1::Temozolomide
OCI-M1::LGK974
LB647-SCLC::KU-55933
WM-115::Veliparib
CPC-N::Veliparib
KP-4::Navitoclax
TE-4::Pictilisib
JHOS-3::Bosutinib
NCI-H1623::LCL161
MEL-HO::Doramapimod
LC-2-ad::BX795
NALM-6::Methotrexate
D-566MG::MK-1775
RT-112::PD0325901
GA-10::PRT062607
RT-112::AMG-319
SU8686::Rapamycin
KP-4::LCL161
WM-115::RVX-208
ESO51::Ipatasertib
GA-10::PFI-1
LC-2-ad::GSK269962A
DMS-114::VE-822
KCL-22::GDC0810
NUGC-4::XAV939
SIMA::Dasatinib
CHP-134::AZ6102
KGN::Cyclophosphamide
ESO51::MIRA-1
SIMA::OF-1
EFO-21::Vinblastine
EFO-21::KU-55933
ESO51::SGC0946
LU-135::Pyridostatin
EFO-21::GNE-317
MEL-HO::Wee1 Inhibitor
KCL-22::BMS-536924
EW-22::Leflunomide
U031::Vinorelbine
LC-2-ad::Pevonedistat
CP50-MEL-B::GSK591
UMC-11::Cytarabine
GA-10::Avagacestat
NALM-6::MN-64
LU-135::GSK2578215A
KCL-22::GSK2830371
NALM-6::SB216763
SIMA::AZD3759
RT-112::GSK2606414
CHP-134::Savolitinib
DMS-114::BMS-536924
DMS-114::JQ1
AU565::ABT737
KP-4::Lenalidomide
KP-4::Nilotinib
HCC1143::Lestaurtinib
EW-22::ABT737
KCL-22::GSK1904529A
LB2241-RCC::Uprosertib
OCI-M1::BMS-345541
CHP-134::Tamoxifen
TE-4::Temozolomide
LC-2-ad::Fulvestrant
SU8686::BI-2536
NALM-6::Alpelisib
CHP-134::Paclitaxel
D-566MG::CCT-018159
SU8686::Vismodegib
Becker::BIBR-1532
UMC-11::Paclitaxel
Becker::Wnt-C59
EW-22::AZD7762
MEL-HO::Fulvestrant
LB647-SCLC::AZD4547
EFO-21::GSK343
WM-115::Sabutoclax
CP50-MEL-B::PD0325901
ESO51::PFI-1
CP50-MEL-B::KRAS (G12C) Inhibitor-12
D-566MG::Cediranib
KARPAS-620::Selumetinib
GA-10::AZD7762
NCI-H1993::Motesanib
Becker::Bosutinib
LS-1034::PFI3
LC-2-ad::Daporinad
NCI-H1623::MIRA-1
SU8686::5-Fluorouracil
U031::VX-11e
ESO51::BMS-536924
RT-112::Entospletinib
MEL-HO::BI-2536
EFO-21::RVX-208
LC-2-ad::5-Fluorouracil
KARPAS-620::NVP-ADW742
RT-112::MIM1
LS-1034::Telomerase Inhibitor IX
AU565::AGI-5198
Becker::GW441756
D-566MG::5-Fluorouracil
RT-112::Dactolisib
CP50-MEL-B::WIKI4
A388::Talazoparib
Becker::MG-132
HPAF-II::OSI-027
U031::AZD8186
LB2241-RCC::GNE-317
LB2241-RCC::GSK269962A
HCC1143::Obatoclax Mesylate
A388::GSK591
RT-112::Navitoclax
NOS-1::Bortezomib
A388::PF-4708671
SN12C::Docetaxel
KARPAS-620::Pevonedistat
SU8686::Olaparib
LB647-SCLC::WEHI-539
D-566MG::Niraparib
CAL-29::Epirubicin
MEL-HO::GSK591
OCI-M1::Pevonedistat
ESO51::Tanespimycin
DMS-114::Tanespimycin
NCI-H1993::ABT737
D-566MG::Pyridostatin
GA-10::Pevonedistat
NOS-1::Epirubicin
CPC-N::Dinaciclib
U031::PFI3
JHOS-3::AZD5582
SN12C::AZD4547
KARPAS-620::Temsirolimus
LU-135::AZ960
CHP-134::Nutlin-3a (-)
U031::Afuresertib
U031::Foretinib
LB2241-RCC::AZD6738
LB647-SCLC::Serdemetan
JHOS-3::GSK343
UMC-11::RVX-208
LC-2-ad::Entinostat
DMS-114::GSK591
NCI-H1623::Avagacestat
NCI-H1623::Uprosertib
WM-115::PD173074
HPAF-II::VX-11e
NUGC-4::KRAS (G12C) Inhibitor-12
LC-2-ad::Tamoxifen
LB2241-RCC::Bortezomib
A388::Bortezomib
NOS-1::Bosutinib
KCL-22::EPZ004777
JHOS-3::Linsitinib
CP50-MEL-B::Methotrexate
CAL-29::Gemcitabine
AU565::BIBR-1532
CP50-MEL-B::I-BET-762
Becker::Sepantronium bromide
NCI-H1623::Camptothecin
SN12C::AZD3759
LU-135::Entospletinib
D-566MG::Sepantronium bromide
CAL-29::Pyridostatin
HCC1143::Axitinib
HPAF-II::Sabutoclax
LB647-SCLC::CZC24832
EW-22::Crizotinib
U031::AZD4547
U031::ML323
NCI-H1623::Bleomycin (50 uM)
KP-4::EHT-1864
KCL-22::Ipatasertib
UMC-11::PD0325901
UMC-11::Leflunomide
TE-4::PRIMA-1MET
LU-135::Luminespib
NOS-1::PD0325901
TE-4::Motesanib
D-566MG::Wnt-C59
KCL-22::Ibrutinib
TE-4::Refametinib
NALM-6::TW 37
Becker::EHT-1864
TE-4::PFI3
NOS-1::Sorafenib
Becker::MIRA-1
ESO51::Sabutoclax
D-566MG::Doramapimod
EW-22::Sabutoclax
Becker::GNE-317
LU-135::AZ6102
LB2241-RCC::5-Fluorouracil
MEL-HO::PD173074
NUGC-4::GSK1904529A
D-566MG::Gefitinib
RT-112::Camptothecin
HCC1143::Pictilisib
CP50-MEL-B::Paclitaxel
CAL-29::Sapitinib
NUGC-4::Docetaxel
OCI-M1::ZM447439
U031::AZ6102
D-566MG::Palbociclib
KGN::Bleomycin (50 uM)
D-566MG::Afatinib
SN12C::Lestaurtinib
AU565::Axitinib
LB647-SCLC::Alisertib
MEL-HO::MK-8776
LS-1034::Entinostat
OCI-M1::PFI-1
ESO51::Epirubicin
MEL-HO::PD0325901
MEL-HO::Rapamycin
LU-135::BI-2536
LB647-SCLC::XAV939
LS-1034::SCH772984
CPC-N::Leflunomide
CPC-N::Telomerase Inhibitor IX
SU8686::GW441756
U031::MK-2206
GA-10::Sabutoclax
GA-10::AGI-5198
CAL-29::Leflunomide
NCI-H1623::Ipatasertib
D-566MG::PCI-34051
EW-22::Temsirolimus
SIMA::AZD8186
ESO51::JQ1
A388::Dactolisib
DMS-114::MIRA-1
UMC-11::LCL161
CP50-MEL-B::Alisertib
LU-135::Temsirolimus
SU8686::NU7441
Becker::BMS-536924
CAL-29::Niraparib
EW-22::Olaparib
GA-10::IWP-2
LS-1034::Vinblastine
RT-112::GW441756
AU565::P22077
SIMA::Vismodegib
OCI-M1::Cisplatin
NCI-H1993::PD173074
CP50-MEL-B::Fulvestrant
TE-4::PD0325901
KP-4::Foretinib
HCC1143::AZD6482
CHP-134::Palbociclib
HPAF-II::Niraparib
SIMA::CCT007093
HCC1143::Pyridostatin
AU565::PD173074
LU-135::Venetoclax
NALM-6::Fulvestrant
NOS-1::Vinorelbine
NALM-6::AZD8186
OCI-M1::AMG-319
CP50-MEL-B::Sabutoclax
KARPAS-620::AGI-6780
LC-2-ad::Vorinostat
JHOS-3::IOX2
EFO-21::PFI3
NCI-H1993::PFI3
U031::CZC24832
KARPAS-620::Serdemetan
EFO-21::OF-1
HCC1143::Palbociclib
KARPAS-620::EPZ5676
TE-4::EPZ004777
NCI-H1623::AZ960
DMS-114::Savolitinib
ESO51::SCH772984
TE-4::Ipatasertib
DMS-114::Temsirolimus
JHOS-3::Serdemetan
LC-2-ad::EPZ5676
SIMA::LY2109761
ESO51::Lapatinib
NCI-H1623::GSK2578215A
Becker::EPZ5676
NALM-6::GSK2606414
SIMA::MK-2206
UMC-11::Talazoparib
SIMA::Linsitinib
LB647-SCLC::Piperlongumine
AU565::UMI-77
KGN::Talazoparib
D-566MG::EHT-1864
A388::JNK Inhibitor VIII
GA-10::Pictilisib
D-566MG::JNK Inhibitor VIII
DMS-114::XAV939
GA-10::Cisplatin
NOS-1::SB590885
JHOS-3::Piperlongumine
LS-1034::PLX-4720
KGN::Vismodegib
TE-4::SB216763
D-566MG::Pevonedistat
A388::BIBR-1532
U031::LY2109761
GA-10::Rapamycin
EW-22::Linsitinib
DMS-114::Motesanib
GA-10::YK-4-279
CAL-29::JQ1
CP50-MEL-B::Vorinostat
KCL-22::PD173074
CHP-134::LJI308
CPC-N::Navitoclax
HPAF-II::MN-64
CAL-29::SGC0946
NOS-1::EHT-1864
KCL-22::Savolitinib
AU565::NVP-ADW742
A388::Pevonedistat
RT-112::Rucaparib
SN12C::AZD8186
KARPAS-620::Talazoparib
WM-115::YK-4-279
SIMA::Docetaxel
NUGC-4::NVP-ADW742
SIMA::Ipatasertib
KCL-22::I-BRD9
SU8686::Entinostat
ESO51::MK-8776
NUGC-4::AMG-319
SN12C::BMS-345541
KP-4::AMG-319
KCL-22::Entinostat
TE-4::Oxaliplatin
LB2241-RCC::Alpelisib
TE-4::Taselisib
TE-4::Uprosertib
CP50-MEL-B::AZD6738
NCI-H1623::Osimertinib
NUGC-4::Talazoparib
ESO51::WEHI-539
LC-2-ad::Bosutinib
EFO-21::GSK2578215A
SU8686::BMS-536924
LC-2-ad::Ibrutinib
Becker::Uprosertib
CP50-MEL-B::CZC24832
SN12C::Bosutinib
NALM-6::Daporinad
A388::Alpelisib
MEL-HO::Entinostat
KP-4::Doramapimod
LU-135::Afuresertib
U031::AMG-319
HPAF-II::Olaparib
CP50-MEL-B::PFI-1
A388::Docetaxel
A388::EHT-1864
LU-135::Alisertib
NOS-1::Uprosertib
LB2241-RCC::I-BET-762
SU8686::ZM447439
DMS-114::Pyridostatin
KP-4::MK-1775
NUGC-4::AZD3759
NCI-H1623::WIKI4
DMS-114::Entospletinib
WM-115::Gemcitabine
NUGC-4::Motesanib
LS-1034::Gemcitabine
EW-22::Bortezomib
OCI-M1::Wnt-C59
UMC-11::Osimertinib
SN12C::VE-822
OCI-M1::GSK591
AU565::GDC0810
WM-115::OF-1
LC-2-ad::Temozolomide
NCI-H1993::Lestaurtinib
KP-4::XAV939
WM-115::MK-1775
NALM-6::Nilotinib
NOS-1::KU-55933
CAL-29::Doramapimod
LS-1034::AZD7762
LB647-SCLC::AZD8186
CPC-N::Trametinib
Becker::LY2109761
Becker::JNK Inhibitor VIII
KCL-22::SB216763
DMS-114::KU-55933
NUGC-4::Oxaliplatin
CPC-N::I-BRD9
CAL-29::AZD4547
SIMA::SN-38
D-566MG::YK-4-279
SN12C::Palbociclib
U031::Picolinici-acid
CAL-29::Erlotinib
Becker::Dinaciclib
LB2241-RCC::Alisertib
JHOS-3::Docetaxel
RT-112::Uprosertib
DMS-114::VE821
SU8686::Sapitinib
EFO-21::Selumetinib
EW-22::Temozolomide
NOS-1::Alpelisib
SIMA::PD173074
CAL-29::Vinorelbine
SN12C::Rucaparib
D-566MG::Trametinib
A388::WEHI-539
KCL-22::Dinaciclib
WM-115::SCH772984
CHP-134::Dabrafenib
LS-1034::WIKI4
NUGC-4::Wnt-C59
KARPAS-620::Entospletinib
U031::LCL161
CPC-N::Vinorelbine
RT-112::SN-38
LB2241-RCC::AGI-6780
DMS-114::Bleomycin (50 uM)
CP50-MEL-B::BMS-536924
LB2241-RCC::Temsirolimus
NOS-1::GSK2830371
UMC-11::Afatinib
KARPAS-620::Ruxolitinib
NUGC-4::Dinaciclib
KCL-22::Picolinici-acid
LU-135::Doramapimod
OCI-M1::Irinotecan
CAL-29::Palbociclib
NALM-6::Taselisib
RT-112::MIRA-1
KGN::Trametinib
A388::GSK1904529A
CPC-N::Avagacestat
KARPAS-620::AZD7762
TE-4::Sabutoclax
HCC1143::Alpelisib
KARPAS-620::Uprosertib
WM-115::Serdemetan
CHP-134::Foretinib
SIMA::Bortezomib
WM-115::MIRA-1
JHOS-3::Fulvestrant
D-566MG::OTX015
EFO-21::Tanespimycin
WM-115::AGI-5198
LU-135::Motesanib
LC-2-ad::Doramapimod
UMC-11::PLX-4720
A388::Paclitaxel
KCL-22::Uprosertib
DMS-114::PD0325901
HCC1143::AZD3759
U031::SN-38
ESO51::AGI-6780
AU565::Oxaliplatin
AU565::AGI-6780
NCI-H1993::MK-1775
LU-135::Oxaliplatin
ESO51::GSK2830371
WM-115::Tamoxifen
OCI-M1::BI-2536
LB2241-RCC::I-BRD9
KGN::UMI-77
KGN::MK-1775
U031::Dasatinib
AU565::Ibrutinib
ESO51::MIM1
KCL-22::WEHI-539
A388::MIRA-1
D-566MG::BIBR-1532
LB647-SCLC::Dabrafenib
WM-115::MK-2206
U031::Bosutinib
HCC1143::Vinblastine
NALM-6::Wee1 Inhibitor
MEL-HO::YK-4-279
TE-4::Rucaparib
A388::BMS-345541
NOS-1::5-Fluorouracil
EFO-21::Savolitinib
U031::Erlotinib
KCL-22::VX-11e
KARPAS-620::Refametinib
Becker::Ipatasertib
CPC-N::GSK591
GA-10::MIRA-1
WM-115::Afuresertib
A388::WZ4003
LS-1034::PCI-34051
LB2241-RCC::Camptothecin
NCI-H1993::AZD4547
U031::Docetaxel
NCI-H1993::EPZ004777
TE-4::Selumetinib
KGN::WEHI-539
KARPAS-620::Dabrafenib
OCI-M1::I-BET-762
LB647-SCLC::BMS-536924
KCL-22::Sapitinib
NCI-H1993::OF-1
MEL-HO::GSK1904529A
TE-4::Doramapimod
LC-2-ad::LGK974
LC-2-ad::AGI-6780
KGN::MIM1
UMC-11::Nilotinib
CPC-N::Dasatinib
JHOS-3::AZD3759
UMC-11::ABT737
JHOS-3::Rucaparib
Becker::Taselisib
JHOS-3::Methotrexate
ESO51::OSI-027
MEL-HO::CCT007093
OCI-M1::IWP-2
MEL-HO::Epirubicin
CP50-MEL-B::Axitinib
ESO51::Cyclophosphamide
DMS-114::CCT007093
SU8686::RO-3306
LC-2-ad::VE821
TE-4::OF-1
TE-4::BMS-536924
CP50-MEL-B::Olaparib
A388::Nilotinib
JHOS-3::GNE-317
NCI-H1993::Alisertib
Becker::AZ6102
WM-115::PRIMA-1MET
LU-135::Tamoxifen
KGN::Axitinib
LS-1034::WEHI-539
U031::BMS-345541
HCC1143::Rucaparib
KARPAS-620::Cyclophosphamide
DMS-114::Trametinib
TE-4::JQ1
SU8686::AZD5582
KGN::Vinblastine
RT-112::GSK591
NOS-1::Vorinostat
LB2241-RCC::JQ1
Becker::Pyridostatin
LS-1034::BMS-536924
NALM-6::BMS-345541
UMC-11::Navitoclax
MEL-HO::SB505124
NALM-6::PCI-34051
LB647-SCLC::SCH772984
KCL-22::5-Fluorouracil
GA-10::5-Fluorouracil
HPAF-II::SB216763
NOS-1::Cediranib
SIMA::Navitoclax
JHOS-3::ZM447439
SIMA::Rapamycin
TE-4::Sapitinib
OCI-M1::OF-1
EW-22::Afuresertib
MEL-HO::Ruxolitinib
NUGC-4::AZ6102
WM-115::KRAS (G12C) Inhibitor-12
SU8686::Dactolisib
TE-4::Tamoxifen
SN12C::Taselisib
LU-135::Camptothecin
OCI-M1::Fulvestrant
NCI-H1623::BMS-345541
LC-2-ad::IWP-2
NALM-6::OSI-027
KP-4::Savolitinib
RT-112::WZ4003
LB647-SCLC::Alpelisib
NCI-H1993::Dactolisib
A388::SCH772984
LC-2-ad::Ipatasertib
HCC1143::Tozasertib
RT-112::AGI-5198
NUGC-4::Sepantronium bromide
U031::CCT007093
SN12C::Vinblastine
KCL-22::GSK2606414
MEL-HO::Dabrafenib
WM-115::Avagacestat
AU565::YK-4-279
U031::Axitinib
JHOS-3::Pyridostatin
ESO51::Sorafenib
U031::LJI308
HPAF-II::Cyclophosphamide
CPC-N::JQ1
NOS-1::SCH772984
EFO-21::AZ6102
WM-115::OSI-027
SU8686::Tamoxifen
KCL-22::Leflunomide
U031::Gefitinib
CPC-N::EPZ004777
SIMA::Refametinib
MEL-HO::AZD4547
EFO-21::Methotrexate
Becker::Bortezomib
LC-2-ad::Refametinib
U031::Vismodegib
RT-112::ABT737
NUGC-4::Lenalidomide
OCI-M1::NU7441
CAL-29::P22077
NCI-H1993::Leflunomide
SN12C::Savolitinib
Becker::Entospletinib
ESO51::AZD4547
Becker::I-BRD9
Becker::AMG-319
LU-135::PD173074
NCI-H1623::PD173074
KARPAS-620::Pictilisib
ESO51::PCI-34051
Becker::Serdemetan
Becker::Lapatinib
NALM-6::JNK Inhibitor VIII
NCI-H1623::NVP-ADW742
HPAF-II::P22077
LU-135::Lenalidomide
TE-4::LGK974
NOS-1::Afuresertib
DMS-114::LY2109761
CHP-134::GSK1904529A
KP-4::Sapitinib
NCI-H1623::Methotrexate
SU8686::Linsitinib
KARPAS-620::RVX-208
LC-2-ad::Picolinici-acid
A388::5-Fluorouracil
CAL-29::Telomerase Inhibitor IX
CAL-29::Temozolomide
CAL-29::Ibrutinib
KARPAS-620::Oxaliplatin
NCI-H1993::Taselisib
LB647-SCLC::Venetoclax
SIMA::AZD5582
KCL-22::Crizotinib
UMC-11::Linsitinib
NCI-H1993::Entospletinib
OCI-M1::AZ960
LU-135::PRIMA-1MET
HPAF-II::Vinblastine
LB647-SCLC::Irinotecan
JHOS-3::OSI-027
UMC-11::MK-1775
ESO51::BIBR-1532
Becker::YK-4-279
AU565::Obatoclax Mesylate
EW-22::MK-8776
TE-4::Dinaciclib
NALM-6::PD0325901
JHOS-3::AZD4547
U031::SL0101
MEL-HO::Docetaxel
UMC-11::Serdemetan
EFO-21::UMI-77
HCC1143::IWP-2
SIMA::Afatinib
ESO51::Obatoclax Mesylate
SN12C::Vismodegib
U031::YK-4-279
NCI-H1623::Veliparib
KP-4::Luminespib
GA-10::UMI-77
MEL-HO::Tanespimycin
U031::GW441756
U031::Lapatinib
AU565::AZ6102
SN12C::Axitinib
KCL-22::WZ4003
D-566MG::WZ4003
CAL-29::Lestaurtinib
SN12C::Telomerase Inhibitor IX
CP50-MEL-B::VE-822
LS-1034::Daporinad
AU565::PRT062607
U031::Osimertinib
HCC1143::Telomerase Inhibitor IX
LB2241-RCC::Afuresertib
RT-112::Tanespimycin
CHP-134::Oxaliplatin
NALM-6::Dabrafenib
HCC1143::MK-8776
MEL-HO::Paclitaxel
SIMA::GSK2578215A
RT-112::AZD6738
LU-135::Afatinib
U031::Wee1 Inhibitor
MEL-HO::Serdemetan
ESO51::PFI3
OCI-M1::Wee1 Inhibitor
ESO51::Camptothecin
SU8686::Methotrexate
KP-4::Tanespimycin
KCL-22::ML323
RT-112::Tamoxifen
NALM-6::YK-4-279
SN12C::I-BET-762
OCI-M1::AZD3759
HCC1143::Taselisib
HCC1143::Gefitinib
LS-1034::Rapamycin
DMS-114::Olaparib
CAL-29::AZD8186
A388::Lestaurtinib
GA-10::Wee1 Inhibitor
NUGC-4::PFI3
CP50-MEL-B::Lapatinib
NCI-H1993::GSK2606414
CHP-134::5-Fluorouracil
KP-4::ZM447439
EFO-21::EHT-1864
UMC-11::Ibrutinib
SN12C::OF-1
EFO-21::Gemcitabine
SIMA::JQ1
RT-112::Axitinib
MEL-HO::CCT-018159
CP50-MEL-B::Tanespimycin
ESO51::Navitoclax
JHOS-3::Uprosertib
CAL-29::Tamoxifen
EFO-21::IWP-2
LC-2-ad::LY2109761
TE-4::GSK591
WM-115::BIBR-1532
HCC1143::Ruxolitinib
WM-115::Foretinib
NOS-1::Oxaliplatin
KARPAS-620::Dinaciclib
JHOS-3::I-BET-762
WM-115::GW441756
NUGC-4::LCL161
KGN::Obatoclax Mesylate
UMC-11::Venetoclax
EFO-21::Dinaciclib
NUGC-4::Olaparib
SU8686::Motesanib
DMS-114::NVP-ADW742
A388::Nutlin-3a (-)
LB647-SCLC::OSI-027
LS-1034::SB216763
LB2241-RCC::AZD4547
SIMA::GSK2830371
AU565::Temozolomide
ESO51::Rapamycin
CHP-134::Docetaxel
OCI-M1::Paclitaxel
CPC-N::Foretinib
LC-2-ad::PLX-4720
ESO51::Docetaxel
SN12C::VX-11e
NUGC-4::Sorafenib
CPC-N::Oxaliplatin
CPC-N::Osimertinib
TE-4::GSK2830371
OCI-M1::RO-3306
SIMA::Cyclophosphamide
HCC1143::MK-1775
LS-1034::GSK1904529A
HPAF-II::PLX-4720
LB647-SCLC::I-BET-762
NCI-H1993::Pictilisib
LU-135::AZD8186
WM-115::MN-64
A388::Tozasertib
SU8686::Dinaciclib
NALM-6::EPZ004777
NALM-6::Telomerase Inhibitor IX
EFO-21::Ibrutinib
NUGC-4::OTX015
ESO51::EHT-1864
CHP-134::I-BET-762
U031::PD0325901
NALM-6::PLX-4720
NALM-6::Dactolisib
NUGC-4::Cytarabine
CHP-134::LCL161
AU565::PF-4708671
OCI-M1::Cediranib
NUGC-4::Nutlin-3a (-)
EFO-21::BI-2536
AU565::MK-1775
SN12C::BI-2536
A388::Refametinib
UMC-11::Erlotinib
RT-112::Sepantronium bromide
LC-2-ad::KRAS (G12C) Inhibitor-12
JHOS-3::Sorafenib
RT-112::Serdemetan
NCI-H1993::Rapamycin
KARPAS-620::MG-132
CAL-29::PFI-1
HPAF-II::GW441756
Becker::Lenalidomide
LC-2-ad::Navitoclax
NCI-H1623::BMS-536924
CHP-134::Irinotecan
WM-115::Motesanib
NOS-1::Lestaurtinib
SIMA::PRIMA-1MET
KGN::SB216763
DMS-114::Dasatinib
EW-22::Ipatasertib
GA-10::Venetoclax
EW-22::MG-132
EW-22::Foretinib
HCC1143::Lapatinib
CHP-134::Vorinostat
LC-2-ad::Docetaxel
KCL-22::Vinorelbine
CPC-N::AZD7762
NOS-1::Selumetinib
WM-115::LCL161
NUGC-4::GSK2578215A
LB2241-RCC::Dactolisib
KP-4::Talazoparib
U031::Elesclomol
JHOS-3::JQ1
CP50-MEL-B::BI-2536
LB647-SCLC::Vorinostat
CP50-MEL-B::SCH772984
HPAF-II::GNE-317
CHP-134::Erlotinib
LU-135::Foretinib
CPC-N::Lapatinib
RT-112::Pevonedistat
NALM-6::MK-1775
HCC1143::Osimertinib
D-566MG::Nutlin-3a (-)
NOS-1::Afatinib
SIMA::Afuresertib
TE-4::MK-8776
OCI-M1::WEHI-539
LC-2-ad::Talazoparib
OCI-M1::Avagacestat
KARPAS-620::Bortezomib
RT-112::AZD4547
U031::GSK269962A
LS-1034::Methotrexate
KP-4::Serdemetan
NCI-H1993::Bleomycin (50 uM)
EW-22::Picolinici-acid
KCL-22::Taselisib
OCI-M1::Rapamycin
ESO51::ML323
LB2241-RCC::SB590885
UMC-11::GSK1904529A
EFO-21::Rucaparib
LU-135::Lapatinib
NUGC-4::SN-38
NALM-6::Olaparib
SU8686::MK-2206
U031::PF-4708671
CP50-MEL-B::Venetoclax
MEL-HO::KRAS (G12C) Inhibitor-12
LU-135::MIRA-1
KARPAS-620::Obatoclax Mesylate
NUGC-4::SB590885
HCC1143::Navitoclax
D-566MG::Olaparib
HCC1143::LCL161
KARPAS-620::PFI3
NCI-H1623::Niraparib
NALM-6::RVX-208
EW-22::Ribociclib
KP-4::MIM1
EFO-21::OSI-027
SIMA::Ribociclib
LU-135::Rapamycin
LB2241-RCC::Nilotinib
CPC-N::Venetoclax
KARPAS-620::OTX015
KCL-22::AZD6738
ESO51::Pevonedistat
SU8686::Fulvestrant
A388::ABT737
AU565::SCH772984
EFO-21::Bleomycin (50 uM)
AU565::Ribociclib
LB2241-RCC::GSK343
AU565::Methotrexate
SN12C::VE821
U031::MK-8776
NALM-6::Vinblastine
DMS-114::KRAS (G12C) Inhibitor-12
TE-4::Pevonedistat
NCI-H1993::AGI-6780
NUGC-4::PLX-4720
OCI-M1::JNK Inhibitor VIII
UMC-11::Lenalidomide
LC-2-ad::CCT-018159
Becker::Irinotecan
MEL-HO::Venetoclax
D-566MG::Crizotinib
D-566MG::Taselisib
MEL-HO::SB590885
MEL-HO::EPZ004777
SN12C::Afuresertib
CHP-134::CZC24832
GA-10::Lapatinib
OCI-M1::Trametinib
KGN::GSK591
D-566MG::Refametinib
NOS-1::AZD8055
GA-10::Ibrutinib
KGN::PD0325901
LU-135::Cyclophosphamide
CPC-N::Selumetinib
D-566MG::Tamoxifen
SIMA::Tanespimycin
LS-1034::GSK2606414
SIMA::MG-132
SU8686::Venetoclax
Becker::Motesanib
AU565::Selumetinib
OCI-M1::Obatoclax Mesylate
AU565::Cytarabine
KARPAS-620::GSK343
SU8686::I-BET-762
SU8686::Lapatinib
KGN::AMG-319
LS-1034::Fulvestrant
U031::Trametinib
U031::OF-1
LS-1034::Taselisib
ESO51::Gefitinib
MEL-HO::PF-4708671
TE-4::Paclitaxel
ESO51::GSK591
NCI-H1993::AZD8055
GA-10::AZ6102
DMS-114::Palbociclib
CPC-N::Dabrafenib
GA-10::GSK2830371
EW-22::RVX-208
ESO51::Cediranib
U031::Ribociclib
SU8686::AZD3759
CPC-N::NU7441
U031::Daporinad
CAL-29::Trametinib
GA-10::LGK974
LB647-SCLC::PFI-1
D-566MG::Ribociclib
D-566MG::CCT007093
CPC-N::MN-64
Becker::LGK974
SIMA::Lestaurtinib
NCI-H1623::Rucaparib
NCI-H1623::AGI-6780
SIMA::KRAS (G12C) Inhibitor-12
A388::Axitinib
ESO51::Osimertinib
SU8686::Vinblastine
Becker::Lestaurtinib
U031::GSK2578215A
LU-135::MN-64
RT-112::KU-55933
SN12C::Niraparib
CHP-134::Vinblastine
LB2241-RCC::AZD5582
LB2241-RCC::OF-1
A388::KRAS (G12C) Inhibitor-12
CHP-134::Camptothecin
KARPAS-620::Veliparib
DMS-114::CZC24832
CHP-134::Lapatinib
KCL-22::Gefitinib
KCL-22::CZC24832
NCI-H1623::Navitoclax
HCC1143::PCI-34051
NOS-1::UMI-77
HCC1143::RO-3306
SN12C::MK-1775
LS-1034::Vismodegib
NUGC-4::Venetoclax
TE-4::Crizotinib
EW-22::Camptothecin
Becker::P22077
LC-2-ad::SB216763
LB2241-RCC::WEHI-539
SIMA::BIBR-1532
EFO-21::EPZ004777
AU565::Doramapimod
KCL-22::Bortezomib
NUGC-4::AGI-6780
LB2241-RCC::CHIR-99021
CP50-MEL-B::Afuresertib
EW-22::JNK Inhibitor VIII
HCC1143::Cyclophosphamide
Becker::GSK2578215A
LB647-SCLC::CCT-018159
KP-4::Methotrexate
TE-4::BI-2536
LC-2-ad::NVP-ADW742
AU565::AMG-319
UMC-11::MIM1
LB2241-RCC::Osimertinib
KGN::GW441756
D-566MG::GSK2578215A
SN12C::Dasatinib
SN12C::GSK591
WM-115::Nutlin-3a (-)
SU8686::Luminespib
LU-135::GSK343
SU8686::MG-132
NOS-1::PCI-34051
D-566MG::Navitoclax
JHOS-3::Irinotecan
CAL-29::Bleomycin (50 uM)
LS-1034::RO-3306
NOS-1::MK-8776
NUGC-4::Nilotinib
KP-4::LJI308
ESO51::Pictilisib
NCI-H1993::Bortezomib
AU565::Vorinostat
MEL-HO::AZD3759
WM-115::Temozolomide
EW-22::I-BET-762
LC-2-ad::AZD4547
SIMA::Dinaciclib
U031::Alisertib
SN12C::GSK1904529A
AU565::Motesanib
AU565::Niraparib
UMC-11::LY2109761
ESO51::Temozolomide
WM-115::Pictilisib
DMS-114::Gefitinib
SIMA::Lapatinib
LC-2-ad::JQ1
JHOS-3::Entinostat
NUGC-4::MG-132
NOS-1::Wee1 Inhibitor
TE-4::Dabrafenib
EFO-21::GSK591
NCI-H1993::Uprosertib
WM-115::Crizotinib
SIMA::Pictilisib
DMS-114::AGI-5198
LB647-SCLC::Epirubicin
TE-4::Nutlin-3a (-)
LS-1034::Gefitinib
EFO-21::CZC24832
LC-2-ad::EHT-1864
UMC-11::WZ4003
D-566MG::Vinorelbine
OCI-M1::Pyridostatin
Becker::PLX-4720
UMC-11::Nutlin-3a (-)
LB647-SCLC::GW441756
DMS-114::Foretinib
KARPAS-620::ZM447439
WM-115::EPZ5676
HPAF-II::LGK974
MEL-HO::Lestaurtinib
HCC1143::Nilotinib
AU565::IWP-2
Becker::GSK343
AU565::Nilotinib
HPAF-II::ML323
U031::Dactolisib
KGN::Rucaparib
SN12C::EPZ5676
GA-10::AZD8055
JHOS-3::Wee1 Inhibitor
CAL-29::PFI3
JHOS-3::MG-132
NCI-H1993::Selumetinib
HCC1143::Irinotecan
MEL-HO::Vorinostat
CHP-134::PRIMA-1MET
WM-115::Linsitinib
LB2241-RCC::Entinostat
Becker::Luminespib
Becker::OF-1
HCC1143::BI-2536
LB647-SCLC::Taselisib
LB2241-RCC::Erlotinib
ESO51::Linsitinib
NCI-H1993::Telomerase Inhibitor IX
GA-10::Vinblastine
KARPAS-620::Tanespimycin
OCI-M1::Dactolisib
GA-10::Alpelisib
WM-115::I-BRD9
LU-135::MK-1775
D-566MG::GSK343
SN12C::Methotrexate
JHOS-3::MK-8776
NCI-H1993::Talazoparib
CAL-29::PCI-34051
AU565::GSK1904529A
KGN::AZ6102
KP-4::Epirubicin
JHOS-3::Foretinib
HCC1143::Paclitaxel
CAL-29::Vismodegib
GA-10::Methotrexate
CP50-MEL-B::CHIR-99021
AU565::Venetoclax
MEL-HO::GSK343
GA-10::Serdemetan
CPC-N::Entinostat
HCC1143::Motesanib
LU-135::GSK591
LB2241-RCC::Foretinib
TE-4::Serdemetan
JHOS-3::Vinorelbine
LB2241-RCC::Bosutinib
KP-4::Lapatinib
CP50-MEL-B::NU7441
DMS-114::LCL161
LB647-SCLC::OTX015
CAL-29::Motesanib
MEL-HO::CZC24832
MEL-HO::Tretinoin
HCC1143::Tanespimycin
LU-135::Bleomycin (50 uM)
GA-10::GDC0810
ESO51::I-BET-762
SU8686::GSK1904529A
LB647-SCLC::Selumetinib
CAL-29::Venetoclax
MEL-HO::EPZ5676
A388::Venetoclax
NUGC-4::Uprosertib
LU-135::Epirubicin
SU8686::JNK Inhibitor VIII
GA-10::Camptothecin
A388::CCT007093
Becker::JQ1
Becker::GSK2830371
SIMA::NU7441
LC-2-ad::BI-2536
UMC-11::PRIMA-1MET
TE-4::AGI-6780
LB2241-RCC::SCH772984
Becker::PFI3
KCL-22::Rapamycin
TE-4::GW441756
EW-22::EPZ004777
KCL-22::MK-1775
OCI-M1::Crizotinib
KP-4::RVX-208
NCI-H1623::VX-11e
GA-10::Doramapimod
Becker::SN-38
NCI-H1993::Palbociclib
JHOS-3::Temozolomide
D-566MG::BMS-536924
OCI-M1::Rucaparib
EFO-21::Dabrafenib
HPAF-II::LY2109761
SIMA::Axitinib
LS-1034::Sepantronium bromide
CPC-N::SB216763
JHOS-3::Doramapimod
SU8686::Obatoclax Mesylate
HPAF-II::IWP-2
RT-112::Nutlin-3a (-)
CPC-N::Cytarabine
WM-115::AZD7762
RT-112::GNE-317
NCI-H1993::GSK343
EFO-21::LY2109761
CAL-29::BI-2536
HCC1143::OTX015
DMS-114::Vismodegib
HCC1143::KRAS (G12C) Inhibitor-12
WM-115::LGK974
ESO51::Talazoparib
SN12C::AZD5582
LC-2-ad::MK-1775
WM-115::Savolitinib
NALM-6::AZD3759
RT-112::Olaparib
LC-2-ad::Vinorelbine
GA-10::Alisertib
ESO51::Vismodegib
MEL-HO::Bortezomib
KARPAS-620::Sorafenib
D-566MG::ABT737
WM-115::BMS-345541
SIMA::Temsirolimus
LC-2-ad::MK-8776
NALM-6::Gefitinib
KGN::Dasatinib
SU8686::Osimertinib
WM-115::Bosutinib
RT-112::OF-1
SIMA::P22077
LB2241-RCC::Sabutoclax
ESO51::RO-3306
NALM-6::RO-3306
LB2241-RCC::AZ6102
TE-4::YK-4-279
KP-4::IWP-2
KARPAS-620::LY2109761
ESO51::Avagacestat
Becker::Axitinib
D-566MG::Linsitinib
EFO-21::Refametinib
LU-135::Obatoclax Mesylate
LB2241-RCC::BMS-345541
LB2241-RCC::ML323
SN12C::Venetoclax
EW-22::UMI-77
LU-135::AGI-6780
LB647-SCLC::Pevonedistat
U031::AZD6482
CHP-134::Nilotinib
WM-115::Palbociclib
AU565::Pictilisib
NCI-H1623::KU-55933
CP50-MEL-B::NVP-ADW742
LS-1034::Refametinib
CHP-134::BIBR-1532
LU-135::BMS-345541
RT-112::Venetoclax
HPAF-II::Pevonedistat
DMS-114::MK-1775
NALM-6::Trametinib
LC-2-ad::Sapitinib
NCI-H1623::EHT-1864
EFO-21::PRT062607
DMS-114::Afuresertib
NALM-6::Afuresertib
UMC-11::AZD3759
MEL-HO::BMS-345541
CAL-29::NVP-ADW742
JHOS-3::SB216763
CHP-134::Fulvestrant
LS-1034::PFI-1
A388::PCI-34051
NCI-H1623::Trametinib
NCI-H1993::Cisplatin
TE-4::AZ6102
HCC1143::5-Fluorouracil
ESO51::Gemcitabine
KARPAS-620::GDC0810
Becker::KRAS (G12C) Inhibitor-12
LC-2-ad::OF-1
A388::AGI-5198
WM-115::Methotrexate
LS-1034::AZD6738
KARPAS-620::NU7441
OCI-M1::Vinblastine
LC-2-ad::Osimertinib
RT-112::Ribociclib
EW-22::Dactolisib
SU8686::LCL161
CP50-MEL-B::Dinaciclib
A388::SB505124
D-566MG::Venetoclax
CAL-29::I-BET-762
JHOS-3::Axitinib
NUGC-4::GSK2830371
DMS-114::OTX015
UMC-11::Selumetinib
LS-1034::Trametinib
ESO51::Nutlin-3a (-)
TE-4::UMI-77
DMS-114::Vinorelbine
WM-115::PLX-4720
DMS-114::Vinblastine
UMC-11::Rapamycin
LU-135::Vinblastine
GA-10::CCT007093
NOS-1::Palbociclib
LS-1034::VX-11e
KARPAS-620::Vismodegib
NALM-6::Cediranib
CP50-MEL-B::Telomerase Inhibitor IX
KGN::Rapamycin
SN12C::Wnt-C59
NALM-6::Epirubicin
TE-4::Palbociclib
KCL-22::Vinblastine
RT-112::KRAS (G12C) Inhibitor-12
Becker::WIKI4
LU-135::SGC0946
HPAF-II::BIBR-1532
UMC-11::GDC0810
EFO-21::Rapamycin
RT-112::LCL161
SU8686::Cediranib
NALM-6::WZ4003
LU-135::Niraparib
SU8686::Temsirolimus
UMC-11::AZD8186
CAL-29::Afatinib
NALM-6::Docetaxel
OCI-M1::Entinostat
AU565::Entospletinib
Becker::WZ4003
CPC-N::Ibrutinib
KGN::Epirubicin
HPAF-II::Sepantronium bromide
AU565::Sorafenib
D-566MG::Sabutoclax
KARPAS-620::TW 37
OCI-M1::Uprosertib
KP-4::Pictilisib
CP50-MEL-B::Piperlongumine
JHOS-3::GSK2578215A
NCI-H1993::MIM1
GA-10::Trametinib
NUGC-4::IWP-2
CAL-29::GSK591
NOS-1::Alisertib
SU8686::ABT737
KCL-22::LJI308
Becker::Navitoclax
KGN::RO-3306
LC-2-ad::Leflunomide
EW-22::Cytarabine
A388::SN-38
UMC-11::VE821
DMS-114::OF-1
WM-115::Luminespib
LB647-SCLC::Sorafenib
OCI-M1::AGI-5198
CAL-29::Vorinostat
NUGC-4::Leflunomide
LC-2-ad::BMS-536924
KARPAS-620::GSK1904529A
DMS-114::Dactolisib
SN12C::GSK2578215A
SN12C::AGI-6780
A388::IWP-2
LS-1034::Venetoclax
KCL-22::Afuresertib
LC-2-ad::Piperlongumine
RT-112::Ruxolitinib
KCL-22::Venetoclax
LU-135::RVX-208
HPAF-II::BMS-536924
NCI-H1993::GSK2830371
CPC-N::GDC0810
KGN::Cisplatin
KCL-22::Ruxolitinib
SN12C::Serdemetan
EFO-21::GSK2606414
SU8686::Wee1 Inhibitor
LU-135::IWP-2
LB2241-RCC::MIRA-1
CHP-134::Wee1 Inhibitor
LS-1034::Crizotinib
LC-2-ad::Uprosertib
EW-22::Veliparib
TE-4::Veliparib
SU8686::AZD6738
EFO-21::Cytarabine
LS-1034::Sabutoclax
Becker::Oxaliplatin
LC-2-ad::Dabrafenib
LS-1034::PD0325901
MEL-HO::Sapitinib
GA-10::Bleomycin (50 uM)
LB647-SCLC::KRAS (G12C) Inhibitor-12
KP-4::JQ1
HPAF-II::LJI308
SN12C::Pyridostatin
U031::CCT-018159
LB2241-RCC::SB505124
WM-115::Camptothecin
D-566MG::MK-8776
KCL-22::Cytarabine
GA-10::Fulvestrant
KCL-22::Palbociclib
NALM-6::Afatinib
U031::OTX015
OCI-M1::PRT062607
RT-112::Pictilisib
U031::Uprosertib
EFO-21::Navitoclax
LB647-SCLC::Bosutinib
A388::Lapatinib
LC-2-ad::P22077
EW-22::SCH772984
DMS-114::GNE-317
SN12C::AZD6738
KP-4::BMS-536924
JHOS-3::LY2109761
AU565::LY2109761
A388::OF-1
OCI-M1::Epirubicin
Becker::Rucaparib
AU565::Epirubicin
ESO51::AGI-5198
JHOS-3::Refametinib
LU-135::Docetaxel
KP-4::Crizotinib
SU8686::Oxaliplatin
EFO-21::Niraparib
MEL-HO::I-BET-762
LB2241-RCC::RO-3306
JHOS-3::Epirubicin
NCI-H1623::Epirubicin
JHOS-3::VE821
NOS-1::Navitoclax
RT-112::NU7441
CAL-29::Foretinib
OCI-M1::Serdemetan
GA-10::PD173074
NUGC-4::Entinostat
A388::Daporinad
NUGC-4::AZ960
D-566MG::NVP-ADW742
NALM-6::Crizotinib
LB647-SCLC::Ipatasertib
JHOS-3::WZ4003
D-566MG::Axitinib
ESO51::Entospletinib
WM-115::GNE-317
U031::Paclitaxel
LU-135::OF-1
WM-115::Rapamycin
NALM-6::GSK2578215A
LS-1034::MN-64
UMC-11::AZD5582
NOS-1::Linsitinib
SIMA::Picolinici-acid
OCI-M1::Docetaxel
Becker::Picolinici-acid
CP50-MEL-B::Afatinib
HCC1143::Bosutinib
DMS-114::UMI-77
EW-22::Refametinib
RT-112::EPZ5676
ESO51::Sepantronium bromide
HPAF-II::Ipatasertib
KGN::AZD4547
HCC1143::AZD8186
RT-112::OTX015
EW-22::LGK974
JHOS-3::Tamoxifen
RT-112::Afatinib
KGN::BIBR-1532
LB647-SCLC::Axitinib
TE-4::Lapatinib
NUGC-4::Bosutinib
CP50-MEL-B::Foretinib
JHOS-3::P22077
KARPAS-620::Erlotinib
EFO-21::Ribociclib
U031::GSK591
SN12C::Sapitinib
EFO-21::Temozolomide
NCI-H1993::PRT062607
WM-115::SN-38
KCL-22::MK-2206
WM-115::SB216763
HPAF-II::Obatoclax Mesylate
ESO51::Taselisib
CPC-N::PRT062607
TE-4::Vorinostat
KCL-22::Tanespimycin
CP50-MEL-B::LY2109761
WM-115::Vismodegib
A388::EPZ5676
LU-135::CZC24832
LS-1034::PD173074
HPAF-II::Pyridostatin
CHP-134::Picolinici-acid
UMC-11::GNE-317
TE-4::Entinostat
SN12C::MG-132
EFO-21::OTX015
HPAF-II::Luminespib
NCI-H1993::Camptothecin
CAL-29::I-BRD9
U031::MIRA-1
CPC-N::CCT007093
KCL-22::Sabutoclax
CP50-MEL-B::WEHI-539
KP-4::Ipatasertib
LC-2-ad::PRIMA-1MET
U031::Vorinostat
LB2241-RCC::EPZ5676
MEL-HO::Alpelisib
LC-2-ad::I-BRD9
NCI-H1993::Nutlin-3a (-)
HCC1143::Sapitinib
NCI-H1623::XAV939
TE-4::SGC0946
D-566MG::GDC0810
UMC-11::AZD8055
HPAF-II::Cisplatin
LS-1034::Obatoclax Mesylate
U031::ABT737
CAL-29::Pevonedistat
GA-10::MK-2206
U031::RVX-208
CPC-N::Methotrexate
HPAF-II::KRAS (G12C) Inhibitor-12
NCI-H1623::CZC24832
D-566MG::Temozolomide
KP-4::NU7441
LU-135::Talazoparib
WM-115::VE-822
WM-115::AZD4547
NCI-H1623::GNE-317
MEL-HO::Sabutoclax
LB647-SCLC::PLX-4720
OCI-M1::Afatinib
JHOS-3::Gemcitabine
NUGC-4::CCT007093
LC-2-ad::Tozasertib
DMS-114::Veliparib
TE-4::EPZ5676
DMS-114::ML323
KP-4::Tamoxifen
KP-4::Alisertib
LB647-SCLC::Niraparib
GA-10::Vismodegib
LB647-SCLC::EPZ5676
NCI-H1623::OSI-027
GA-10::GSK2606414
JHOS-3::Luminespib
NOS-1::OTX015
NALM-6::ML323
LS-1034::Cediranib
NCI-H1993::CCT007093
HPAF-II::GDC0810
NCI-H1993::IWP-2
NUGC-4::UMI-77
OCI-M1::LY2109761
DMS-114::VX-11e
NALM-6::Nutlin-3a (-)
NOS-1::Venetoclax
OCI-M1::XAV939
SIMA::AZ6102
DMS-114::BI-2536
GA-10::LJI308
DMS-114::ABT737
OCI-M1::Oxaliplatin
HCC1143::LGK974
CPC-N::Wee1 Inhibitor
A388::OTX015
WM-115::Daporinad
EW-22::Telomerase Inhibitor IX
UMC-11::Ruxolitinib
LB2241-RCC::Vinorelbine
OCI-M1::CZC24832
MEL-HO::LCL161
AU565::VX-11e
SU8686::PLX-4720
EW-22::XAV939
U031::AZD6738
DMS-114::Daporinad
NOS-1::Foretinib
CAL-29::IWP-2
UMC-11::AZD6738
A388::AZD3759
EW-22::PRIMA-1MET
KCL-22::AZD4547
HPAF-II::XAV939
LC-2-ad::GSK2606414
CAL-29::PLX-4720
MEL-HO::AGI-6780
AU565::Fulvestrant
A388::Linsitinib
CHP-134::Sabutoclax
SN12C::Foretinib
SN12C::AZ6102
SIMA::MIRA-1
KP-4::TW 37
KCL-22::AZD7762
KP-4::PRIMA-1MET
MEL-HO::Pictilisib
KGN::Oxaliplatin
KP-4::PFI3
NOS-1::PFI-1
SU8686::LJI308
LB647-SCLC::PF-4708671
DMS-114::Pictilisib
SU8686::Erlotinib
LB2241-RCC::Dasatinib
HPAF-II::NVP-ADW742
KCL-22::LCL161
SIMA::WZ4003
CPC-N::Cisplatin
NOS-1::Axitinib
KARPAS-620::AZ6102
TE-4::OSI-027
KP-4::Entospletinib
U031::SB505124
SN12C::Selumetinib
TE-4::KRAS (G12C) Inhibitor-12
HCC1143::Ipatasertib
HPAF-II::Doramapimod
TE-4::XAV939
MEL-HO::MG-132
CPC-N::MK-8776
WM-115::ZM447439
LC-2-ad::Palbociclib
GA-10::SB590885
HPAF-II::Cediranib
NCI-H1993::Oxaliplatin
CPC-N::GSK1904529A
LC-2-ad::Niraparib
CP50-MEL-B::Navitoclax
ESO51::AMG-319
EW-22::NU7441
AU565::Dinaciclib
LC-2-ad::Bortezomib
NUGC-4::Bortezomib
SIMA::PD0325901
HPAF-II::AZD7762
WM-115::Doramapimod
KP-4::Fulvestrant
EW-22::TW 37
EW-22::5-Fluorouracil
KP-4::PCI-34051
NALM-6::Lenalidomide
KARPAS-620::Temozolomide
CP50-MEL-B::Linsitinib
DMS-114::Fulvestrant
HCC1143::Linsitinib
KCL-22::SN-38
TE-4::Epirubicin
TE-4::Nilotinib
NCI-H1993::SB216763
Becker::Afuresertib
CHP-134::Venetoclax
KP-4::I-BRD9
LC-2-ad::GSK1904529A
NCI-H1993::ML323
WM-115::Cisplatin
KARPAS-620::Cisplatin
WM-115::MK-8776
AU565::WEHI-539
JHOS-3::MK-1775
EW-22::Serdemetan
CP50-MEL-B::AZD6482
GA-10::LY2109761
GA-10::EHT-1864
NALM-6::MG-132
D-566MG::LJI308
LU-135::Wee1 Inhibitor
KARPAS-620::Wnt-C59
Becker::Leflunomide
AU565::Talazoparib
CAL-29::Camptothecin
NALM-6::AZD6738
AU565::Crizotinib
LU-135::Crizotinib
EW-22::PD173074
CPC-N::GW441756
CP50-MEL-B::Gefitinib
KARPAS-620::5-Fluorouracil
RT-112::RO-3306
CPC-N::WEHI-539
LC-2-ad::GSK343
CHP-134::MK-8776
KARPAS-620::Afatinib
JHOS-3::AGI-5198
CAL-29::EPZ004777
SIMA::SCH772984
ESO51::Selumetinib
LB647-SCLC::Camptothecin
SN12C::Fulvestrant
LB2241-RCC::YK-4-279
TE-4::AZD3759
LB2241-RCC::Ruxolitinib
EFO-21::Cyclophosphamide
WM-115::Afatinib
NCI-H1993::Afatinib
KP-4::MK-2206
CAL-29::OF-1
LU-135::Sabutoclax
HCC1143::BIBR-1532
JHOS-3::SB590885
TE-4::ABT737
SU8686::Telomerase Inhibitor IX
LS-1034::VE821
KP-4::AGI-5198
HCC1143::BMS-536924
MEL-HO::Niraparib
SU8686::Entospletinib
A388::VX-11e
OCI-M1::Motesanib
TE-4::SB590885
NUGC-4::Alisertib
WM-115::GSK1904529A
KP-4::LGK974
MEL-HO::WIKI4
CPC-N::MK-1775
SIMA::EPZ5676
D-566MG::PD0325901
A388::Dasatinib
D-566MG::Dabrafenib
CHP-134::AMG-319
EFO-21::Leflunomide
LB647-SCLC::JQ1
RT-112::Lenalidomide
CHP-134::AGI-5198
HCC1143::Sepantronium bromide
NCI-H1993::Rucaparib
SU8686::Sorafenib
EFO-21::Tamoxifen
GA-10::LCL161
CP50-MEL-B::Nutlin-3a (-)
LS-1034::MIRA-1
ESO51::Alisertib
EW-22::WEHI-539
SU8686::Ibrutinib
OCI-M1::PD0325901
SN12C::OSI-027
LU-135::MK-8776
D-566MG::Selumetinib
KGN::EPZ004777
NALM-6::AGI-5198
SU8686::VE-822
U031::AZD7762
HCC1143::BMS-345541
LC-2-ad::Oxaliplatin
GA-10::RO-3306
LS-1034::5-Fluorouracil
NCI-H1993::AZD6738
ESO51::Ribociclib
KARPAS-620::Docetaxel
LS-1034::Ribociclib
GA-10::AZD5582
LC-2-ad::ML323
NOS-1::NU7441
GA-10::Ipatasertib
LB2241-RCC::Taselisib
D-566MG::Osimertinib
CAL-29::Lenalidomide
LB2241-RCC::Daporinad
LB2241-RCC::IOX2
NOS-1::Ribociclib
SIMA::MIM1
NUGC-4::Picolinici-acid
ESO51::SB216763
NCI-H1623::GSK1904529A
Becker::LCL161
Becker::EPZ004777
GA-10::KRAS (G12C) Inhibitor-12
KP-4::Camptothecin
MEL-HO::NVP-ADW742
HCC1143::Luminespib
SU8686::Irinotecan
D-566MG::Dinaciclib
NCI-H1993::GDC0810
A388::Palbociclib
EW-22::GSK2606414
LB2241-RCC::P22077
NALM-6::WIKI4
SN12C::LJI308
SU8686::AMG-319
DMS-114::Lestaurtinib
CPC-N::Temsirolimus
LB647-SCLC::LY2109761
LB2241-RCC::Linsitinib
HCC1143::EPZ5676
SIMA::Foretinib
NCI-H1623::MK-8776
D-566MG::Paclitaxel
EW-22::NVP-ADW742
SN12C::Veliparib
LB647-SCLC::Dasatinib
SN12C::Vinorelbine
RT-112::TW 37
LC-2-ad::AGI-5198
HPAF-II::Cytarabine
UMC-11::KRAS (G12C) Inhibitor-12
EW-22::VE821
CPC-N::ML323
CPC-N::LJI308
KGN::Nutlin-3a (-)
UMC-11::Axitinib
NCI-H1623::5-Fluorouracil
KP-4::PFI-1
KARPAS-620::Lenalidomide
WM-115::Tanespimycin
U031::Methotrexate
NCI-H1993::Temozolomide
ESO51::AZ960
SU8686::Savolitinib
MEL-HO::Nilotinib
WM-115::Alpelisib
KARPAS-620::PFI-1
LB2241-RCC::Afatinib
CP50-MEL-B::Palbociclib
WM-115::Wee1 Inhibitor
UMC-11::SB590885
Becker::Alpelisib
CAL-29::OSI-027
SN12C::MIM1
EW-22::Nutlin-3a (-)
CAL-29::NU7441
SIMA::Gemcitabine
JHOS-3::Lestaurtinib
D-566MG::JQ1
OCI-M1::Vorinostat
RT-112::LY2109761
KP-4::AZD5582
AU565::Sabutoclax
DMS-114::Afatinib
DMS-114::RO-3306
LU-135::LGK974
Becker::OTX015
EW-22::BMS-536924
LB647-SCLC::Ibrutinib
UMC-11::Obatoclax Mesylate
KP-4::Sorafenib
EW-22::AZD5582
OCI-M1::PFI3
LU-135::Savolitinib
AU565::EPZ004777
LU-135::EHT-1864
A388::Erlotinib
D-566MG::GSK591
NCI-H1993::Irinotecan
NOS-1::CCT007093
KCL-22::Dabrafenib
D-566MG::KRAS (G12C) Inhibitor-12
LB647-SCLC::BX795
NCI-H1993::JQ1
LU-135::SB590885
JHOS-3::XAV939
CHP-134::XAV939
LU-135::Cediranib
CAL-29::MG-132
NCI-H1623::PD0325901
LB2241-RCC::AZD8186
LS-1034::Uprosertib
UMC-11::Tanespimycin
LB647-SCLC::I-BRD9
SU8686::OTX015
AU565::Tamoxifen
CHP-134::Ruxolitinib
SN12C::MK-2206
KCL-22::PCI-34051
UMC-11::JQ1
SIMA::Wnt-C59
LB2241-RCC::RVX-208
KARPAS-620::VE-822
SIMA::VE-822
UMC-11::BMS-536924
LS-1034::Oxaliplatin
CHP-134::Dasatinib
KCL-22::ZM447439
LU-135::Sapitinib
CHP-134::Afatinib
AU565::MK-8776
SU8686::Nilotinib
GA-10::Lestaurtinib
KCL-22::YK-4-279
U031::GSK2606414
EW-22::Irinotecan
Becker::SB590885
DMS-114::AZD4547
LB647-SCLC::Doramapimod
SN12C::Nilotinib
LB647-SCLC::Elesclomol
TE-4::SCH772984
AU565::GNE-317
HCC1143::Wee1 Inhibitor
UMC-11::Dasatinib
LS-1034::Selumetinib
EW-22::VE-822
SN12C::5-Fluorouracil
TE-4::VE-822
LB2241-RCC::OTX015
LB2241-RCC::Savolitinib
HCC1143::AGI-6780
KP-4::Sabutoclax
CPC-N::CZC24832
AU565::Camptothecin
Becker::WEHI-539
CP50-MEL-B::BMS-345541
SU8686::Alpelisib
SU8686::SB216763
AU565::Alisertib
CPC-N::ZM447439
EW-22::MK-2206
NCI-H1993::EPZ5676
CP50-MEL-B::OSI-027
NCI-H1993::UMI-77
LB647-SCLC::GSK2578215A
LS-1034::Nutlin-3a (-)
SN12C::Talazoparib
AU565::SN-38
LC-2-ad::ZM447439
EFO-21::WZ4003
JHOS-3::Olaparib
HPAF-II::JNK Inhibitor VIII
LB647-SCLC::Sepantronium bromide
NOS-1::SN-38
LB2241-RCC::Crizotinib
LU-135::Refametinib
AU565::Cyclophosphamide
NOS-1::Temsirolimus
D-566MG::AZD8186
D-566MG::AZD6738
A388::IOX2
HCC1143::P22077
LC-2-ad::RVX-208
EW-22::PLX-4720
ESO51::Bortezomib
UMC-11::Bleomycin (50 uM)
KGN::Refametinib
JHOS-3::ML323
CPC-N::Rucaparib
Becker::Trametinib
UMC-11::Ribociclib
DMS-114::AZ960
GA-10::BI-2536
NUGC-4::SB216763
GA-10::GSK1904529A
LS-1034::Cisplatin
LS-1034::AGI-6780
KARPAS-620::Telomerase Inhibitor IX
NALM-6::BMS-536924
NUGC-4::MN-64
DMS-114::Leflunomide
KP-4::Osimertinib
NCI-H1623::AZD5582
NCI-H1623::AZD8186
ESO51::IWP-2
EW-22::Talazoparib
WM-115::Bortezomib
NUGC-4::Avagacestat
JHOS-3::Avagacestat
HCC1143::RVX-208
CPC-N::Pyridostatin
LB2241-RCC::PRT062607
JHOS-3::Tozasertib
SIMA::XAV939
KP-4::Rapamycin
NCI-H1993::MN-64
ESO51::Dactolisib
NALM-6::EHT-1864
HCC1143::Sorafenib
KGN::BI-2536
RT-112::Bortezomib
NUGC-4::PRIMA-1MET
TE-4::OTX015
MEL-HO::CHIR-99021
TE-4::PCI-34051
MEL-HO::Pyridostatin
LB2241-RCC::AZD6482
HCC1143::LJI308
UMC-11::GW441756
KP-4::AZD6738
KCL-22::Olaparib
Becker::PD0325901
SN12C::Bortezomib
NCI-H1993::Temsirolimus
KARPAS-620::EHT-1864
KCL-22::KU-55933
NALM-6::Luminespib
EFO-21::TW 37
OCI-M1::RVX-208
LS-1034::AZD3759
NOS-1::SGC0946
RT-112::GSK343
DMS-114::NU7441
NOS-1::Camptothecin
RT-112::GSK2830371
RT-112::AZD5582
EFO-21::Paclitaxel
CAL-29::Nutlin-3a (-)
NOS-1::Nutlin-3a (-)
U031::PRIMA-1MET
JHOS-3::Nutlin-3a (-)
NUGC-4::Doramapimod
EFO-21::Cediranib
NALM-6::Temozolomide
LB2241-RCC::Lapatinib
RT-112::MK-2206
ESO51::WIKI4
CP50-MEL-B::OTX015
CHP-134::Osimertinib
LS-1034::AMG-319
KCL-22::SGC0946
RT-112::ZM447439
CHP-134::Luminespib
WM-115::5-Fluorouracil
A388::Wee1 Inhibitor
CPC-N::Bortezomib
KARPAS-620::WEHI-539
EFO-21::NU7441
OCI-M1::EPZ5676
LS-1034::AZD8055
MEL-HO::Piperlongumine
UMC-11::BIBR-1532
NUGC-4::Vinblastine
MEL-HO::AZD6738
AU565::Osimertinib
A388::SGC0946
NUGC-4::PRT062607
EW-22::CCT007093
KARPAS-620::Camptothecin
NCI-H1623::MIM1
GA-10::ML323
RT-112::Bleomycin (50 uM)
CHP-134::Alpelisib
NALM-6::VE-822
SU8686::PRT062607
LU-135::BIBR-1532
TE-4::WIKI4
HCC1143::Temsirolimus
GA-10::Osimertinib
CP50-MEL-B::Sepantronium bromide
HCC1143::AZD4547
RT-112::Foretinib
EFO-21::5-Fluorouracil
SU8686::AZD8186
AU565::VE-822
ESO51::Luminespib
NUGC-4::Refametinib
NCI-H1623::Luminespib
ESO51::Temsirolimus
OCI-M1::NVP-ADW742
CP50-MEL-B::AZD5582
LU-135::Linsitinib
SIMA::PCI-34051
A388::GSK343
EW-22::MIM1
ESO51::Tamoxifen
KARPAS-620::Leflunomide
NCI-H1623::Lenalidomide
NCI-H1623::NU7441
WM-115::Uprosertib
A388::Tretinoin
GA-10::AMG-319
WM-115::VX-11e
HPAF-II::PRT062607
ESO51::EPZ5676
MEL-HO::Navitoclax
CAL-29::Docetaxel
TE-4::Docetaxel
CHP-134::Pevonedistat
NCI-H1993::Olaparib
EFO-21::Gefitinib
RT-112::Motesanib
NUGC-4::I-BET-762
OCI-M1::Bleomycin (50 uM)
A388::CHIR-99021
LB647-SCLC::Tamoxifen
DMS-114::SB590885
NCI-H1993::Serdemetan
AU565::Refametinib
NCI-H1993::JNK Inhibitor VIII
KGN::EPZ5676
MEL-HO::Cyclophosphamide
AU565::Dabrafenib
TE-4::AZD7762
WM-115::Vinblastine
NOS-1::CZC24832
LB2241-RCC::Avagacestat
AU565::Gefitinib
CHP-134::BMS-536924
LS-1034::EPZ5676
D-566MG::GW441756
AU565::EPZ5676
CP50-MEL-B::Ibrutinib
GA-10::WEHI-539
DMS-114::GSK343
SIMA::Osimertinib
AU565::PD0325901
GA-10::Palbociclib
UMC-11::Irinotecan
SU8686::PRIMA-1MET
HCC1143::PD173074
AU565::EHT-1864
SU8686::Ruxolitinib
D-566MG::PLX-4720
SN12C::I-BRD9
KGN::LJI308
KARPAS-620::AZ960
UMC-11::Pictilisib
LC-2-ad::CCT007093
NUGC-4::Telomerase Inhibitor IX
SN12C::KU-55933
SU8686::Dasatinib
AU565::AZD8186
NOS-1::Olaparib
KP-4::Selumetinib
D-566MG::Ipatasertib
KCL-22::PRT062607
Becker::SB216763
KARPAS-620::Olaparib
HPAF-II::GSK1904529A
GA-10::Vorinostat
KARPAS-620::ML323
SU8686::GSK2830371
AU565::JQ1
CP50-MEL-B::KU-55933
SU8686::Docetaxel
HPAF-II::EPZ5676
GA-10::Paclitaxel
HCC1143::AMG-319
LU-135::Veliparib
CHP-134::Sepantronium bromide
UMC-11::YK-4-279
NUGC-4::Irinotecan
EFO-21::Oxaliplatin
HCC1143::AZD7762
CPC-N::Uprosertib
SN12C::Entospletinib
A388::Afuresertib
Becker::Telomerase Inhibitor IX
HPAF-II::Wee1 Inhibitor
SIMA::UMI-77
LS-1034::Epirubicin
